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Abstract
Abstract
In the post-genomic era of biological research, integrative studies, examining how low- 
level biological components “re-assemble” into organised systems are becoming 
increasingly common. Integrative approaches of the past have often been limited by the 
complexity of systems of interest and by the techniques available to visualise and 
quantify biological events. Recently there have been significant advances in techniques 
to measure dynamic and complex intra-cellular phenomena. Importantly, these have 
included higher-throughput, quantitative experimental approaches using fluorescent 
protein fusions. It is now possible to take advantage of such quantitative data to 
construct mathematical models that are capable of simulating the complexities found in 
many dynamical systems. The success of future systems-level studies lies in the 
strength of such interdisciplinary approaches.
The data presented here represent an application of interdisciplinary Systems Biology 
to characterise interactions between two intra-cellular signalling systems; E2F-1 
involved in cell cycle regulation, and NF-k B, involved in inflammatory responses and 
cancer. These two systems are both “oscillatory”, as one or more of their components 
changes regularly over time in their predominant localisation within an individual cell 
(eg. NF-k B, with a time scale of minutes) or concentration and stability (eg. E2F-1, with 
a time scale of hours).
Evidence is presented for both physical and functional interactions between 
components of the NF-k B and E2F-1 systems. Physical binding between NF-k B 
proteins and E2F-1 was determined by Forster Resonance Energy Transfer (FRET) 
and Co-lmmunoprecipitation. This supported concurrent live cell imaging data 
suggesting ectopically expressed E2F-1 was able to sequester NF-k B in the nucleus, 
altering its dynamics in response to TNFa stimulation. Due to the complex nature of 
these dynamics, it was necessary to develop a predicative mathematical model for the 
interactions between the NF-k B system and E2F-1. The model was fitted to quantified 
live cell imaging data, and subsequently used to make non-intuitive predictions for 
system behaviour, including the suspension of nucleo-cytoplasmic oscillations in 
response to TNFa in the presence of E2F-1, and a difference in degradation rate of 
E2F-1 between cellular compartments. Validation of model predictions involved 
investigations into the functional effects of these interactions. Quantitative PCR and 
Luciferase Reporter Assays were used to examine transcriptional activity associated 
with exogenous expression of NF-k B and E2F-1. These data suggested that certain 
target genes (Ik Bo and Ik Be for NF-k B and Cyclin E for E2F-1) are repressed. 
Concurrently, ectopic expression of NF-k B was able to rescue -40%  of cells from 
apoptosis associated with ectopic expression of E2F-1. The relationship between 
endogenous NF-k B and E2F-1 was investigated by addition of TNFa at different times 
after release from a cell cycle block. Both live cell imaging and Immuno-cytochemistry 
showed different NF-k B dynamics in response to stimulus at G1/S (when E2F-1 
reaches peak levels) in synchronised cells compared to normally cycling cells. 
Considered together, these data suggested that the signalling dynamics of NF-k B 
regulated in a cell cycle-dependant manner. The integration of such oscillatory systems 
over different time-scales presents a paradigm for the coupling of similar systems in 
general. The physiological implications of cell cycle control in the dynamics of 
responses are also considered, through the development of a hypothetical “balance” 
model based on the presented data and the emergent view from current literature.
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Introduction I -  Systems Approaches to Biological Research
1.1 Introduction I - Systems approaches to biological research
1.1.1 What is Systems Biology?
Definitions of Systems Biology vary, albeit with common principles. The Biotechnology 
and Biological Sciences Research Council (BBSRC) characterises a Systems Biology 
approach broadly as “...placing a greater emphasis on the interactions between 
components, and the consequences of such interactions, than on the components 
themselves (BBSRC Website 2008). Put simplistically, there is a need to appreciate the 
context of biological phenomena. As such, “integration” of biological processes has 
now become favourable to “reduction” of systems to their components, which, in a post- 
genomic era, may be largely known. The Systems Biology approach may be 
considered “integrative” in a number of further ways, most obviously by bringing 
together scientists from different disciplines, The Institute for Systems Biology (ISB) 
characterise Systems Biology as “...the study of an organism, viewed as an integrated 
and interacting network of genes, proteins and biochemical reactions which give rise to 
life... aided by the infusion of scientists from other disciplines...” (SystemsBiology.org 
2008). However, interdisciplinary approaches are by no means novel in Biology (Lotka 
1925; Volterra 1926; Hodgkin et al. 1952). Denis Noble, pioneer of arguably the 
longest-standing Systems Biology approach, modelling Ion channels in the human 
heart (Noble 2006) argues that their increasing popularity in recent times is 
symptomatic of a change in thinking: “[Systems Biology]...is about putting together 
rather than taking apart, integration rather than reduction. It requires that we develop 
ways of thinking about integration that are as rigorous as our reductionist programmes, 
but different....lt means changing our philosophy, in the full sense of the term” (Noble 
2006). One might argue that in order to deal with the rise in complexity brought about 
by systems-level approaches, mathematical models are becoming essential, 
interdisciplinary collaboration is now a necessity.
Systems Biology applied to the study of intra-cellular signalling is best illustrated with 
an example. Consider two proteins ‘X’ and Y  which display evidence of physical 
interaction when examined. Many characteristics of the X:Y interaction, such as 
quantification of relative protein levels, analysis of their dynamics over time, and 
response to stimuli may be investigated in isolation from networks of proteins that may
2
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also interact with X and Y. The picture of X:Y has in effect been simplified, or reduced. 
This reductionist approach may take us a long way towards quantifying the observed 
behaviour of X and Y in terms of space and time and with the mathematical tools it may 
even be possible to build a computer model which mimics an interaction between X 
and Y.
However, the reductionist approach is not enough to fully characterise such an 
interaction because it lacks an appreciation for context. It has emerged over a number 
of years that single genes cannot usually be attributed to single phenomena, and that 
proteins do not act in isolation but rather in collaborative networks or systems (Noble 
2006). As such, a study of X and Y may give interesting results, but this is arguably 
less important from a physiological viewpoint, than the behaviour of the system or 
systems in which they act, their context. Investigating the behaviour of single biological 
entities whilst maintaining an appreciation for their role as components in larger 
systems is the essence of Systems Biology.
1.1.2 Integration in the Systems Biology approach
Despite presenting an alternative to reductionist approaches, systems-level 
approaches are able to incorporate data from such studies. Such approaches applied 
to intra-cellular signalling may draw upon quantitative data gathered from bulk cell and 
single cell based experimental work, as well as from high-throughput proteomic, 
transcriptomic and bioinformatic techniques. Integration of data from a variety of 
sources helps to form a central conceptual picture or “model”, allowing entire systems 
to be mapped out (Kohn 1999; Kohn et at. 2006). Conceptual models are key to 
assessing the roles of individual components and therefore provide the basis of a 
Systems Biology approach. However, as the complexity of these systems increases (if 
for example protein X regulates the transcription of an inhibitor protein, generating 
negative feedback), holistic appreciation of system dynamics may prove difficult from a 
conceptual model alone.
However, with a conceptual model at its foundation, the Systems Biology approach can 
be taken a step further, turning conceptual models into mathematical in-silico models. 
For a mathematical Systems Biology approach, Mathematics, Computer Science and 
Biology may overlap, combining advanced techniques to both measure and quantify
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experimental data with predictive modelling techniques to provide a dynamic view of an 
entire system, that is able to test (and hence make predictions for) the effect of 
changes to individual systems components (such as protein X) to the overall systemic 
context. As such, integration of techniques from different disciplines provides a further 
strength of the Systems Biology approach.
It is important to note that in addition to being integrative in terms of approach, Systems 
Biology often aims to be integrative in terms of results, resolving linked processes 
across different time scales (such as stress signalling and the cell cycle) or 
physiological scales (such and cellular and tissue). This is considered in greater detail 
below (Section 1.1.6)
1.1.3 Requirements of Mathematics in Systems Biology
Interdisciplinary Systems Biology approaches are becoming increasingly popular 
(Sauer et at. 2007), to the extent that “Systems Biology” itself is often synonymous with 
“mathematical modelling”. This may be misleading as mathematical modelling may 
equally be applied to reductionist studies as much as to Systems Biology. As such, 
care must be taken to apply mathematical approaches appropriately. A well-formed 
mathematical Systems Biology approach requires three elements; a biological context 
on which the current conceptual view of a system is based, the ability to make a 
hypothetical prediction for system behaviour and the experimental means with which to 
provide an answer which resolves the prediction. We shall now consider each of these 
requirements in greater detail.
1.1.3.1 Biological context
There is a calculated risk to defining biological systems as models. Model boundaries 
must be defined to include processes driving systemic behaviour, whilst simplifying less 
important processes, hence reducing complexity and allowing a conceptual model to be 
clearer, or a mathematical model to be more easily fitted. Definition of the context for a 
model is therefore highly subjective. Indeed, defining the boundary or “level of 
abstraction” of a system has principles deeply rooted in Applied Mathematics and 
Computer Science and is arguably best approached from a philosophical stand-point 
(Wright 1983; Colburn etal. 2007; Floridi 2008)
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Figure 1.1 shows a step-wise approach to coupling intracellular signalling systems 
linked by interacting proteins ‘X ’ and Y .  Firstly, models are defined for each system 
(A1 and A2 in Figure 1.1). Once the separate models are fitted, the interaction between 
X and Y may be modelled through boundary expansion encompassing either “the effect 
of Y on system 1” or “the effect of X on system 2”, as an intermediate step (A#). An A#- 
type model may be expanded further to define a model for both “linked” systems (B).
Figure 1.1 Stepwise approach to coupling linked systems in Systems Biology: A1 and A2
Showing models defined for system 1 and system 2 respectively involving processes which may 
occur over different temporal or physiological scales. Systems 1 and 2 have unique, or separable, 
inputs and outputs with respect to each other. A# Model A2 is expanded to include interaction 
between protein Y  (system 2) and protein ‘X’ (system 1). Interaction between X and Y may now be 
considered within the context of system 2. B Once characterised, model A# may be expanded 
further to encompass system 1 and fitting proceeds. Solid lines represent physiological boundaries 
for Systems 1 and 2, dotted lines represent models that can conceivably be defined. Black arrows 
represent system inputs and outputs.
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1.1.3.2 Predictive ability
A mathematical model should be able to make non-intuitive predictions regarding the 
behaviour of a given system. Strictly, mathematical models should only be created 
when the complexity of a system exceeds the ability of a conceptual model to make 
intuitive predictions. Cross-talk between linked signalling systems is an example of 
such a situation, allowing us to make predictions regarding the effect of protein X from 
system 1 on system 2 behaviour through cross-talk with Protein Y (Figure 1.1 A#). The 
ability of a model to make predications depends heavily on the ability of the 
experimental model system to supply a strong experimental foundation.
1.1.3.3 Resolution
In order to be functional, a model of a system requires at least one quantifiable input 
and output. These should be system specific, for example, in the case of model B in 
Figure 1.1 Input 1 should not be able to elicit a response through Output 2 
independently of interaction between systems 1 and 2. This is a common issue when 
investigating linked signalling systems involving transcription factors, where care must 
be taken to ensure stimuli used as inputs and target genes used as outputs are system 
specific. Choice of both biological and experimental model systems is therefore 
important, firstly to provide the correct context in which model predictions can be made, 
and secondly to be able to test these predictions experimentally, in a quantifiable 
manner.
1.1.4 Experimental model system -  Protein dynamics in single living 
cells
Within all complex biological systems, cells must communicate to produce co-ordinated 
temporal, local or global responses. Cells regulate these responses by alterations in 
complex intra-cellular signalling cascades. Proteins undergo changes in their 
interactions, stability and location within and between cell compartments. Dynamic 
modifications, such as the phosphorylation state of proteins that typically transduce a 
signal into a response, are usually measured using techniques that necessarily give a 
population average. These and other measures are often from a population of cells 
over time, or single cells at a given time point; and any temporal heterogeneity is lost
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as a result. The onset of fluorescent fusion protein technology and time-lapse 
fluorescence microscopy has provided the ability to perform non-invasive measurement 
of protein dynamics in the same cell over time. Transient exogenous expression, stable 
integration or the generation of transgenic animals provide tools for studying the 
localisation, translocation and stability of specific proteins of interest at the single cell 
level and ultimately in living tissues. Where single cell time-lapse data is available, such 
as in NF-kB signalling (Nelson et at. 2004), or circadian rhythms (Welsh et at. 2004), 
single cell heterogeneity is shown to be masked by population averaging. An in silico 
model derived from population data may miss crucial dynamic and functional details. 
However, single cell studies unmask stochastic events that lead to cell to cell variation. 
Incorporation of the stochastic non-linear dynamics of the system into a model allows a 
better understanding and appreciation of the kinetics and function of mechanisms 
within signalling networks.
1.1.5 Biological model system - Oscillatory behaviour in cell signalling
Although complex when taken as a whole, intra-cellular networks are often made up of 
a common set of simple motifs (for example feedback loops; (Milo et at. 2002)), which 
generate a wide range of dynamic behaviours, including oscillations. The negative 
feedback loop (e.g. when a protein inhibits its own transcription, considered further in 
Section 1.1.9) is one example which can lead to oscillatory behaviour, such as cycles in 
protein concentration or translocation between cellular compartments. Although a 
single delayed negative feedback loop is all that may be required to drive oscillatory 
behaviour, many systems have multiple feedback loops, leading to much more complex 
dynamic behaviour (Tsai et at. 2008). It can be argued that this level of complexity can 
only be fully understood with a mathematical Systems Biology approach.
The involvement of a core negative feedback loop to generate sequential cycles of 
nuclear to cytoplasmic (nucleo-cytoplasmic) protein translocation are particularly well 
documented in the transcription factor Nuclear Factor kappa B (NF-k B) signalling 
system (Nelson et at. 2004) and thus this provides a good model system for evaluating 
complex and non-linear protein dynamics (Chapter 2). Oscillations in other signalling 
systems have been discovered using fluorescence techniques and imaging at a single 
cell resolution. Variation in oscillatory kinetics between single cells was first
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characterised in acute responses such as cytoplasmic calcium concentration (Berridge 
1990), where the response to stimuli was transduced by changes in the frequency of 
oscillations in intracellular calcium concentration that can occur from fractions of a 
second (Nelson etal. 1995) to minutes (Cuthbertson etal. 1985). Although changes in 
intracellular calcium concentration were detected many years ago with the calcium- 
specific photoprotein, Aequorin (Ridgway etal. 1976); (Woods etal. 1986) the onset of 
highly selective fluorescent calcium indicators enabled the visualisation of small, high 
frequency changes in ion concentration within individual live cells (Grynkiewicz et at. 
1985), and thus first made the connection between oscillatory behaviour and target 
gene expression (Dolmetsch etal. 1997) (Dolmetsch etal. 1998) (Li etal. 1998). 
Oscillatory movement between nuclear and cytoplasmic compartments shown by the 
tumour suppressor protein p53 result from a negative feedback loop, involving the 
relationship between p53 and its inhibitor MDM2 (Lahav et al. 2004). In contrast to the 
timing of calcium oscillations, these changes occur in the order of hours (Lahav et al. 
2004). Regulation of MDM2-independent nuclear export depends on the exposure of 
the p53 NES, contained within a leucine-rich tetramerisation domain. Upon import as a 
monomer species, p53 tetramerises to become transcriptionally active (Friedman et al. 
1993), masking its intrinsic NES from exportins and maintaining its active, nuclear 
localisation. It is only upon fragmentation of the p53 tetramer to dimers that its NES 
becomes accessible and subsequently targetable for nuclear export. Not only have 
oscillations in p53/MDM2 been shown at the single cell level (Geva-Zatorsky et al. 
2006) but also from an MDM2-luciferase reporter in vivo from living irradiated 
transgenic mice (Hamstra et al. 2006). The emergence of molecular oscillators have 
been documented in recent studies for example Notch/Hes1 and Wnt (Shimojo et al. 
2008). These genes have been shown to have significant roles in the somitic 
segmentation clock, most notably in showing oscillations within cell populations in 
whole embryos independent of p-Catenin levels (Aulehla et al. 2008). Similar 
oscillations have also been suggested in the Smad and Statl (Yoshiura et al. 2007) 
signalling systems.
Molecular oscillations have also been visualised on much longer time-scales, for 
example in the mammalian and plant circadian clocks (reviewed in (Ko etal. 2006) and 
(Schultz et al. 2003) respectively). Here, the discovery that circadian rhythms could be
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induced in mammalian culture cells (Balsalobre et al. 1998) has allowed new and 
detailed single cell investigations of the mammalian circadian clock (Welsh etal. 2004). 
Single cell studies have also given new insights into the mammalian cell cycle 
oscillator. Live cell imaging has been used to show dynamic shuttling of both Cyclin E 
and Cyclin A (associated with G1/S and S phase progression respectively) (Jackman et 
al. 2002). Recently, non-invasive “markers” of cell cycle transition have been developed 
to track particular phases of specific proteolysis (Sakaue-Sawano et al. 2008), and 
destabilised GFP constructs used to investigate fail-safe mechanisms to maximise cell 
cycle synchrony between single budding yeast (Bean etal. 2006).
1.1.6 Integration of linked processes across scales
A key challenge in Systems Biology is to integrate the behaviour of systems across 
both physiological scales, ranging from single molecules to whole organisms and time 
scales ranging from seconds to hours. A classic example linking ion channel function to 
organ physiology comes from the model of the virtual heart (DiFrancesco et al. 1985). 
Other modelling projects have encompassed biochemical (Novak et al. 2004), cellular 
(Turner et al. 2002), organ (Noble 2006), and population (Spencer et al. 2008) level 
based approaches. Cell signalling networks are integral to organism adaptation and 
survival and underlie normal cell function, communication and disease. The 
observation that key systems may oscillate suggests a possibility that this may be one 
important feature of many signalling networks. Such oscillatory processes may span 
periods of time from fractions of a second/minutes (calcium) to minutes/hours (NF-k B, 
p53, segmentation clock) to hours/days (circadian clock and cell cycle) suggests an 
intriguing possibility that interactions between these dynamical processes may well 
intermesh like the cogs in a clock to provide error-free interpretation of signalling 
information in normal cells. These ideas are developed further in Chapter 8.
1.1.7 Interdisciplinary Systems Biology in practice
The interdisciplinary step between conceptual Systems Biology and mathematical 
Systems Biology requires close collaboration between experimentalists and 
theoreticians. Where possible, the transfer of skills between disciplines is desirable, not 
only to help researchers to be more flexible, but to foster an appreciation and
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understanding for the critical timescales involved in both approaches. Figure 1.2 shows 
a typical cycle for interdisciplinary research. An important observation about the cycle is 
that the experimental path (pink) drives the resolution of prediction to result and is 
therefore critical. The blue theoretical paths, whilst not critical, aim to speed up the 
cycle by making it shorter (conceptualised here by the sub-cycle of “Model > Prediction 
> Answer > Model”). A model abstracted carefully from a context (conceptual model) 
should be able to make non-intuitive predictions about a given system as complexity 
increases past the point of intuitive prediction. In addition to predictive experimental 
design, a mathematical model may be used to assess system sensitivity to quantitative 
changes in model parameters.
Testing
Figure 1.2 A typical interdisciplinary research cycle: Showing three requirements of a Systems 
Biology approach; Context (from which a conceptual model is derived), predictive ability and 
answer. Critical path of experimental research (pink), and paths made possible by the 
interdisciplinary approaches to Systems Biology (blue), including non-intuitive prediction and a 
faster cycle of research between prediction, answer and model abstracted from a conceptual 
model.
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1.1.8 The application of Mathematics in Systems Biology
Although the application of mathematical models to the study of biological systems is 
not a new approach (Lotka 1925; Volterra 1926; Hodgkin et al. 1952), in recent years 
the field has enjoyed a resurgence in popularity. This is due in part to increased 
awareness and appreciation for systems-level approaches to biological investigation 
(building on reductionist studies of the past), but also the concurrent development of 
high throughput techniques, driving an increase in both the complexity of systems 
under investigation and the volume of data available for analysis.
As we have discussed (Section 1.1.3.1), the process of abstracting a model from 
physiology requires careful consideration. This usually involves a compromise since 
“no single model can simultaneously optimise generality, realism and precisiori’ (Levins 
1966), so care must be taken to assess which processes are critical to adequately 
represent the behaviour of a system (Ting et al. 2002). When considering modelling 
approximations to intra-cellular signalling systems, mechanical processes are often 
grouped into several categories; ‘physical binding’ involving association and 
dissociation between proteins, ‘transport’ involving import or export of proteins between 
cellular compartments, ‘protein modification’ involving processes such as 
phosphorylation and acetylation, and ‘protein stability’ involving processes such as 
synthesis and degradation. These processes are mathematically modelled as 
biochemical reactions, involving the transition of molecular species between specific 
states in combination with kinetic parameters defining the rate of a given process. 
Using these conventions, biochemical reactions can be converted into systems of 
Ordinary Differential Equations (ODEs) with each reaction expressed as one such 
equation, as shown in Figure 1.3. Systems of linked ODEs allow changes in 
concentration of given molecular species to be quantitatively assessed over time with 
respect to other interacting species.
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A B
. d[xy\/ dt = ka[x][y]~ kd[xy]
cl
x + Y XY d[x]/dt = ka[x\y\
kd d[y]/dt
Figure 1.3 An example of a Deterministic ODE system: A Showing a reversible biochemical 
reaction representing the association and dissociation of two species ‘X’ and ‘Y’ and a complex 
species ‘XY’. The forwards reaction, association, is driven by the kinetic parameter ‘kst, the reverse 
reaction, dissociation is driven by 'kd’. B A system of ODEs describing the dynamics of the reaction 
in A.
There are certain implicit assumptions taken into account by the ODE approach; firstly, 
that reaction probability is proportional to the (product of the) concentration of 
molecular species involved in a given process (Fall 2002) and that reaction times are 
small. Secondly, that reaction space is homogenous. The latter of these assumptions is 
increasingly important when considering modelling systems which involve movement of 
species between cellular compartments, for example oscillatory systems such as NF- 
k B, p53 or the cell cycle, as discussed in Section 1.1.9.
ODE based models constitute the conventional approach to modelling dynamical 
systems (Phair et al. 2001) and assume each value of a given species is determined 
uniquely by given parameters and by previous values of model species, such models 
are therefore termed “Deterministic”. A deterministic approximation to a biochemical 
reaction assumes that the discrete movement of reactant molecules (moving from one 
space to another) is adequately approximated as a continuous process (molecules 
occupy all space at all times). This is acceptable when numbers of molecules of 
reactant species are high. However, for processes involving low numbers of molecules 
of reactant species (such as transcription involving a small gene copy number or 
cytokine signalling involving a low number of receptors) fluctuation in species 
concentration becomes increasingly significant, leading to randomness or 
“Stochasticity” in given reactions and discrete kinetics cannot be approximated as 
continuous (Figure 1.4). Stochasticity in key processes may have concomitant effect on
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the overall system behaviour. Stochastic models, can be used to simulate randomness 
in system processes, accounting for the probabilistic occurrence of collisions of 
reactant molecules (Elowitz et al. 2002; Kerszberg 2004; Cai et al. 2008) and have 
been recently applied to extend deterministic models involving linked ODEs of the NF- 
k B system (Lipniacki etal. 2007; Ashall etal. 2009)
A
Large number o f reactant
molecules__________
Discrete but approximated
as Continuous_______
Deterministic
B
Small number o f reactant
molecules__________
Discrete, unable to be
approximated________
Stochastic
Figure 1.4 Comparing Deterministic and Stochastic processes: A Showing a large number of 
reactant molecules, the discrete kinetics of which can approximated as continuous by a 
Deterministic approach. B Showing a small number of reactant molecules, the discrete kinetics of 
which cannot be approximated as continuous. The randomness in this situation calls for a 
Stochastic modelling approach.
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1.1.9 Mathematical Systems Biology applied to oscillatory systems
As introduced in (Section 1.1.5), oscillatory behaviour in intra-cellular signalling 
systems stems from feedback. The simplest form of negative feedback is outlined in 
Figure 1.5 and can be modelled with ODEs.
Figure 1.5 Simple negative feedback: A Showing negative feedback between C which positively 
regulates X, and X which negatively regulates C. B Showing ODE system describing negative 
feedback between X and C, where 5 and yj are arbitrary kinetic parameters.
In this example, species ‘X’ is positively regulated by species ‘C ’, so the level of X at 
time t+1 is equal to the sum of Xto and C multiplied by a positive kinetic parameter, +5. 
Species C is negatively regulated by protein X, so that the level of C at time t+1 is 
equal to the sum of Cto and X multiplied by a negative kinetic parameter, -<//. As such 
the depletion of C over time is proportional to the rise of X which is regulated by C, 
leading to negative feedback.
This core oscillatory motif is at the heart of deterministic approaches to modelling both 
NF-k B (Hoffmann et al. 2002), p53 (Lahav et al. 2004) and cell cycle (Novak et al. 
2004). Subsequent development of modelling approaches to the NF-k B system provide 
a suitable example for the discussion of model development in general. As has been 
highlighted in Section 1.1.4 and (Ting et al. 2002) model development is highly 
influenced by the data in which it takes foundation. Consequently, there has been some 
disparity between subsequent development of NF-k B models based on data derived 
from single cell (Nelson et al. 2004) and bulk cell techniques (Hoffmann et al. 2002). 
Groups have sought to extend existing NF-k B models through provision for additional 
feedback mechanisms (Lipniacki et al. 2005; Basak et al. 2007; Ashall et al. 2009) and 
stochastic representation of processes involving randomness, such as gene expression 
((Lipniacki et al. 2006; Ashall et al. 2009). Extension of models to consider “upstream”
B
d[x]/ dt =  +S[c] 
d[c]/ dt = -y/[x\
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activation of the system in greater detail has allowed emergent experimental data to be 
fitted (Lipniacki et al. 2007; Werner et al. 2008). Models have also been used to 
quantifiably predict the effects of drugs on the NF-k B system (Sung et al. 2004). 
Further examples of modelling approaches to oscillatory systems are discussed in 
Chapter 8, including the Systems Biology of the cell cycle, which is discussed in detail 
in Section 8.6.
1.1.10 Discussion - Systems Biology applied to this project
In this chapter we have presented a view of Systems Biology. Systems Biology is 
presented as an integrative approach as the antithesis of Reductionism, but capable of 
adsorbing data from such studies, highlighting the importance of integration. We then 
considered the requirements for a mathematical Systems Biology approach in terms of 
context, predictive ability and experimental resolution, which were used to define the 
step-wise process for model expansion (Figure 1.1). We went on to discuss the 
importance of biological and experimental model systems in resolving model 
predications experimentally, and proposed a research cycle linking context, prediction 
and answer (Figure 1.2).
The work described in this thesis applies a mathematical Systems Biology approach to 
the coupling of oscillatory systems operating over different time scales; the cell cycle 
(outlined in Section 1.2) and the NF-k B signalling system (outlined in Section 1.3) 
through interaction between NF-k B and the G1/S phase cell cycle regulator E2F-1. It 
involves both bulk and single cell based biological studies characterising the effects of 
E2F-1 on NF-k B signalling, and the expansion of a deterministic mathematical model 
for the NF-k B system. As such, the study has focused on the NF-k B system, with the 
model extended to include interaction with cell cycle regulator E2F-1 in a similar 
manner to model A# in Figure 1.1. However, work outlined in Chapter 7 is aimed to 
provide significant scope for future work characterising the reciprocal relationship within 
the context of the G1/S progression of the mammalian cell cycle.
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1.2 Introduction II -  E2F and G1/S cell cycle progression
1.2.1 Summary
The life cycle of the mammalian cell is heavily regulated, with transition from apparent 
resting states (“gap” phases) to the critical activities of DNA Synthesis (S-phase) and 
Mitosis (M-phase) subject to passage through checkpoints (Figure 1.6). Normal 
transition from early growth in the first gap phase through to S-phase (G1/S) is 
mediated by interactions between members of protein families including the E2-factor 
(E2F) family, Cyclins, Cyclin Dependent Kinases and CDK Inhibitors. These 
mechanisms are robust, ensuring healthy cells are able to repeatedly cycle through the 
G1/S checkpoint towards the point of senescence. However, the multiple levels of 
regulation also provide many molecular targets sensitive to stress response systems 
such as those controlled by p53 and NF-k B. The well characterised mechanisms for 
interaction between the p53 and G1/S systems allow us to introduce a conceptual 
model for DNA damage response prior to S-phase. The principles behind this model 
may be used to consider in detail the data presented on E2F-1 interaction with NF-k B 
(Chapters 5-7) within the context of a TNFa-mediated inflammatory response at G1/S 
(Chapter 8).
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G 1
C yclin  A, B 
C D K  1 
C ip  CDKI
G o/M
Figure 1.6 Phases of the mammalian cell cycle: Showing Gap phases G1 and G2 prior to “S- 
phase” DNA Synthesis and “M-phase” Mitosis, respectively. Transition from Gap phase into S or M 
phase is subject to passage through checkpoints (G1/S and G2/M). Cell cycle progression is 
regulated by the E2F family of transcription factors, Cyclins, CDKs and CDKIs, explained in detail in 
Section 1.2.3.
1.2.2 The E2F family of proteins
E2F-1 was originally discovered as a transcriptional activator of the viral E2 promoter 
(Kovesdi et al. 1986) predominantly bound by a protein later characterised as the 
retinoblastoma protein (pRB) (Bagchi et al. 1990). E2F-1 was subsequently found to 
regulate the transcription of genes essential for cell division (Bracken et al. 2004) many 
of which are outlined below. The E2F family currently consists of 9 members, although 
only the first 7 (E 2F1,2 , 3a, 3b, 4 ,5 ,6 )  share any sequence homology (Figure 1.7). All 
E2F proteins form heterodimeric complexes with members of the DRTF-1 Polypeptide 
(DP) family, which are essential to E2F transcriptional activity (Trimarchi et al. 2002). 
E2F-1-3a are known as the “activating E2Fs” due to their transcription role governing 
entry into S-phase (Johnson et al. 1993; DeGregori et al. 1997), and are thought to be 
predominantly nuclear (characterised in Section 3.2). Over-expression of the activating 
E2Fs has been shown to drive progression into S-phase (Johnson et al. 1993), 
consequently leading to higher levels of apoptosis in mammalian cells (Qin et al. 1994).
17
Introduction II -  E2F and G1/S Cell Cycle Progression
Excluding the lesser characterised E2F-7 and E2F-8, the latter half of the E2F family 
(including E2F3b, a splice variant of E2F3a) are predominantly associated with 
transcriptional repression. E2F-4 and E2F-5 lack the Nuclear Localisation Sequence 
(NLS) present in E2F-1-3a, and possess a Nuclear Export Sequence (NES), yielding a 
predominant cytoplasmic localisation (Muller etal. 1997). However, it has been shown 
that E2F-4 and E2F-5 may take a nuclear localisation when bound in an inactive state 
to pocket proteins (possessing their own NLS), and bind to E2F promoters in 
competition with the activating E2Fs (Verona et al. 1997; Takahashi et al. 2000). As 
such, E2F-4 and E2F-5 are considered repressive, although it is possible that they may 
be able to activate certain genes (Wells et al. 2000). E2F proteins have a well 
characterised degradation pathway involving ubiquitination by the Skp2-SCF E3 
Ubiquitin ligase (Campanero et al. 1997) and subsequent destruction in the nucleolar 
proteosome (Martelli etal. 2001).
E2F-1
E2F-2
E2F-3a
E2F-3b
E2F-4
E2F-5
E2F-6
m
Cyclin A:
CDK2 NLS 
; Binding
e n
¡1
ONA Dp
Bindinq ■ Dimérisation. Transactivation
Associated 
Pocket Protein
pRb 
pRb 
pRb 
pRb
'////////A  pRb, p107, p130 
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^  P130
Localisation
Nuclear
Nuclear
Nuclear
Nuclear
Nuclear/
Cytoplasmic
Nuclear/
Cytoplasmic
Nuclear
E2F-7 [ rn mzm1--------------------------------------------1 Nuclear
NuclearI__________ 1 .. l____ 1
Figure 1.7 Characteristics of the E2F family of proteins. Showing strong sequence homology 
between the activating E2Fs (E2F-1,2,3a) and E2F-3b, which have a NLS. E2F-4 and E2F-5 
contain a NES but not a NLS leading to a predominantly cytoplasmic localisation. Adapted from 
(Tsantoulis etal. 2005).
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1.2.3 The G1/S checkpoint
Cell cycle progression from early growth in G1 to the onset of S-phase DNA synthesis 
is strictly controlled (Pardee 1974; Hartwell et al. 1989). As previously highlighted, 
transcription factors from the E2F family of proteins, namely E2F-1, E2F-2 and E2F-1- 
3a (in complexes with members of the DP family) have functional and physical roles in 
preparing the cell for S phase transition and the irreversible commitment to division 
(Dyson 1998) (Figure 1.8). Progression from G1 requires the activation of these 
E2F/Dp complexes via hyper-phosphorylation of inhibitor “pocket” protein, pRB by 
Cyclin:CDK complexes CyclinD:CDK4/6 and Cyclin E:CDK2 (Dyson 1998) enabling 
E2F-mediated transcription of a regulon containing over 200 cell cycle genes (Bracken 
et al. 2004), including Cyclins D, E and A which are essential for normal S-phase 
progression (Sherr et al. 1997; Ohtsubo et al. 1995; Assoian 1997). Concurrently, a 
loss of the activating E2Fs is attributed to cell cycle arrest and quiescence (Attwooll et 
al. 2004). Progressive activation of E2F-1-3a is reinforced through E2F auto­
transcription, and generates a ramping level of active E2F throughout G1 which peaks 
at G1/S. This level falls during early S-phase as Cyclin A builds to a threshold (Schulze 
et al. 1995) (Figure 1.9), enabling the CyclinA:CDK2 complex to change the 
phosphorylation states of pRB and E2F-1-3a thus increasing binding affinity for the 
pRB/E2F/DP complex and effectively ending E2F related transcription (Peeper et al. 
1995).
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G^S
Figure 1.8 G1/S phase: Regulation of S-phase transition by E2F-1. A G1 phase - growth factors 
promote a rise in active CyclinD:CDK4/6, phosphorylating pRB, leading to a rise in active E2F-1. B 
Late G1 phase -  hyper-phosphorylation of pRB occurs through CyclinE:CDK2 complex, levels of 
Cyclin D, E, A and E2F-1-3a rise due to E2F related transcription. C G1/S phase -  Cyclin E:CDK2- 
mediated phosphorylation leads to degradation of E2F-1, Cyclin A may also phosphorylate E2F-1 
increasing affinity for rebinding to pRB. D E2F-1-3a related transcription ends E Early S-phase 
Cyclin E and A complexes chaperone S-phase related processes (see text for details). Solid black 
lines represent direct processes, dotted lines represent indirect and delayed processes. An 
arrowhead represents positive regulation, a flat-head line represents repression. Large arrows 
mark the transition between cell cycle stages.
A further “off switch” to E2F-related transcription is the concurrent activation of 
predominantly repressive E2F complexes (E2Fs 4 and 5 together with their pocket 
protein binding partners p107 and p130, respectively) which compete for the same 
genetic loci as E2F-1-3a whilst bound in an inactive state to their pocket proteins 
(Verona etal. 1997; Takahashi etal. 2000) (Figure 1.9).
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Figure 1.9 Relative levels of cell cycle proteins at G1/S phase. Showing a peak of E2F-1-3a at 
G1/S and the progressive decrease in active levels corresponding with a rise in E2F-4 and 5 which 
are transcriptionally repressive.
1.2.4 Robustness in G1/S progression
To reach the point of replicative senescence, cells must complete their life cycle many 
times (Mathon et al. 2001). As previously highlighted, the commitment to critical 
activities such as DNA replication is irreversible and requires well-timed transcription of 
large sets of genes (Bracken et al. 2004; Carey et al. 2008). The mechanisms 
governing this progression must therefore be accurate (i.e. timely) and repeatable. The 
picture of “normal” G1/S cell cycle progression outlined in Figure 1.8, although already 
complex, encompasses further subtle mechanisms which add to the robustness of S- 
phase progression.
1.2.4.1 Functional robustness
As described in Figure 1.7 E2F1, 2 and 3a share a high degree of structural and 
functional similarity. This allows for functional redundancy and robustness in 
transcriptional activity (Wu etal. 2001). All combinations of E2F1 E2F2 and E2F3a with 
transcriptional binding partners DP-1 and DP-2 have been discovered in vivo (Wu et al. 
1995). Indeed, only a complete loss of all of the “activating” E2Fs is attributed to cell 
cycle arrest and quiescence (Attwooll et al. 2004). Redundancy also extends to the 
Cyclin:CDK complexes with three known functional proteins comprising Cyclin D 
(Bartkova et al. 1998) and two each of cyclins A and E (Murphy et al. 1997; Lauper et
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al. 1998). Indeed it can be argued that the mechanisms governing G1/S progression 
are evolutionarily robust with many G1/S proteins highly conserved across species 
(Skotheim et al. 2008; van den Heuvel et al. 2008; Doonan etal. 2009).
1.2.4.2 Robustness arising from feedback
The cell cycle is an oscillatory system. The cycle oscillates between two checkpoints, 
one governing transition into DNA Replication phase (G1/S) and one into Mitosis 
(G2/M). Progression through these checkpoints is controlled by families of proteins 
which themselves oscillate in level with a period of several hours (see Figure 1.9). 
Individual cell cycle controlling components may also oscillate in terms of their 
localisation, phosphorylation status, stability and activity.
Feedback in oscillatory systems, involving direct and indirect auto-regulation of protein 
activity (previously introduced in Sections 1.1.5 and 1.1.9), has been shown as a 
source of robustness, allowing the adjustment of frequency in oscillatory systems 
involving coupled positive and negative feedback (Tsai etal. 2008). Transition from G1 
to S-phase (Figure 1.8) involves multiple coupled feedback mechanisms. Progressive 
activation of E2F1-3a throughout late G1 requires hyper-phosphorylation of inhibitor 
“pocket” protein, pRB by Cyclin:Cyclin dependent kinase (CDK) complexes 
CyclinD:CDK4/6 and Cyclin E:CDK2 (Stanelle et al. 2002), both of which are under the 
transcriptional control of E2F1-3a (Young et al. 2003) and are essential for S-phase 
progression (Sherr et al. 1997) (Ohtsubo eta l. 1995). Indeed, Cyclin E itself has been 
theorised to drive oscillations in E2F-1 transcriptional activity through coupled positive 
and negative feedback (Baguley et al. 2005; Yao et al. 2008), both contributing to 
hyper-phosphorylation of pRB at G1/S freeing E2F-1 (Dyson 1998) and the CDK2- 
mediated phosphorylation of E2F-1, marking it for proteolytic degradation (Reis et al. 
2004). Cyclin A is also part of the E2F regulome (Assoian 1997) and builds to a 
threshold during early S-phase (Schulze et al. 1995), enabling the CyclinA:CDK2 
complex to contribute to the decrease in E2F related transcription in S-phase, as 
outlined above (Peeper etal. 1995).
In addition to indirect feedback through the Cyclins, E2F is subject to direct positive and 
negative self-regulation. The progressive activation of E2F-1-3a is reinforced through 
E2F auto-transcription, with E2F-1 regulating the gene products of E2F-1,2 and 3
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(Hsiao etal. 1994) However, E2F-1 also regulates the gene product of its inhibitor, pRB 
(Ishida etal. 2001).
In summary, the robust mechanisms at G1/S contribute to flexibility in the expression 
profile of the active E2F complexes, both in the rising level of E2F1-3a though multiple 
positive feedbacks (Cyclin:CDK activity, auto-transcription) leading up to S-phase - and 
hence the correct timing of target genes - but also to the abrupt termination of E2F- 
related transcription through multiple negative feedbacks (inhibitory E2Fs, pocket 
proteins, S-phase Cyclins) (profiles summarised in Figure 1.9). These coupled positive 
and negative feedbacks have been suggested to contribute to the role of E2F as a bi­
stable switch at G1/S (Yao etal. 2008).
1.2.5 Sensitivity of G1/S progression
A caveat to the robust nature of cell cycle progression is that arrest is inevitable 
(Hayflick 1965), meaning mechanisms controlling cell cycle progression must be 
sensitive to arrest. At G1/S, arrest is commonly mediated by specific Cyclin:CDK 
inhibitors (CDIs). CDIs are predominantly grouped into two families:- INK -  p15, p18, 
p19 and principal member p16INK4, and CIP/KIP -  p21, p27 and p57 (Collins et al. 
2003).These CDIs inactivate G1 CDK:Cyclin complexes (the INK family being specific 
to CDKs 4 and 6) by stably binding to the CDK in direct competition with the Cyclins 
(Carnero et al. 1998), or (in the case of the CIP family) by direct inactivation of CDK 
complexes (Polyak et al. 1994; Harper et al. 1995). Prior to permanent senescent 
arrest the cell cycle may be temporarily arrested (“delayed”) at G1/S in the event of 
DNA damage (Pellegata et al. 1996; Galbiati et al. 2005). The regulatory mechanisms 
involved in normal G1/S progression (Figure 1.8) provide multiple molecular targets for 
stress response systems such as p53 and NF-k B.
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1.2.5.1 p53 DNA damage response at G1/S -  The importance of context
E2F-1 plays a crucial role in DNA damage response at G1/S via interaction with the 
p53 system (reviewed in (Tsantoulis et al. 2005; Braithwaite et al. 2006)). Normally the 
p53 tetrameric complex is bound to MDM2 and sequestered in the cytoplasm (Chen et 
al. 1995). Upon phosphorylation by p14ARF, MDM2/p53 binding is disrupted, leading to 
exposure of the p53 Nuclear Localisation Sequence (NLS), leaving p53 free to 
translocate and begin transcription of target genes, including that for MDM2 
(considered in greater detail in (Prives et al. 1999)). The feedback between p53 and 
MDM2 has been shown to lead to nucleo-cytoplasmic and concentration based 
oscillations of the active p53 complex (Lahav et al. 2004).
Crosstalk between the G1/S and p53 systems may involve p53-mediated cell cycle 
arrest through up-regulation of target gene p21 (waf-1/cip-1) (el-Deiry etal. 1993), E2F- 
1 reinforcement of p53 through up-regulation of E2F-1 target gene p14 (Dimri et al. 
2000) and direct binding of E2F-1 to p53 at a region which blocks the intrinsic nuclear 
export sequence of p53 (Sakaguchi et al. 1997). p53 mediation of cell cycle 
progression may occur through up-regulation of MDM2, ending p53-mediated 
transcription of p21, and releasing E2F-1 to bind to Cyclin A in a manner consistent 
with S-phase progression (Price etal. 1995).
Considered simultaneously, these interactions may appear to be contradictory as 
factors associated with both cell cycle arrest and proliferation are up regulated. Similar 
situations occur in inflammatory responses through the NF-k B system (Guttridge et al. 
1999; Hinata et al. 2003). This reinforces both the importance of context to cell fate 
decisions and a potential flaw in reductionist approaches as confirming transcriptional 
control of a gene or set of genes might not be enough to determine or predict specific 
outcome(s). Interaction and collaboration between networks of proteins must therefore 
be considered in context, which may change over time. As an example a model may be 
constructed to describe the response to DNA damage at G1/S, describing both the p53 
signalling network and G1/S checkpoint control systems.
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1.2.5.2 Introducing the G1/S “balance” model
In senescent cells, DNA damage signals transduced through the RB/E2F and p53 
systems result in permanent withdrawal from the cell cycle (Shay et al. 1991). 
However, in dividing cells DNA damage may require only provisional arrest of passage 
through the G1/S checkpoint, (Galbiati et al. 2005) i.e. successful resumption of the 
cell cycle once the damage has been repaired or, alternatively the invocation of 
apoptotic cascades should the damage be irreparable (considered in greater detail in 
(laquinta et al. 2007)). In cells with reparable DNA damage, the interactions involving 
E2F-1-3a and the p53 system at G1/S can be separated into those which contribute to 
temporary arrest, to the coordination of the p53 response to DNA damage, and to 
successful resumption of the cell cycle.
Figure 1.10 The p53:G1/S balance model: A p53-mediated cell cycle arrest through 
transcriptional up-regulation of CDI p21. B Interaction of G1/S proteins with p53 coordinating the 
p53 response (see text for details) C p53-mediated resumption of the cell cycle through up- 
regulation of MDM2 which ends transcription of p21 and stabilises E2F-1, and the release of Cyclin 
A from p53 binding to bind to E2F-1. The intensity of the green line represents the level of E2F-1 
which reaches its peak at the G1/S transition. Red crosses represent cell cycle arrest at different 
stages.
The model in Figure 1.10 presents a scenario for p53-mediated DNA damage 
responses at G1/S assuming this involves temporary arrest of the cell cycle. As such, 
the interaction between the G1/S and p53 systems logically must provide mechanisms 
for both prompt cell cycle exit (to ensure genomic stability) and re-entry at the 
appropriate phase, hence resolving the apparent contradiction presented by both 
proliferative and anti-proliferative behaviour. Successful re-entry of the cell cycle prior 
to S-phase depends on the outcome of a period of “balance” in which G1/S proteins 
may coordinate p53-mediated invocation of further mechanisms associated with repair,
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or indeed with apoptosis, senescence or differentiation (Tanaka et al. 2000), 
considered in greater detail in (Gatz etal. 2006) and (Braithwaite etal. 2006).
The balance model is considered in greater detail in Chapter 8, but is introduced here 
to provide a context for the major focus of this thesis which is to investigate a similar 
scenario connecting G1/S with stress responses and the NF-k B system. Interactions 
between NF-k B and G1/S proteins such as E2F-1 are less well characterised than 
those between the G1/S and p53 systems, but share common proliferative/anti- 
proliferative function. In order to consider interactions between E2F-1 and NF-k B in 
context, it is now necessary to introduce the NF-k B system in detail.
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1.3 Introduction III -  The NF-kB signalling system
1.3.1 NF-kB - A key oscillatory system
The NF-k B signalling system describes one of the most important stress and 
inflammatory response networks in mammalian cells. Activation of the system leads to 
down-stream expression of genes involved in a range of critical activities such as 
inflammation (Shakhov etal. 1990), and apoptosis (Schauvliege etal. 2002), as well as 
proliferation and the cell cycle (Guttridge et al. 1999), the latter is discussed in detail in 
Section 1.3.4.
The NF-k B system acts to convey an extracellular signal through cell surface 
receptor(s), through the cytoplasm to the nucleus via protein interactions centred 
around members of the Reticuloendotheliosis (Rel) and Inhibitor kappa B (Ik B) 
families, including p65 (RelA), p50/p105, RelB, p52/p100, cRel (and its retroviral 
homologue vRel), Ik Bo , Ik BP and Ik Be. The architecture of the system involves 
interactions between different Rel and Ik B family members, several of which are under 
the transcriptional control of NF-k B, leading to regulatory feedbacks.
In resting, unstimulated conditions the prototypical transcriptionally active NF-k B 
complex, a heterodimer of p65 and p50 (often referred to simply as NF-k B) is held in a 
dormant cytoplasmic state by the Ik B proteins. Inflammatory stimuli, for example the 
cytokine TNFa, induce rapid phosphorylation (within 5 minutes), ubiquitination, and 
proteasomal degradation of Ik Bo , via activation of the Ik B kinase IKK (Miyamoto et al. 
1994). The degradation of inhibitor IkBo enables free NF-kB to move to the nucleus 
where it can activate transcription of target genes, which include IkBci. Following 
protein maturation, newly synthesised Ik Bo binds to nuclear NF-k B removing it from 
the nucleus via Ik Bci nuclear export sequence (NES) to be sequestered in the 
cytoplasm, exemplifying negative feedback. In addition to Ik Bo , NF-k B regulates the 
transcription of genes coding for further inhibitory proteins, such as the Ik Bo 
homologue IkBe (Kearns et al. 2006) and IKK regulator A20 (Lee et al. 2000) (Figure 
1.11).
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Figure 1.11 Conceptual model of the NF-kB system. A Stimulation by TNFa induces a rise in 
levels of IKK, which phosphorylates Ik Bo marking it for ubiquitination, freeing the NF-k B 
heterodimer and allowing it to translocate into the nucleus B NF-k B activates the transcription of 
Ik B proteins and A20 which blocks their phosphorylation by IKK C De-novo Ik B proteins 
translocate into the nucleus and “pull” NF-k B back into a dormant cytoplasmic state. The system 
exemplifies negative feedback.
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1.3.2 Structure of NF-kB proteins
This project is primarily focussed on interaction between cell cycle regulator E2F-1, and 
the canonical NF-k B system, involving p65, p50 (the cleavage product of p105) and 
IkBo. Structures for these classical NF-kB family members are shown below (Figure 
1.12). NF-k B oscillatory behaviour is driven by Nuclear Localisation and Nuclear Export 
Sequences (NLS and NES). Combinations of these structural motifs in proteins and 
protein complexes lead to a steady state localisation. This may change as the make-up 
of a complex changes. Crystallographic studies of the p65:p50 complex bound to Ik Bci 
revealed that IkBci binds to NF-kB in such a way that the p65 NLS is masked but the 
p50 NLS is left exposed leading to nucleo-cytoplasmic shuttling of the complex 
(Huxford et al. 1998; Jacobs et al. 1998; Malek et al. 2001; Malek et ai. 2003) but a 
predominant “steady state” in the cytoplasm due to the combined effect of the p65 and 
IkBci NES (Harhaj etal. 1999; Johnson ef al. 1999; Huang et al. 2000). TNFa-mediated 
degradation of IkBo is enough to alter the steady state as it both removes the 
contribution of the IkB NES to the complex and leads to the exposure of the p65 NLS. 
Re-synthesis of IkBo restores the cytoplasmic localisation, leading to nucleo- 
cytoplasmic oscillations in the presence of continuous TNFa stimulation. Homodimers 
of p50 lack transactivation domains but have a strong combined NLS leading to a 
largely repressive role (Zhong et al. 2002) p65 homodimers however, may be 
transcriptionally active (Chen etal. 2000).
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Figure 1.12 Structure of members of the classical NF-k B system. Showing p65 able to bind to 
both p50 (the cleavage product of p105) and Ik Bci leading to a predominant cytoplasmic 
localisation for the p65:p50:lKBa complex. Pegradation of Ik Bo leads to removal of the Ik Bci NES 
from the complex and unmasking of the p65 NLS, leading to predominant nuclear localisation of the 
p65:p50 complex. TP= Transactivation Pomain, AR= Ankyrin Repeats, GRR= Glycine Rich Region, 
PP= Peath Pomain.
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1.3.3 Characterisation of NF-kB dynamics
Original bulk-cell studies suggested that stimulus-induced movement of NF-k B 
occurred as a biphasic response (Baeuerle etal. 1988; Hoffmann etal. 2002), resulting 
from degradation and subsequent re-synthesis of Ik Bo . However, recent theoretical 
and experimental studies focussing on single cell protein dynamics have suggested 
that this negative feedback leads to asynchronous nucleo-cytoplasmic oscillations in 
NF-k B protein localisation among single cells (Nelson et al. 2004). These oscillations 
are observed to persist for several hours, with a period of tOOminutes (Nelson et al. 
2004). Asynchrony in the timing of the oscillations, makes them undetectable at the 
population level even though they are readily observable in single cells subject to time 
lapse imaging, discussed in Chapter 5 and (Ankers etal. 2008).
In single cell studies, time-lapse imaging of p65-dsRedXP has been used as a 
quantifiable output of the NF-k B system, representative of the dynamics of the p65:p50 
NF-k B complex (Nelson etal. 2004). The effects of different experimental conditions on 
TNFa-mediated dynamics of the NF-k B system for the work presented in Chapters 4-7, 
were assessed by analysing p65-dsRedXP dynamic traces in detail (Figure 1.13, movie 
M1.13 on accompanying DVD). The Maximum Nuclear Localisation (MNL) Time of NF- 
k B was defined as the time taken to reach the peak of nuclear occupancy from a 
predominant cytoplasmic state. The Nuclear Retention (NR) time of NF-k B was defined 
as the time taken to reach a predominant cytoplasmic state following MNL. 
Correspondingly, peak width is equal to MNL+NR. In experiments involving persistent 
oscillations, the second Maximum Nuclear Localisation time (MNL2) is defined as the 
time taken to reach a steady oscillatory state from the point of post-peak1 predominant 
cytoplasmic localisation. Throughout this thesis these calculations are made from 
Nuclear:Cytoplasmic ratio or nuclear fluorescence trajectories, over time.
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Figure 1.13 Dynamics of p65-dsRedXP - a quantifiable output of the NF-kB system. N:C ratio 
is taken from a time lapse image series images every 3 minutes analysed by Cell Tracker 
software (Section 2.2.5) Showing a Maximum Nuclear Localisation (MNL) time of 30 minutes after 
TNFa stimulation. A nuclear retention (NR) time of 50 minutes follows. The steady state oscillatory 
period is roughly 100 minutes from peak to peak. This figure shows a representative SK-N-AS cell 
stimulated at t=10 minutes with 10ng/ml TNFa.
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1.3.4 Thesis context: Crosstalk between NF-kB and G1/S of the cell 
cycle
As previously highlighted, NF-k B may interact with a large number of other signalling 
systems, such as the Glucocorticoid Receptor system (Nelson et al. 2003) and the p53 
system (Webster et al. 1999) to give rise to markedly different physiological events. 
Such prevalence again highlights the importance of context when considering the 
influence of NF-k B on cell fate. Similarly to p53, NF-k B has also been shown to have 
both proliferative and anti-proliferative roles at G1/S phase of the cell cycle, (Guttridge 
etal. 1999; Hinata etal. 2003).
Throughout G1, cell cycle arrest may be mediated by the NF-k B system in several 
ways. Cyclin D may be targeted for degradation as a result of phosphorylation by IKK 
(Kwak et al. 2005) with Ik Bo shown to inhibit Cyclin D substrate CDK4 in certain 
contexts (Li et al. 2003). Activity of the Cyclin D:CDK4 complex may be further inhibited 
by NF-KB-mediated transcription of CDK inhibitor p21 (Hinata et al. 2003). Through 
transcription of p21, NF-k B also plays a role in cell cycle arrest from late G1 through to 
early S-phase through inhibition of Cyclin E:CDK2 activity, which is further targeted by 
direct binding between Cyclin E and NF-k B family member c-Rel (Eying Chen 1998). 
Proliferative activity attributed to NF-k B is also contextually linked to G1/S. 
Interestingly, given the relationships described above, Cyclin D is a well characterised 
NF-k B target gene (Guttridge et al. 1999). Furthermore, IKK, previously described as 
an inhibitor of Cyclin D, has been attributed to promotion of Cyclin D activity in certain 
contexts (Lamberti et al. 2001; Albanese et al. 2003). In addition, the expression of 
Ik Bci which has been shown to stabilise G1 progression through stabilisation of E2F-1 
in breast cancer (Tu etal. 2006).
Similar to relationships between the p53 and G1/S systems, the interactions between 
NF-k B and G1/S proteins present apparent contradiction when considered 
simultaneously. However, considering an inflammatory response within the scenario of 
progression from G1 into S-phase, we may suggest a model similar to that for DNA 
damage response at G1/S (Figure 1.10), which takes into account all of the 
relationships outlined above. The NF-k B:G1/S balance model (Figure 1.14) assumes 
an NF-k B response at G1/S involves temporary cell cycle arrest, allowing a response
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to occur prior to S-phase entry. Logically, this model requires mechanisms for cell cycle 
resumption, to allow the cell to resume its S-phase related activity at a later stage. 
Successful re-entry of the cell cycle prior to S-phase depends on the outcome of a 
period of “balance” which involves the coordination of the NF-k B response by G1/S 
proteins. Previous work has suggested the promotion of certain genes requires both 
E2F-1 and p65 to be bound to promoter regions (Lim et al. 2007), but intriguingly also 
to suggest that E2F-1 and p50 (the binding partner of p65) interact to repress certain 
target genes (Kundu et al. 1997). An exemplary recent study has also suggested cell 
cycle phase-dependant regulation of NF-k B subunits, concomitantly controlling the 
expression of NF-k B related cell cycle genes (Barre et al. 2007), complimenting the 
presented model for an NF-k B response at G1/S.
( I k B cO
Figure 1.14 The NF-kB:G1/S “balance” model: A NF-KB-mediated cell cycle arrest through 
transcriptional up-regulation of p21. B Balance phase involving coordination of the NF-k B response 
by G1/S proteins. C Cell cycle resumption through transcription of Ik Bo which terminates 
transcription of p21, and Cyclin D which is required for G1/S progression.
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1.4 Project Aims -  A Systems Biology framework
This project aims to take a Systems Biology approach towards characterising an NF- 
k B response at G1/S phase of the mammalian cell cycle. The central hypothesis of this 
work is that E2F-1 takes a temporal role in the control of NF-k B signalling dynamics in 
a similar manner to its role in p53 signalling.
Towards resolving this hypothesis, it is first intended to characterise interaction 
between E2F-1, and the NF-k B dimer (p65:p50) experimentally, within the context of 
the NF-k B system. Subsequently, it is intended to extend a mathematical model for the 
NF-k B system to include a module for interaction with E2F-1, in a manner consistent 
with the step-wise model expansion detailed in Figure 1.1 A#, and to use this model to 
make experimentally resolvable predictions for the behaviour of the NF-k B system in 
the presence of E2F-1 .This approach will be reviewed at intermediate stages to 
consider the significance of any data both in terms of Systems Biology and 
physiological context.
Work contributing to this thesis is considered in four stages:
1. Experimental work designed to provide a foundation for both conceptual and 
mathematical models depicting interaction between E2F-1 and the NF-k B system.
2. Theoretical work implementing a mathematical model for NF-k B:E2F-1 that is able to 
make non-intuitive predictions for the role of the interaction within the context of the NF- 
k B system.
3. Subsequent experimental resolution of dynamic model predications.
4. Work towards extending this model to the context of G1/S and cell cycle progression 
(Figure 1.1 B), and to consider the reciprocal relationship of NF-k B on E2F-1 signalling. 
Recalling the requirements of dynamic Systems Biology (Section 1.1.3), the biological 
context to this approach is provided by the NF-k B system in the first instance. The 
predictive ability stems from a mathematical model of the NF-k B extended to include 
E2F-1 and experimental resolution may proceed via biological and experimental model 
systems outlined in Sections 1.1.4 and 1.1.5. With these aims defined, we begin by 
providing an experimental foundation for the NF-k B:E2F-1 model.
34
Materials & Methods
Chapter 2 - 
Materials & Methods
35
Materials & Methods
2.1 Materials
2.1.1 Reagents
Tissue culture medium and non-essential amino acids were purchased from Gibco Life 
Technologies (UK) and Foetal Bovine Serum (FBS) from Harlan Seralab (UK). Human 
recombinant TNFa was supplied by Calbiochem (UK). All other chemicals were 
supplied by Sigma-Aldrich (UK) unless stated otherwise. Oligodeoxynucleotides were 
purchased from Invitrogen (UK).
2.1.2 Plasmids
The expression vectors pCMV-E2F-1, pCMV-E2F-2 and pCMV-E2F-3 were kindly 
supplied by Emmanuelle Trinh (BRIC, Copenhagen), and genes excised for use with 
Invitrogen’s Gateway cloning system (see Section 3.1). Luciferase reporter vector 
CyclinE-luc was obtained from Peggy Farnham (University of Wisconsin-Madison.USA) 
p65-DsRed-XP, Ik Bq-EGFP, iKBa-AmCyan, NF-luc (Clontech), have been described 
previously (Nelson etal. 2002).
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2.2.1 Molecular Biology
Materials & Methods
2.2.1.1 Transformation of competent cells
Employed to integrate ‘foreign” plasmid DNA into competent bacterial cells as a 
purcusor step to large-scale DNA preperation.
Competent cells were previously produced in the laboratory using the DH5a or Db3.1 
Escherichia coli (E.coli) strain. 1 p,g of plasmid was incubated on ice for 45 min with 50 
pi of cells and subsequently heat shocked at 42°C for 1 min. Heat-shocked cells were 
then returned to ice for a further 2 min, before being rescued by addition of 800 pJ of 
“Rescue media” (LB Broth, 20 mM glucose). The cells were then incubated at 37°C with 
shaking (-25 0  rpm) for 1 h. Cells were then pelleted by centrifugation at 4000rpm for 2 
min and resuspended in 40p I of media. This was then plated onto selective LB agar 
(100 og/ml kanamycin or Ampicilin) and incubated overnight at 37°C.
2.2.1.2 Amplification of plasmid DNA (Maxiprep)
Employed to provide a good quality working stock of plasmid DNA. Typically yielding up 
to 300/j I of DNA at a concentration > Ipglp l.
Plasmid DNA was amplified from transformed E.coli DH5a or DB3.1 cells that were 
cultured overnight in 250ml of selective LB broth using the QIAfilter Plasmid Maxi Kit 
(Qiagen, Germany) according to manufacturer’s instructions. Plasmid DNA was 
quantified using a UV-1601 UV-Visible spectrophotometer (Shimadzu, Japan). The 
absorbance was measured at 260 and 280 nm using monochromatic light. All 
expression vectors were of sufficient purity with a A260/A280 ratio between 1.8-1.9 for 
transfection into cells.
2.2.1.3 Agarose gel electrophoresis and gel extraction
Employed to separate DNA fragments from reaction mixtures post-restriction digest, 
both In order to extract an purify specific bands or carry out diagnostic restriction tests 
on DNA samples.
DNA fragments were separated by 1% (w/v) Agarose gel electrophoresis using 1x TAE 
buffer (Tris-acetate-EDTA: For a 50x solution -  242g Tris base, 57.1ml glacial acetic 
acid, 100ml 0.5M EDTA (pH 8.0)). Restriction-digested DNA samples were combined
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with 1/5 volume 6x Orange G loading dye solution (0.35% (w/v) Orange G; 30% (w/v) 
sucrose) and ran alongside a 1kb Plus DNA Ladder (Invitrogen) at 80mA for 1.5 h.
Gels were visualised under 302nm (UV) light using a trans-illuminator and imaged 
using the Syngene G-Box gel imaging system (Syngene, UK). Selected DNA fragments 
were cut from the gel with a scalpel blade and purified using the QIAquick Gel 
Extraction Kit (Qiagen). In this protocol, Agarose is dissolved to release the DNA, which 
is then bound to an anion-exchange membrane as used in plasmid preparation kits. 
Purified DNA fragment is then eluted in 30pl TE.
2.2.1.4 Restriction endonuclease digestion
Employed to cut DNA samples (usually from plasmid DNA for this work) into pieces of 
desired size, for either diagnostic checks or as part of molecular cloning procedures.
For complete digestion, in a 20pl reaction volume, 5pg of DNA was incubated with the 
appropriate restriction enzyme (RE) (3U/pg DNA) in 1x RE buffer (supplied) for 3h at 
the appropriate temperature (usually 37°C). If two REs were used simultaneously 
(double digest), 3U of each RE was used per pg DNA. DNA from the reaction was then 
purified with the QIAquick Gel Extraction Kit (Qiagen) or modified further as below. For 
diagnostic digestion of 0.5-1.Opg of plasmid DNA where partial digestion was preferred, 
less RE was used per reaction(<1 U/pg DNA) and the incubation time was reduced to 1-
1.5 h.
2.2.1.5 Blunting 5 '- and 3'- DNA overhangs
Employed to allow greater flexibility in RE digestion and subsequent cloning steps.
At the end of the 3h RE digest, polishing of 5’-overhangs and filling-in of 3’-overhangs 
was performed by adding T4 DNA Polymerase (1 U/pg) and 100pM dNTPs (final 
concentration) to the reaction mixture and incubating for a further 15min at room 
temperature. T4 DNA Polymerase works in any RE buffer when supplemented with 
dNTPs. The DNA in this reaction was then cleaned up with the QIAquick Gel Extraction 
Kit (Qiagen) or separated by electrophoresis on an agarose gel
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2.2.1.6 5'-Phosphate removal
Employed to prevent self-ligation in post-digest cloning reactions.
5'-phosphates were removed from RE-digested vector backbones. This was achieved 
by incubation with 1U/pg DNA of Shrimp Alkaline Phosphatase (SAP) (Promega, UK) 
for the final 15min of the RE digest. SAP is also active in RE buffers. Alternatively, SAP 
was incubated for 15min at 37°C in a 1x concentration of its own reaction buffer along 
with target DNA at 1U SAP per pg DNA. DNA was then purified by QIAquick Gel 
Extraction Kit (Qiagen) or separated on an agarose gel and used in ligation reactions.
2.2.1.7 DNA ligation
Employed to join together DNA fragments, usually involving a plasmid vector 
“backbone” and an insert purified after RE digest.
T4 DNA ligase (Invitrogen) was used to promote the formation of circular plasmids from 
two complementary pieces of linear DNA formed through some or all of the reactions 
described above. For the ligation of two fragments of DNA, an appropriate amount of 
insert and vector DNA was used. A 3:1 molar ratio of insertvector gave efficient 
ligation. To calculate the amount of each, the following equation was used:
Vec/lns (ng/pl) X  InsA/ec (kb) = p i Insert per p i  Vector that gives a 1:1 ratio.
The final figure was multiplied by 3 to achieve the 3:1 ratio. (In practice a range of 
ratios were chosen typically 3:1, 5:1 and 10:2). Depending on whether the DNA 
fragments had cohesive or blunt ends, the reaction conditions were altered but the 
volume of reaction mixture was kept constant. Cohesive “Sticky”-ended ligations were 
performed with a maximum of 0.1 pg DNA, 0.5U T4 DNA ligase and incubated at 25°C 
for 3h. Non-cohesive “blunt”-ended ligations were found to work best with a maximum 
of 1.0pg total DNA, 1U T4 DNA ligase and were incubated at 14°C for 20h. 2-4pl of the 
ligation reaction was then transformed into competent E. coli cells. Transformants were 
selected by their antibiotic resistance, plasmid DNA was purified, prior to diagnostic 
restriction digests and agarose gel electrophoresis.
39
Materials & Methods
2.2.1.8 DNA sequencing
Employed to compare desired DNA sequences to actual physical samples.
Automated DNA sequencing was carried out by The Sequencing Service, University of 
Dundee, UK (www.DNASEQ.co.uk). Sufficient DNA for two sequencing reactions were 
prepared for each sample, which consisted of the following: 500ng template DNA, 
6.4pM sequencing primer, made up to 32pl with TE. The theoretical melting 
temperature (Tm) of the sequencing primers were all designed to be approximately 
55°C and their Guanine/Cytosine content was constrained within a range of 40-60%. 
Sequence analysis was performed with MegAlign software (DNA Star) along with NCBI 
BLAST searches.
2.2.2 Cell culture
2.2.2.1 Subculturing cells
SK-N-AS (ECACC No. 94092302) and HeLa cells were cultured as a monolayer and 
grown in Minimal Essential Medium (MEM) with Earle’s salts, supplemented with 10% 
(v/v) Foetal Bovine Serum (FBS) and maintained at 37QC with 5% CO2 in a humidified 
incubator (Sanyo, Japan). Cells (-10-25% ) were passaged when the monolayer 
reached 80% confluency in a 75 cm3 tissue culture flask (Corning, UK) in a final volume 
of 20 ml. Cells were washed with Mg2+/Ca2+ free Phosphate Buffered Saline (PBS) then 
incubated with 1 ml of 0.05% (w/v) trypsin in 0.53 mM EDTA / PBS (Gibco.UK) to 
detach the monolayer from the flask. Cells were resuspended in 9 ml of medium and 
centrifuged in an Eppendorf Centrifuge 5804 (Eppendorf, UK) at 1000 rpm for 5 min to 
remove the trypsin and cell debris. The supernatant was discarded and the cell pellet 
resuspended in 10 ml of fresh gassed medium. A sample from the cell suspension was 
counted using a Z2 Coulter counter (Coulter, UK), and the remaining cells were diluted 
in medium and seeded as required. Different seeding densities were used for each type 
of experiment as shown in Table 2.1. For most applications, seeding was optimised to 
give a 60% confluency 24 h post-transfection.
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Dish size Cell no. SK-N-AS Cell no. HeLa Example Application
16mm 6 x104 - Luciferase Reporter As.
35mm 16x104 6x104 Live cell imaging
60mm 50x104 20x104 Immuno-blot, Q-PCR
100mm 200x104 80x104 Co-IP
Table 2.1 Numbers of HeLa and SK-N-AS cells seeded for different applications: The number 
of cells seeded depended on the size of the dish, the cell type, the duration of the experiment and 
the number of cells required to perform the assay.
22.2.2 Transient transfection
Employed to introduce plasmid DNA into host cells for the purpose of exogenous 
expression.
Cells were transfected at 60% confluency (usually 24 h after seeding) with the 
appropriate plasmid(s) using Fugene 6 (Roche Diagnostics, Germany) according to the 
manufacturer’s protocol. The optimum Fugene 6:DNA ratio was 2:1 and 4:2 for SK-N- 
AS and HeLa cells respectively. For all experiments involving transient transfection, 
cells were seeded to ensure a 60-70% confluency at time of transfection.
2.22.3 Cell cycle synchronisation
Employed to synchronise populations of HeLa cells in early S-phase (G1/S)
Thymidine was used to block cells at the G1/S boundary. It acts primarily through 
altering the balance of the deoxy-triphosphate base building blocks, which inhibits DNA 
replication. Growth inhibition by the addition Thymidine to the culture medium was also 
shown to involve feedback involving several other Pyrimidine biosynthetic enzymes 
(Bjursell et al. 1973; Kufe et al. 1980; Whitfield et al. 2000). The Double Thymidine 
Block protocol (adapted from (Whitfield et al. 2000)) was found to be most suitable for 
synchronising HeLa cell cultures. HeLa cells were seeded on Day 1 according to 
densities described in Figure 2.1. Following a 24 hour incubation period, Thymidine 
(Sigma,UK) was added to the culture medium to a final concentration of 2mM. 19 h 
later the Thymidine was removed from the cells using 3 PBS sequental washing steps 
and fresh MEM was added to the cells. Cells were transfected at thistime as required 
using the methods described above (2.2.2.2.). Following a 9 h incubation, Thymidine
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was again added to the culture medium to a final concentration of 2mM, Following a 
further 16 h incubation, the cells were successfully synchronised at G1/S as confirmed 
by flow cytometric DNA analysis (Chapter 7). Cells were then washed 3 times with 
PBS, and fresh medium was added to release the cell cycle block. The cells were 
subsequently analysed by live cell Imaging (Section 2.2.3.1), immuno-blot (Section 
2.2.4.3) or Q-PCR (section 2.2.4.6) at the appropriate time after release from the cell 
cycle block. The time at which the majority of cells were at each stage of the cell cycle 
was estimated using flow cytyometic DNA analysis, (see Chapter 7)
2.2.2A TNFa stimulation
Employed to stimulate the NF-kB pathway through induction of IKK activity. 
Stimulation with human inflammatory cytokine TNFa proceeded as a saturated dose of 
10ng/ml. Stimulation timing varies between experimental techniques as indicated. Cells 
were stimulated with a saturating dose of 10ng/ml human recombinant TNFa (Sigma, 
UK) at the indicated times prior to analysis.
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2.2.3 Single cell techniques
2.2.3.1 Live cell fluorescence imaging
Employed to measure levels of transiently transfected fluorescent fusion proteins over 
time in single living cells, giving quantifiable data relating to localisation and stability. 
Imaging of transfection cells (as indicated) proceeded 24 h post-transfection with a 
Zeiss LSM510 confocal microscope using AIM version 3.2 software. Prior to imaging, 
cells were incubated on the microscope stage for 30 min at 37°C, 5% CO2. EGFP 
fusion proteins were excited using the minimum amount of 488nm light from an Argon 
ion laser. Fluorescent signals were collected with a 545nm dichroic mirror through a 
505-550nm band-pass filter. Similarly, dsRedXP fluorescence was excited with a 
543nm Helium Neon laser and collected with a 545nm dichroic mirror and a 560nm 
long-pass filter. In all cases a transmission image was collected at the same time as 
the fluorescent image(s). Stimulation with TNFa, where applicable, normally occurred 
after an initial period of time lapse imaging. For imaging experiments involving 
synchronised cells (double Thymidine block method, as above) TNFa stimulation 
proceeded after release from Thymidine, prior to desired cell cycle time points (as 
indicated).
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2.2.3.2 Forster (Fluorescence) Resonance Energy Transfer (FRET) imaging
Employed to provide evidence of a physical interaction between two proteins in-vivo 
FRET involves the transfer of non-radiant energy between two fluorophores with 
overlapping donor emission and acceptor excitation spectra (typically Cyan and Yellow 
Fluorescent proteins; ECFP and EYFP (Karpova et al. 2003)) each “tagged” to one 
terminus of a protein of interest. Using the Acceptor Photo-bleaching method, 
increases in the levels of donor protein fluorescence are observed if the two proteins 
are close enough (~8nm) together to cause FRET and energy is no longer transferred 
to the acceptor and is therefore emitted as light (at the donor emission wavelengths). 
FRET was carried out using a Zeiss LSM510 with “META” spectral detector mounted 
on a Axiovert 100S microscope with a Plan-Apochromat 63x, 1.4 NA oil-immersion 
objective (Zeiss). ECFP and EYFP were excited with 458nm laser light, emitted 
fluorescence was collected in 8 images each separated by 10nm between 467nm and 
638nm in lambda scanning mode. Separation of ECFP and EYFP fluorescence was 
carried out using the linear unmixing algorithms of the Zeiss LSM510 software (Zeiss), 
using reference spectra taken from cells expressing the ECFP or EYFP fusion proteins 
alone or nothing (background reference). The fluorescence spectrum was separated 
into ECFP, EYFP and background signals. FRET was assayed by acceptor (EYFP) 
photo-bleaching. Bleaching was accomplished using 50 iterations of 514nm laser light 
with no attenuation from the acousto-optical tuneable filter (AOTF).
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2.2.4 Bulk cell techniques
2.2.4.1 Flow cytometric DNA analysis
Employed to determine the subsets of populations of HeLa cells at different cell cycle 
phases.
Following synchronisation, HeLa cells cultured in 100mm2 dishes were detached as a 
single cell suspension with 900pl trypsin. The cells were stained by addition of 250pl of 
50 pg/ml propidium iodide, 0.15% TritonX-100, and 150 pg/ml RNase A before analysis 
in an Altra flow cytometer (Beckman Coulter).
2.2.4.2 Luciferase reporter assays
Employed to determine the relative transcriptional activity for a given condition by 
assaying an enzymatic reaction between luciferin and the luciferase protein product 
from a transiently transfected luciferase reporter construct with a specific promoter.
Cells (as indicated) were seeded into 16mm wells of 24-well plates and transfected 
after 24 h with an appropriate luciferase reporter construct, with or without additional 
expression vectors. After an appropriate period of incubation, media was poured off, 
cells were rinsed with Ca2+-free PBS, and 250pl of lysis buffer added (0.025% (w/v) 
dithiothreitol (DTT), 1% (w/v) bovine serum albumin (BSA), 25mM Tris-phosphate, 1% 
Triton X -1 0 0 ,15% (v/v) glycerol, 0.1 mM EDTA, 8mM MgCh) (White etai. 1990). Lysis 
was aided by agitation at room temperature and supplemented with 1mM ATP (final 
concentration). 100pl lysate was transferred in duplicate to an opaque 96-well plate 
(Greiner ,UK). Luminescence was measured using a LUMIstar plate reading 
luminometer (BMG, Germany). 100pl 2mM D-luciferin (Biosynth AG, Switzerland) was 
added to each well and photons counted and integrated over 5 sec. Luminescence 
from each lysate duplicate was averaged and exported to Excel for data analysis.
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2.2A.3 Immuno-blotting
Employed as a semi-quantitative measure of protein levels across a cell population.
SK-N-AS and HeLa cells were seeded into 60mm dishes (Iwaki, Japan), incubated for 
24 h and subjected to experimental conditions (transfection, TNFa stimulation etc.). 
Cells were lysed in 200pl of a lysis buffer consisting of 40mM Tris-HCI, p H 6 .8 ,1% w/v 
SDS, 1 %v/v glycerol, 1% v/v p-mercaptoethanol and 0.01% w/v bromophenol blue. 
Samples were boiled for 10 min to reduce viscosity and eliminate protease activity and 
20pl of each was loaded onto a 10% SDS-PAGE gel. Electrophoresis and blotting was 
carried out using the Bio-Rad Protean II apparatus (Bio-Rad, UK) according to the 
manufacturer’s instructions. Detection of the proteins was carried out using the 
appropriate primary and secondary antibodies as per manufacturer’s instructions (Cell 
Signalling, USA, Santa Cruz, USA, UpState, USA, see below). Nitrocellulose 
membranes were incubated in ECL reagent, (100mM Tris HCI pH8.5, 0.001% H2O2, 
1.25mM luminol, 0.2mM para-coumaric acid made up to 10ml per membrane with H20) 
for 1 minute. Membranes were then either exposed to photographic film (Pierce CL- 
Xposure, England) or imaged in real time with the Syngene G-Box gel imaging system 
(Syngene UK) to visualize protein bands on the membranes. Primary antibodies used 
for this study are described in Table 2.2.
Probe Source Typical dilution Species/ Type Application
p65
(65kDa)
Cell Signalling, 
Cat no. 3034
1:1000 Rabbit
Polyclonal
Immuno-blot
p50
(50kDa)
Cell Signalling, 
3035
1:1000 Rabbit
Polyclonal
Immuno-blot
Ik Bci
(38kDa)
Cell Signalling, 
9242
1:1000 Rabbit
Polyclonal
Immuno-blot
E2F-1
(55kDa)
Upstate,
KH95
1:1000 Mouse
Monoclonal
Co-IP,
Immuno
CycloA
(18kDa)
Cell Signalling, 
2175
1:1000 Rabbit
Polyclonal
Immuno-blot
Table 2.2 Details of primary anti-bodies used in this study.
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2.2.4A Co-lmmunoPrecipitation (Co-IP)
Employed to assess physical binding between proteins across a cell population.
The general principle of Co-IP is that it is possible to indentify unknown or predicted 
species in a protein complex by specific antibody targeting of a known member of a 
complex. Firstly, an antibody against a target protein is coupled to Sepharose beads 
through protein A or G, then the complexes containing the target protein are 
immunoprecipitated (“pulled-down”) with the antibody-coupled beads. Protein species 
in the complexes are subsequently investigated by immuno-blotting using specific 
antibodies.
SK-N-AS and HeLa Cell lysates were prepared using combinations of the above 
techniques, typically involving either synchronisation or transfection of cells seeded at 
appropriate density into 100mm dishes. After 3 PBS washes, lysis proceeded using 
500pl of specific buffer (20mM Tris-HCI, 250mM NaCI, 3mM EDTA, 2mM EGTA, 0.5%  
Triton (x100)) to which was added a 1:100 dilution of Protease Inhibitor cocktail 
(Roche, UK). Lysates were then scraped into 1.5ml microfuge tubes and placed onto 
an orbital rocker for 15 min at 4°C, samples were then centrifuged at 14,000 rpm for 
15 min, maintaining the 4 °C temperature. In between lysate preparatory steps, 
quantities of Agarose A/G beads were prepared (Pierce,UK) for each lysate. This 
involved washing 30-50pl of beads in 5x 1ml PBS, pulsing the bead samples at 8,000 
rpm for 30 sec after each wash. After removal of as much supernatant as possible from 
the beads, the supernatant from the Co-IP lysates were added to bead samples and 
placed on an orbital rocker for 1 hour at 4 °C. The supernatant from these samples 
were then incubated with specific antibodies overnight on an orbital rocker at 4°C. The 
following day, similar amounts of A/G beads were prepared, and added to the 
lystate/antibody samples. After a further 2 hour incubation on an orbital rocker at 4°C, 
the beads should in theory be bound to protein complexes In which a target protein is 
bound. These samples were subjected to a 5x PBS wash and then resuspended in an 
equal volume of 2x immuno-blot lysis buffer (see Section 2.2.4.3). Samples were then 
boiled to detach proteins from beads and probed for proteins of interest via immuno- 
blot.
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2.2A.5 Immuno-cytochemistry (ICC)
Employed to visualise the localisation of endogenous protein or proteins
SK-N-AS and HeLa Cells were prepared using combinations of the above techniques, 
typically involving synchronisation and/or TNFa stimulation of cells seeded at 
appropriate density into 35mm glass-bottomed dishes (see Table 2.1). Dishes were 
subsequently washed three times with PBS and fixed with 1 ml 4% Paraformaldehyde 
for 15 min. Dishes were then washed three times with PBS, and “blocked” to prevent 
non-specific antibody binding with the addition of 1-2ml of 1% BSA, 0.1% Triton X-100 
(in PBS) from 20 min up to overnight.
The primary antibody (or antibodies for dual-staining) dissolved in 1% BSA,0.1% Triton 
X-100 -PBS were added to the dishes for 60/90 min at a 1:2000 dilution. Dishes were 
then subjected to 3 1 ml washes of 1% BSA,0.1% Triton X-100 -PBS of 10 min length. 
Secondary Antibody(s) were subsequently added to dishes (Cy3-anti-mouse, 1:200 
dilution (Sigma), FITC Rabbit, 1:200 (AbCam)) for 30/45 min, prior to 3 sequential 
washes of PBS blocking buffer (described above). Subsequent to the addition of light- 
sensitive secondary antibodies, dishes were covered in aluminium foil and left in 2ml 
PBS prior to imaging.
2.2A.6 Quantitative RT-PCR
Employed to quantify transcript levels for specific genes upon conversion of mRNA to 
cDNA.
The RNeasy Mini Kit (Qiagen, Germany) was used to extract mRNA from SK-N-AS and 
HeLa cells previously seeded into 60mm dishes. Cells were washed with ice cold PBS 
prior to lysis, then 600pl of buffer RLT containing p-Mercaptoethanol (1 % (v/v)) was 
added. The lysed cells were scraped and the lysate homogenised by passing through a 
20-gauge needle (0.9 mm diameter) approximately 10 times to mechanically cleave 
long strands of genomic DNA that may reduce the efficiency of mRNA extraction. The 
‘Spin Protocol’ was then used to extract the mRNA, which was eluted into 30 pi of 
RNase free water and stored at -80°C. The mRNA concentration and purity was 
quantified using a UV-1601 UV-Visible spectrophotometer (Shimadzu, Japan). The 
absorbance was measured at 260 and 280 nm monochromatic light. All mRNA were of
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sufficient purity with a A260/A280 ratio between 1.9-2.1 used in the reverse transcriptase 
reaction.
The VILO reverse transcription kit (Invitrogen, UK) was used for the production of 
cDNA. For each sample, 1 pg of mRNA was used. The cDNA was diluted 1:1 with 
RNase free H20 . In each reaction 1 pi of cDNA was incubated with 300 nM of each 
primer: IkBo left TGGTGTCCTTGGGTGCTGAT right GGCAGTCCGGCCATTACA, 
IkBe left GGACCCTGAAACACCGTTGT right CCCCAGTGGCTCAGTTCAGA, E2F-1 
left TGCAGAGCAGATGGTTATGG right TATGGTGGCAGAGTCAGTGG, cyclophilin A 
left GCTTTGGGTCCAGGAATG right GTTGTCCACAGTCAGCAATGGT, 1 x Power 
SYBR Green PCR mastermix (Applied Biosystems) with RNase free H20  added to a 
total volume of 20 pi. The cycling parameters are as follows: initial denaturation at 95 
°C for 20 sec, followed by 95 °C for 3 sec (45 cycles) followed by 95 °C for 15 sec, 60 
°C (2 cycles), carried out on an ABI7500 Fast thermocycler. The efficiency of the 
primers was tested, which gave a slope value of -  -3.13 and R2 value of 0.99. Relative 
quantification was used to calculate the fold difference based on the threshold cycle 
(CT) value for each PCR reaction using 2 - ^ T method. The target gene was normalised 
to the reference gene cyclophilin A, with calibrator as indicated.
2.2.5 Analytical tools and databases
The live-cell time lapse imaging data sets were analysed using Cell Tracker, a program 
specifically developed for use with such data (Shen et al. 2006). Analysed data was 
then exported to Excel (Microsoft, USA) for further analysis. Imaging and experimental 
Meta data and tags to high-throughput imaging data (typical imaging files are between 
4-6Gb in size) were managed using a custom database designed for the purpose 
(Jameson et al. 2008).
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2.3 Theoretical work
2.3.1 Mathematical modelling
All modelling work was implemented using MatLab Release 14 (MathsWorks.USA), 
and solved using MATLAB function ODE15s. Analysis of simulated time course data 
was performed in both Microsoft Excel and MATLAB. Model ODEs are described in 
Chapters 5 and 6, and all MatLab code is included on the accompanying DVD.
Model simulation protocols were designed to approximate transient transfection 
experiments. Typical modelling experiments involved two concurrent simulations 
(Figure 2.1). The first involved initialisation of model species representing IKK and 
cytoplasmic Ik BccNF-k B (model species IkBaNFkB), to 0.1 j iM, in order to achieve a 
“steady-state” equilibrium for the NF-k B system. The model was then recapitulated 
using the initial conditions provided by the steady-state to provide a stage on which to 
simulate “transfection”. This involved a Heaviside function “step” in the levels of 
cytoplasmic NF-k B (NFkB) and/or E2F-1 (E2F), as desired. Concentrations of involved 
species were supplemented with an additional 0.1 |t M (at T=1000 in Figure 2.1). 
Stimulation of the NF-k B system was simulated by activation of TNFa signal (T fi), 
represented as a binary switch.
Time (mins)
Figure 2.1 A typical model simulation protocol: Involving transfection and stimulation (at 
T=1000) simulated from a steady state (see text for details).
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Specific strategies for modelling are discussed at length in Chapters 5 and 6. Full lists 
of initial conditions for pre- and post- equilibration are shown in Table 3.1.
Species Initial Conditions 
pre- Equilibration
m
Initial Conditions 
post- Equilibration
(MM)_______
NFkB 0 0.004 (+0.1)
nNFkB 0 0.015
E2F 0 0(+0.1)
nE2F 0 0
tlkBa 0 lx e-005
IkBa 0 0.017 (+0.1)
nlkBa 0 0.004
IKKn 0.1 0.1
IKK 0 0
IKKi 0 0
tA20 0 lx e-005
A20 0 0.001
plkBa 0 0
plkBaNFkB 0 0
NFkBE2F 0 0
nNFkBE2F 0 0
IkBaNFkB 0.1 0.091
nlkBaNFkB 0 0.001
Table 3.1 Initial conditions for NF-kB:E2F-1 mathematical model: Involving transfection 
(typically transfected species indicted in red) and stimulation modelled from a steady state (see text 
for details).
51
Generation & Characterisation of Tools
Chapter 3 -
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3.1 Generation of E2F fluorescent fusion constructs
E2F expression vectors were created using the Invitrogen Gateway® system. The 
Gateway system allows the creation of multiple expression vectors via site-specific, 
bacteriophage lambda recombination of preparatory “Entry” or “Donor vectors with 
“Destination” vectors for a variety of expression types. For this project, the majority of 
the work will focus on live cell fluorescence microscopy as an experimental model 
system. It was therefore decided to develop fluorescent expression vectors for E2F-1, 
E2F-2 and E2F-3 for transfection into cells. Destination vectors for Enhanced Green 
Fluorescent Protein (EGFP) were initially chosen in the knowledge that co-transfection 
would proceed with a p65 Discosoma-Red-Express (dsRedXP) vector, which has 
excitation and emission spectra easily separable from EGFP. These experiments were 
designed to compliment previous work characterising the dynamics of p65-dsRedXP 
alone.
Recombination between Entry and Destination vectors was the product of a straight­
forward, hour-long Clonase reaction. Correspondingly, the majority of the work in 
Gateway cloning involves manipulating the gene of interest into the preparatory Entry 
vector. Invitrogen provide a PCR method for engineering backbone DNA specific for 
producing peptide sequences onto the N- and -C termini of the gene to allow easy 
recombination from a starting vector into a “pDonr” vector and then into a choice of 
destination vector. However, for the creation of the E2F vectors, a more traditional 
approach was chosen, involving restriction enzyme digest of starting vector and ligation 
into Entry vector.
E2F gene fragments were excised from pCMVHA-E2F using a BamH\ restriction 
enzyme (NEB) and inserted via sticky ligation into Gateway Entry vector p-ENTR-2A at 
the BamHI site, then subsequently transformed into Db3.1 bacteria. The ccdb 
“placeholder” gene present in p-ENTR-2A was then removed via EcoRI digest and the 
new entry vector “pENTR-2A-E2F-1” transformed in Dh5a cells. The Entry Vectors for 
E2F-1 ,E2F-2 and E2F-3 were then sequenced to ascertain the correct reading frame(s) 
for subsequent recombination (to ensure consistency of reading frame between 
fluorescent tag and protein of interest). Using an N-Terminus, C1-frame destination 
vector, Gateway LR-Clonase reactions were performed to produce EGFP-E2F-1
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(Figure 3.1), EGFP-E2F-2 and EGFP-E2F-3. These vectors were then sequenced prior 
to use.
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Figure 3.1 Gateway cloning steps for EGFP-E2F-1: A Showing pCMVHAE2F-1 from which the 
human E2F-1 gene was excised using BamHI digest. B Showing pENTR2A, modified Gateway 
Entry vector, into which the E2F-1 gene is inserted (see text for details). C Final map for 
pENTRA2A-E2F-1. D pG-EGFP-C1, EGFP destination vector with EGFP in reading frame C. E 
Final map for EGFP-E2F-1, produced after clonase reaction between pG-EGFP-C1 and 
pENTRa2A-E2F-1.
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3.2 Characterisation of EGFP-E2F-1 and endogenous controls
GFP variants of E2F-1 have been previously used for studies in the context of the G1/S 
cell cycle system (Angus et al. 2003; Yao et al. 2008). Expression of the newly 
generated EGFP-E2F-1 in SK-N-AS human neuroblastoma cells was used to 
characterise the exogenous E2F-1 protein and to draw comparisons with previously 
published work characterising the endogenous E2F-1 protein. Firstly, the sub-cellular 
localisation of EGFP-E2F-1 was observed via live cell imaging and compared to that of 
endogenous E2F-1, determined via Immuno-cytochemistry. Figure 3.2 shows 
representative SK-N-AS cells showing a predominantly nuclear localisation for both 
exogenous and endogenous E2F-1, with roughly 10% of the protein localised in the 
cytoplasm at equilibrium.
Figure 3.2 Localisation of exogenous and endogenous E2F-1: A Showing EGFP-E2F-1 
predominantly localised to the nucleus with -10% cytoplasmic in SK-N-AS cells. B Showing 
immuno-staining for E2F-1 in SK-N-AS cells showing a similar pattern of localisation.
This is consistent with previously published work suggesting a dynamic balance 
between nuclear and cytoplasm shuttling producing a steady-state predominantly 
nuclear localisation that is subject to dynamic changes (Magae et al. 1996; Verona et 
al. 1997), subsequently likened to the NF-k B system (Cartwright et al. 2000; Baguley et 
al. 2005). The observation of dynamic equilibria in live cell imaging is introduced in 
Chapter 4.
The degradation half-life of endogenous E2F-1 was reported to be between 2 and 3 
hours, although this may be extended by up to 3 fold through stabilisation by pRB
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(Hofmann etal. 1996; Campanero etal. 1997). As discussed in Section 1.2.3, pRB was 
found to be a transcriptional target gene of E2F-1 (Ishida et al. 2001). Assuming the 
fusion construct was transcriptionally active, exogenous expression of the fusion 
protein may have changed its own half life through transcription of pRB. Figure 3.3 
(movie M3.3 on accompanying DVD) shows SK-N-AS cell expressing EGFP-E2F-1 at 
an appropriate level, i.e. across a population of cells expressing EGFP-E2F-1, cells 
were selected based on a level of fluorescence that would allow non-saturated images 
to be recorded and analysed, whilst allowing the cytoplasmic fraction of EGFP-E2F-1 to 
be observed (see below). Analysis of EGFP-E2F-1 fluorescence levels over time 
revealed an average degradation time of between 3 and 4 hours, with certain cells 
showing a EGFP-E2F-1 half-life of up to 7 hours. The half-life of EGFP-E2F-1 is 
considered further in Chapter 7.
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Figure 3.3 Degradation of EGFP-E2F-1: A Showing a typical SK-N-AS cell expressing EGFP- 
E2F-1 with an empty-Red control plasmid. B Quantification of EGFP levels over time. Fitted to an 
exponential curve giving a degradation half-life of -180 min. Data set considered further in Chapter 
6 .
These data suggest that the E2F-1-EGFP construct has a similar degradation time to 
the endogenous protein. Direct evidence supporting a transcriptional role for EGFP- 
E2F-1 was gathered from luciferase reporter assays, considering the effect of EGFP- 
E2F-1 expression on an E2F-luc luciferase reporter construct (Figure 3.4).
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Figure 3.4 Transcriptional functionality of EGFP-E2F-1: Showing data from luciferase reporter 
assays using an E2F-luc construct to report on relative levels of E2F associated transcription in 
unstimulated SK-N-AS cells. Transient transfection with EGFP-E2F-1 alone gives a ~19 fold rise 
above an empty transfection. Co-transfection with a non fluorescent RB vector inhibited the 
transcriptional activity associated with EGFP-E2F-1 transient transfection.
Further evidence for the functionality of EGFP-E2F-1 is referred to throughout this work 
as appropriate, such as the link between exogenous expression of E2F-1 and 
apoptosis (Sections 4.6 and 7.5) and the endogenous E2F-1 profile generated by 
successful synchronisation with double-Thymidine block (Section 7.4). As EGFP-E2F-1 
was shown to be transcriptionally active and show a similar intracellular localisation to 
that of endogenous E2F-1, further E2F-1 vectors were created from pENTFt-2A-E2F-1. 
These included Enhanced Cyan and Yellow Fluorescent Proteins, ECFP-E2F-1 and 
EYFP-E2F-1 used for FRET studies (Section 4.4) and DsRedXP-E2F-1, to provide 
flexibility for live cell imaging studies involving co-transfection with different 
combinations of expression vectors.
59
E2F-1 and T he NF-k B System: Towards a Model Foundation
Chapter 4 -
E2F-1 and The NF-k B System: 
Towards a model foundation
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4.1 Introduction -  Shuttling and Translocation
Protein localisation is a dynamic process. Protein molecules move constantly around 
the cell, shuttling between nuclear and cytoplasmic compartments. The dynamic 
balance between nuclear and cytoplasmic protein concentration is influenced, at least 
in part, by the relative strength of nuclear import and export sequences contained in the 
structure of some proteins and protein complexes, resulting in an apparent 
predominant “steady-state” localisation. Rather than proteins being fixed in one place, 
an image of a live cell at a particular point in time gives a relative indication of how long 
molecules spend in a particular localisation by their abundance.
Perturbations to intracellular protein networks may result in bulk movement of protein 
molecules between compartments and a shift in their predominant localisation. As such 
there is an important difference between “shuttling” which is a constitutive process 
where molecules exchange places at equilibrium and “translocation”, a process 
involving bulk movement from one equilibrium to another.
This is an important distinction to make when considering patterns of translocation or 
“oscillations”, as mechanistically distinct from protein shuttling. The bulk dynamics of 
transcription factor NF-k B (where stochastic events such as gene transcription depend 
heavily on its nuclear protein concentration) involve oscillations driven by negative 
feedback and shifts in the suitability of the NF-k B complex for nuclear import (due to 
the exposure of the NLS of p65 and p50) or export (due to the binding of Ik Bo to p65 
which masks the p65 NLS and exposes the Ik Bo NES) as highlighted in Section 1.3.2.
The dynamics of the NF-k B system in response to TNFa have been well defined 
((Nelson et al. 2004) and Section1.3.3) and provide a model “system output” for 
quantitative or semi-quantitative assessment of the effect of perturbations to the 
system. One may assess the role of an external factor, for example cell cycle regulator 
E2F-1, on p65 and p50 within the context of the NF-k B system simply by looking for 
changes in predicted localisation and dynamics.
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4.2 The effects of exogenous E2F-1 on NF-kB localisation
As previously stated, NF-k B family members p65 and p50 form the prototypical NF-k B 
transcriptional complex, and remain predominantly sequestered in the cytoplasm by 
Ik B proteins in non-stimulated conditions. Initial work investigated the potential 
changes to the localisation of fluorescently labelled, transiently expressed NF-k B and 
E2F family members in order to determine relationships between E2F-1 and NF-k B. 
Combinations of expression vectors were transiently transfected into SK-N-AS human 
neuroblastoma cells and imaged at least 24 h later (Figure 4.1). When expressed 
alone, p65-dsRedXP had a predominantly cytoplasmic localisation whereas EGFP- 
E2F-1 was mainly nuclear. However, when expressed together, both p65-dsRedXP 
and EGFP-E2F-1 were predominantly nuclear. Interestingly, a triple-transfection of 
plasmids expressing p65-dsRedXP, EGFP-E2F-1 and a CMV-Ik Bo construct (that 
expressed a non-fluorescently tagged Ik Bo protein) yielded a cytoplasmic localisation 
of p65-dsRedXP (protein) which was consistent with the localisation observed when the 
same protein was expressed alone or in combination with Ik Bo-EGFP. These results 
suggest that EGFP-E2F-1 sequestered p65-dsRedXP to the nucleus and that this 
effect is reversed by Ik Bo co-expression. The cytoplasmic localisation of p65-dsRedXP 
when expressed alone implied that the endogenous levels of Ik Bo were higher than 
that of E2F-1 in SK-N-AS cells, requiring exogenous expression of E2F-1-EGFP to 
over-turn the balance. Furthermore, cells emitting lower levels of E2F-1-EGFP 
fluorescence showed a predominantly cytoplasmic localisation of p65-dsRedXP whilst 
E2F-1-EGFP remained predominantly nuclear.
When p50-dsRedXP and EGFP-E2F-1 fluorescent proteins were expressed alone both 
showed a predominant nuclear localisation (Figure 4.1). The observed localisation of 
p50-dsRedXP was expected as p50 contains an intrinsic NLS (Huxford et al. 1998). 
When p50-dsRedXP and EGFP-E2F-1 fluorescent proteins were expressed in 
combination they co-localised in the nucleus. This observation was consistent with (but 
not evidence for) physical interaction between p50 and E2F-1.
Similarly to cells expressing p65-dsRedXP, a triple transfection of plasmids expressing 
p50-dsRedXP, EGFP-E2F-1 and Ik Bo yielded a predominant cytoplasmic localisation 
for p50-dsRedXP consistent with co-expression of p50-dsRedXP and EGFP-Ik Bq .
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A p65-dsRedXP F p65-dsRedXP + E2F-1-EGFP (high)
B E2F-1-EGFP G p65-dsRedXP + E2F-1-EGFP (low)
C p50-dsRedXP H p50-dsRedXP + E2F-1-EGFP
D p65-dsRedXP + IkBq-EGFP I P65-dsRedXP + E2F-1-EGFP + IkBq
E p50-dsRedXP + IkBo-EGFP J p50-dsRedXP + E2F-1-EGFP + IkBq
Figure 4.1 Localisation of transiently expressed NF-kB and E2F-1 fluorescent reporter 
proteins: Showing SK-N-AS cells transfected with combinations of plasmids expressing 
fluorescent fusion proteins. A, B and C Showing the predominant localisation taken by p65- 
dsRedXP (cytoplasmic), EGFP-E2F-1 (nuclear) and p50-dsRedXP (nuclear), respectively, when 
expressed alone. D and E The effect of co-expression of Ik Bo EGFP on the predominant 
localisation of p65-dsRedXP (no change; remaining cytoplasmic) and p50-dsRedXP (changed; 
cytoplasmic). F and G The different effects of high and low levels of E2F-1 on p65-dsRedXP 
localisation. H The expected co-localisation of EGFP-E2F-1 and p50-dsRedXP in the nucleus upon 
co-expression. I and J The restored cytoplasmic localisation for p65-dsRedXP and p50-dsRedXP 
respectively when co-expressed with non fluorescent Ik Bo in addition to EGFP-E2F-1, suggesting 
a competition between E2F-1 and Ik Bq.
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4.3 The effect of transiently expressed E2F-1 on NF-kB 
localisation
The observed relationship between high E2F-1-EGFP level and predominantly nuclear 
p65-dsRedXP and low E2F-1-EGFP level and predominantly cytoplasmic p65- 
dsRedXP suggested a possible physical relationship. This was investigated by imaging 
SK-N-AS cells expressing p65-dsRedXP and EGFP-E2F-1 for up to 12 hours. The 
time-lapse imaging data represented by the selected images and graph in Figure 4.2 
(movie M4.2 on accompanying DVD) showed that when p65-dsRedXP and EGFP-E2F- 
1 were expressed simultaneously p65-dsRedXP resumed a predominant cytoplasmic 
localisation upon degradation of EGFP-E2F-1. These data were consistent with a 
nuclear sequestration effect of E2F-1 on p65 that is proportional to the level of E2F-1 in 
the cell, and supported the hypothesis that there is competition between E2F-1 and 
Ik Bq for NF-k B binding.
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Figure 4.2 The effect of E2F-1 level on NF-kB nuclear occupancy in unstimulated conditions:
A SK-N-AS cells imaged over time by fluorescence microscopy. Both cells show a predominant 
nuclear localisation for both EGFP-E2F-1 and p65-dsRedXP at 0, but show a movement of p65- 
dsRedXP to take a predominant cytoplasmic localisation coincident with the degradation of EGFP- 
E2F-1. B Quantification of nuclear fluorescence levels in the two cells shown in Panel A, showing a 
difference in levels of EGFP-E2F-1 (green lines) at 0. The cell with a lower level of EGFP-E2F-1 at 
0 shows an earlier drop in nuclear p65-dsRedXP fluorescence (red lines), suggesting a proportional 
nuclear sequestration effect of E2F-1 on p65 in the nucleus. Red lines show p65-dsRedXP nuclear 
relative fluorescence intensity, orange lines show p65-dsRedXP cytoplasmic relative fluorescence 
intensity, green lines show EGFP-E2F-1 nuclear relative fluorescence intensity, for two different 
cells labelled by n and o . Fluorescence intensity is measured as average intensity per pixel. Time 
series images post-processed for clarity.
Co-localisation of EGFP-E2F-1 and p65-dsRedXP was measured over time in cells 
showing varied expression levels of both fluorescent proteins. Longitudinal imaging of 
cells expressing high EGFP-E2F-1 levels shows a much longer nuclear retention (NR) 
time of p65-dsRedXP than observed in cells expressing low levels of EGFP-E2F-1 or 
p65-dsRedXP alone. The resultant data set shows high correlation (R2=0.8592)
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between level of EGFP-E2F-1 nuclear fluorescence and the duration of p65 nuclear 
retention (Figure 4.3).
Figure 4.3 Proportional relationship between p65-dsRedXP nuclear occupancy and EGFP- 
E2F-1 degradation: Showing a high degree of correlation between p65-dsRedXP translocation 
from nucleus to cytoplasm, and the loss of nuclear EGFP-E2F-1 fluorescence in SK-N-AS 
expressing both fluorescent proteins. Chart representative of 10 SK-N-AS cells.
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4.4 Binding between ectopically expressed E2F-1, p65 and p50 
and licBa
It might be assumed that in the studies above the p65-dsRedXP dynamics represent 
the dynamics of both the p65:p65 homodimer and the p65:p50 heterodimer. As can be 
seen from Figure 4.1, p50 takes a nuclear localisation in un-stimulated conditions, 
making the co-localisation of E2F-1-EGFP and p50-dsRedXP consistent with, but not 
evidence for, physical interaction. Similarly, the proportional relationship between 
EGFP-E2F-1 degradation and p65-dsRedXP nuclear retention time could be explained 
by indirect interaction between the NF-k B and E2F systems.
To investigate direct protein-protein interaction between NF-k B proteins and E2F-1 in 
vivo, binding between E2F-1, p65 and p50 was assessed using Forster Resonance 
Electron Transfer (FRET) (Figure 4.4). Although there are many FRET-based 
techniques, the approach is not straightforward due to overlaps between the excitation 
and emission spectra of both the donor and acceptor fluorophores. For example, when 
using the 458 and the 514 laser lines in confocal microscopy the emission spectrum of 
ECFP fusions have an emission peak at the same wavelength as EYFP which itself is 
excited with the 458 laser line used to excite ECFP. To alleviate these problems, 
acceptor photobleaching is commonly used as a control. SK-N-AS cells were 
transiently transfected with plasmid vectors expressing pairs of ECFP and EYFP fusion 
variants of NF-k B and E2F-1 proteins and assessed for FRET. The results yielded 
positive results for p65 and p50 (components of the predominant NF-k B heterodimer) 
but also for p65 and E2F-1 and p50 and E2F-1 (Figure 4.4, example shown in movie 
M4.4) in both nuclear and cytoplasmic compartments. No FRET was detected between 
Ik Bq and E2F-1 fusion proteins.
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Figure 4.4 FRET between E2F-1, p65 and p50 fusion proteins: A Typical cell showing a 
decrease in p65-EYFP fluorescent signal following bleaching coincident with a rise in ECFP-p50 
fluorescent signal, indicating positive FRET. B Loss of signal from CMV-EYFP does not lead to a 
rise in CMV-ECFP signal, no FRET produced C FRET between EYFP-E2F-1 and ECFP-p50 D 
FRET between p65-EYFP and ECFP-E2F-1 E and F show the respective average fold changes in 
fluorescent signal for the EYFP-E2F-1 /  ECFP-p50 and p65-EYFP / ECFP-E2F-1 FRET pairs. 
Averages are taken from a data set of at least 25 cells and displayed +/-1 std. deviation.
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Physical binding of E2F-1 and NF-k B proteins was confirmed in vivo via Co-lmmuno- 
Precipitation. Populations of SK-N-AS cells were subject to protein pull-down with an 
E2F-1 antibody, and yielded bands representative of p65 and p50 when probed (Figure
4.5). No positive Co-IP results were found between E2F-1 and Ik Bci.
A p65 R p50
E2F-1 Ctrl IgG E2F-1 Ctrl IgG
Figure 4.5 Assessment of endogenous binding between E2F-1, p65 and p50 via Co- 
Immunoprecipitation in SK-N-AS cells: A Showing a band representative of p65 in E2F-1 protein 
pull-down that Is not present in the rabbit IgG lane. B Showing a band representative of p50 in E2F- 
1 protein pull-down that Is not present in the rabbit IgG lane. Positive control ‘Ctrl’ was SK-N-AS 
cells immuno-blotted for specific antibody against p65.
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4.5 The NF-kB:E2F-1 conceptual model and its assumptions
Binding between E2F-1 and both members of the prototypical NF-k B complex, together 
with nuclear sequestration of p65 by E2F-1 observed in unstimulated conditions, 
allowed a conceptual model to be drawn up (Figure 4.6). The nuclear occupancy of 
p65-dsRedXP in the presence of ectopic levels of EGFP-E2F-1 is consistent with 
binding between the predominant NF-k B complex p65:p50 and E2F-1, in competition 
with endogenous levels of Ik Bo . This competition concurs with the observed 
translocation of p65-dsRedXP into the cytoplasm following EGFP-E2F-1 degradation. 
In order to explain the bulk cytoplasmic movement of NF-k B, it is necessary that levels 
of Ik Bci are high enough to remove free NF-k B from the nucleus. The most obvious 
mechanism to offer in explanation is that the NF-k B is transcriptionally active whilst 
bound to E2F-1 in the nucleus allowing the induction of the expression of Ik Bq .
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Figure 4.6 The NF-kB:E2F-1 conceptual model Mk.l: A Competition for binding to “free” NF-k B 
between Ik Bo and E2F-1 is mutually exclusive. In transient transfection conditions ectopic levels of 
E2F-1 are higher than endogenous Ik Bo leading to a balance turned in favour of the formation of 
the NF-k B:E2F-1 complex, which translocates to the nucleus and initiates transcription of target 
genes including Ik Bo. B E2F-1 degrades over time, leading to dissociation of the NF-k B:E2F-1 
complex and an increased amount of free NF-k B in the nucleus. C De-novo Ik Bo translocates to 
the nucleus, binds to free NF-k B and pulls it back to a predominantly cytoplasmic localisation.
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To test this assumption, luciferase reporter assays were carried out, examining the 
effects of combinations of transiently transfected plasmids expressing EGFP-E2F-1 
and p65-dsRedXP proteins on NF-KB-related transcription. Luciferase activity was 
measured from an NF-k B reporter construct (NF-luc) composed of five NF consensus 
sequences fused to luciferase (Figure 4.7). It can be clearly seen that the combination 
of EGFP-E2F-1 and p65-dsRedXP produced a reduced level of NF-k B transcription 
compared to that measured in cells expressing p65-dsRedXP alone. However, this 
level was still significantly higher than the NF-luc signal measured in cells transfected 
with empty plasmids. These data may suggest that the nuclear NF-k B:E2F-1 complex 
is less active (2.5-fold) at this promoter compared to the “free” NF-k B complex.
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Figure 4.7 NF-kB transcriptional activity in transient transfection conditions: Showing data 
from luciferase reporter assays. NF-luc construct used to report on NF-k B associated transcription 
in SK-N-AS cells in unstimulated conditions, 24-hours post transfection. Expression of p65- 
dsRedXP alone gives a ~10 fold rise above an empty transfection. EGFP-E2F-1 does not cause an 
increase in NF-luc activity when expressed alone and significantly inhibits the level of transcription 
derived from p65-dsRedXP when co-expressed. Chart representative of 3 biological replicates. 
Error bars indicate +/- Standard Error Mean (SEM) values.
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4.6 NF-kB affects E2F-1 related Apoptosis
As highlighted in Section 1.2.2, over-expression of E2F-1 habitually leads to apoptosis 
due to premature “entry” into S-Phase (Johnson et al. 1993; Qin et al. 1994). One 
striking observation made from time-lapse imaging experiments was that SK-N-AS cells 
expressing p65-dsRedXP and EGFP-E2F-1 show low levels of cell death compared to 
cells expressing EGFP-E2F-1 alone (Figure 4.8). The number of cells expressing 
EGFP-E2F-1 at the start of imaging was calculated, and compared to the number of 
these cells that remained alive after a 12-hour period. The percentage of cell death was 
compared to a similar calculation for cells expressing p65-dsRedXP alongside EGFP- 
E2F-1. From data sets of at least 50 cells per condition, 68% of cells expressing EGFP- 
E2F-1 were dead after 12 hours. However, cells co-expressing p65-dsRedXP showed 
a -36 %  decrease in cell death with 32% of transfected cells dead after 12 hours. From 
these data it was concluded that the interaction between NF-k B and E2F-1 may block 
E2F-related apoptosis. This work is extended in Chapter 7.
p65-dsRedXP
Figure 4.8 NF-idB affects the level of E2F-1 -mediated Apoptosis: Levels of cell death were 
measured in cells expressing EGFP-E2F-1 alone and EGFP-E2F-1 together with p65-dsRedXP in 
a 12 hour period, 24-hours post-transfection. Expression of EGFP-E2F-1 alone resulting in 68% 
cell death whereas co-expression of p65-dsRedXP resulted in only 32% cell death. Data sets 
representative of at least 50 cells per condition.
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4.7 Discussion
In the work described in this chapter, we have presented evidence of physical 
interaction between E2F-1 and the NF-k B system. E2F-1 affects a change in NF-k B 
protein localisation in unstimulated conditions (Figure 4.1). Time-lapse imaging reveals 
this effect to be proportional to the level of EGFP-E2F-1 in the cell, and is therefore 
variable from cell to cell (Figures 4.2 and 4.3). This relationship was found to be a 
result of direct physical interaction between E2F-1, p65 and p50 (Figures 4.4 and 4.5). 
The proportional sequestration of NF-k B through direct binding to E2F-1 raised a 
question over the transcriptional efficiency of NF-k B whilst bound to E2F-1, which was 
subsequently found to be less than that of “free” NF-k B (Figure 4.7). The relationship 
between E2F-1 and NF-k B was shown to be functional as well as physical due firstly to 
the effect of E2F-1 on NF-k B transcription, but also due to the ability of NF-k B to 
decrease the apoptotic effect of E2F-1 ectopic expression.
A conceptual model of the NF-k B system, extended to include E2F-1 is the simplest 
way to explain observed dynamics (Figure 4.6). This conceptual model provides an 
ideal foundation for a Mathematical Systems Biology approach. Recalling the criteria 
defined for the application of Mathematical Systems Biology, there is now a choice of 
context (either NF-k B at G1/S of the cell cycle or E2F-1 interaction in the NF-k B 
system); predictions to resolve (characterisation of the effects of E2F-1 on the NF-k B 
system and it’s dynamics); and an experimental system with which to provide an 
answer (An NF-k B response to stimulus, with TNFa as system input and p65-dsRedXP 
dynamics as system output). The next step in this study was to create a testable 
mathematical model from the conceptual model.
74
TheNF-k B:E2F-1 M o d e l : E x t e n s i o n , P r e d ic t io n  a n d  E x p e r im e n t a l  V e r if ic a t io n
Chapter 5 -
The NF-k B:E2F-1 Model: 
Extension, Prediction, and Verification
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5.1 Introduction and rationale
In this chapter the conceptual model created in chapter 4 will be implemented using 
mathematical description. As highlighted in Section 4.7, there is a choice of biological 
context for this model; either NF-k B at G1/S of the cell cycle or E2F-1 interaction in the 
NF-k B system. Although the cell cycle context presented the opportunity to obtain 
novel data, it was decided to apply the model to the context of the NF-k B system. This 
was due to the presence of well characterised experimental systems to allow some 
experimental work to proceed immediately, and the availability of an existing 
deterministic mathematical model for the NF-k B system providing a foundation for 
subsequent extension. This strategy was also intended to provide the opportunity to 
gather data comparable to previous and current studies (Nelson et al. 2004; Ashall et 
al. 2009)
5.2 Revision and extension of the NF-kB model
To mathematically describe the NF-k B:E2F-1 conceptual model as a deterministic 
mathematical model, the existing deterministic model of the NF-k B system fitted to 
single cell SK-N-AS cells (Ashall et al. 2009) was extended to include a “module” for 
interaction with E2F-1.
Inclusion of the E2F-1 module required revision of the existing NF-k B model to ensure 
consistent nomenclature between original and new species. The convention chosen 
was to name complexes in a hierarchical manner, i.e. with the order of Ik Bci (denoted 
by IkBa) in front of NF-k B (NFkB) in front of E2F-1 (E2F). Although the experimental 
work outlined in Chapter 4 confirms binding between E2F-1 and the active NF-k B 
complex (p65 and p50 are modelled as a single complex in the NF-k B model), 
hypothetical complexes involving E2F-1 and Ik Bo were included in the design, giving 8 
new species, 4 of which involve complexes of E2F-1 and Ik Bo which were left 
unpopulated in the first version of the model (Table 5.1).
There are several reasons for including complexes involving Ik Bo and E2F-1 in the 
model structure. Firstly, lack of positive FRET or Co-lmmunoprecipitation does not 
discount direct interaction between two protein species, if for example, the bound
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complex is unstable or the binding occurs in such a way that fluorescent fluorophores 
are too far away from each other for FRET to occur (this situation becomes increasingly 
likely if a protein complex is composed of multiple protein species). Secondly, it is much 
easier to make provision for all potential interacting species during the early stages of 
model creation (and leave some species inactive during implementation) than it is to 
include a new species to all related ODEs of a working model. Thirdly, should it be 
required, any network species may be renamed and still retain its effect on other model 
species, allowing redundancy to be built into the model for easier expansion of the 
network in the future.
Cytoplasmic Species
S p e c ie s R e p re se n ts A sso c ia te s  w ith
l NFkB N F-kB 2,3
2 E2F E2F-1 1,3
3 IkBa IkB(x 1,2
4 NFkBE2F N F-kB:E2F-1 3
5 IkBaNFkB IkB<x:NF-kB 2
6 IkBaE2F IkB(x:E2F-1 1
7 IkBaNFkBE2F IkB(x:NF-kB :E2F-1 -
Nuclear Species
S p e c ie s R e p re se n ts A sso c ia te s  w ith
8 nNFkB nNF-KB 9,10
9 nE2F nE2F-l 8,10
10 nlkBa nltcBa 8,9
11 nNFkBE2F nNF-KB:E2F-l 10
12 nlkBaNFkB nlKBa:NF-tcB 9
13 nIkBaE2F nlKBa:E2F-l 10
14 nIkBaNFkBE2F nlKBa:NF-KB :E2F-1 -
Table 5.1 New or amended species introduced to the NF-kB:E2F-1 model: Populated species, 
shown in red, represent cytoplasmic and nuclear species for E2F and the NFkBE2F complex 
species. Unpopulated species, shown in blue, represent hypothetical complexes involving E2F and 
IkBa allowing redundancy to be built into the network.
Network parameters were also given a coherent nomenclature; Association ka, 
Dissociation kd, Import ki, Export ke, Constitutive degradation kg, Inducible (phospho) 
degradation kgp, catalysis kc, constitutive transcription kcscpt, inducible transcription 
kiscpt, translation trl. A full list of model parameters for the NF-k B:E2F-1 model, 
together with listings of initial conditions can be found in Section 2.3.1 or in the full 
model code (see attached DVD).
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With the aim of ensuring a sound network structure of correctly linked ODEs prior to 
implementation, a network wiring diagram of the system was drawn for both nuclear 
and cytoplasmic species in the NF-kB:E2F-1 model (Figure 5.3) Taking the nNFkB 
species as an example, reactions affecting the concentration of nNFkB as shown in 
Table 5.2.
R e a c tio n T yp e P a ra m e te r s
N F-kB nNF-KB Import/Export il, el
ilNF-kB +  nE2F -*■ nNF-KB :E2F Association/ Dissociation a7,d7
nNF-KB + nlKBa —> nlKBa:NF-KB Association/ Dissociation a6,d6
nlKBa:NF-KB —> Sink + nNF-KB Degradation g2
nNF-KB :E2F -+  Sink + nNF-KB Degradation g!4
Table 5.2 Considering reactions in the NF-kB:E2F-1 model: Showing reactions contributing to 
the overall value of nNFkB, showing association/dissociation (parameter prefix “a” and “d”), 
import/export (parameter prefix “i” and “e”), and degradation (parameter prefix “g”).
The reactions in Table 5.2 can be converted into an ODE describing the change of 
nNFkB concentration over time (Figure 5.1).
inNFKB(t)=  A
< ---------------------------- A -N
kd6x(nNFKB: n lh£a \t) -  ka6x nlsBa(t) x  nNF/d3(t)
B
-^-----------------------------^
+ kd lx  (nNFxB: nE2F\t) -  ka l x  nE2F{t) x  nNFKB(t)
C
. ------------------------^ ^
+ kilxkvx NFxB(t)—kelxkvx nNFhB(t)
+kg2x(lKBa:NFKB)(t)+kgl4x(nNFKB: nE2F\t)
Figure 5.1 Ordinary Differential Equation for nNFkB\ A Association/Dissociation equilibrium of 
the nlkBaNFkB complex B Association/Dissociation of the nNFkBE2F complex C Import/Export of 
nNFkB normalised by ‘kV to allow for change of cellular compartment D Degradation of the 
nlkBaNFkB complex contributes to the level of nNFKB complex E Degradation of the nlkBaNFkB 
complex contributes to the level of uncomplexed nNFKB. A, C and D re-formulated from original 
model. B and E added as part of E2F module. Equation shown that for nNFkB in initial NF-k B:E2F- 
1 model.
78
TheNF-k B:E2F-1 M o d e l : E x t e n s i o n , P r e d ic t io n  a n d  E x p e r im e n t a l  V e r if ic a t io n
The full set of populated ODEs for the NF-k B:E2F model is shown in Table 5.3, with 
new or amended ODEs added to the original NF-k B model marked in red.
Î  NFxB(t) =  kdl x (ixBa : NFkB \ î) -k a lx  IhBa(t) x  NFkB(t) -  ki\ x  NFxB(t)
+ ke 1 x  nNFxB(t) +  kgp2 x  (plhBa : NFkB \ î) + kg\ x  (ihBa : NFkB \ t)
+ kd3x {NFkB : E2F\t) -  ka3X E2F(t) X NFhB(t) + kg\3x {NFkB : E2F\t)
71 nNFxB(t) = kd6x(nNFKB : nlhBa^t)- ka6xnlKBa(t)xnNFhB(t)
+kil x kvx NFxB(t) -  kel x kvx nNFxBit)+ kg2 x {IkBcc : NFkB \t) 
+kdlx(nNF*B\nE2FXt)-kalXnE2F(t)XnNFtâ(t)+kg\4x(nNFKB\nE2FXt) 
i : E2F(t) = —ld2 x E2F(t) + ke2 X nE2F(t) -  kg3 x E2F(t)
+ kd3x {.NFkB : E2FXt) -  ka3 x E2F(t) x NFkB(î)
T, nE2F(t) = + k i2 x k v x E 2 F (t) -k e 2 x k v x n E 2 F (t) -k g 4 x n E 2 F { t)
+ k d lx {n N F kB : n E 2 F \t) -k a lx n E 2 F ( t)x n N F kB {î)
Tt Itôcc(t) = kd\x(lKBa:NFkBXî) - kalxIxBa(t)xNF kB(î) +  ktrllxtIxBa(t)
-  kg6xlKBa(t) -  ki3xhB a(t) + ke3 x nlxBait) -IcclxIKK(t)xIxBa(t)
7  nlxBa(t) = kd6x {nlxBa : kNFkB \ t) -k a 6 x  nlkBcdf) x nNFnB(t)
-  kg7 x  nlhBa(t) + ki3xkvxlKBa(t) + ke3xkvxnIxBa(t)
ÎIK K n(t) = kpdx — 0^ A20{t) xIKKi(t) -TRxkactlxIKKn(t) 
i  IKK ( t)  = TRx kactl x  IKKn{t) -  kinactl x  IKK(t)  
iIK K i( t)  = k in a c tlx IK K (t)-k p d x 15Æ^ i m xIKK i(t)
i t A 2 m  = k i s c p a x O B x ^ ^ + k i s c p a x ^ ^ - k g n x tA 2 m
i  A20(t) = ktrl2 x  tA20(t) -  kgl 2 x A20(t)
i  plK B a(t) = kcl x IKK ( t) x  I*Boc(t) -  kgpl x p I jB a {t)
j-t {pIkBa : NF KB\t) = kc2xIKK(t)x{lKBa : NFtB\t)-kgp2x{phBaoNFkB\t)
i  (.NFkB : E 2 F \t)  = ka3x E2F(t) x NFkB(î) -k d 3 x  {NFkB : E 2 F \t)
-  ki4x {NFkB : E 2 F \t)  + ke4 x {nNFKB : n E 2 F \t) -k g l3 x  {.NFkB : E 2 F \t)  
i  (nNFKB : nE 2F \t)  =  kal x nE2F(t) x  nNFkB{î) -  k d l x {nNFKB : nE 2F \t) 
+ ki4xkvx  {NFkB : E 2 F \t)  -k e 4 x k v x  {nNFKB : n E 2F \t)
-  kgl4 x {nNFKB : nE 2F \t)
i { I kBcx : NFkB \ t) = k a lx lÆ a it)x N F kB(î) - kdlx{lkBcr. NFkB \ î)
-  kgl x {IkB oc : NFkB \ t) + ke6 x {nlKBa : nNFkB \ î)
-  kc2 x IKK (t) x {iKBa : NFkB \ î)
Î  {nitB a : nNFjB\t) = ka6x n lt£ a (t)  x nNF/B(t) -k d 6 x  {nlKBa ° nN FtB\t)  
_________________ -  ke6 xkvx{nlKBa  ° nNFjB\t) -  kg2 x {n lÆ a  : nNFtB\t)
( 1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
( 10)
( H )
( 12)
(13)
(14)
(17)
(18)
(21)
(22)
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Table 5.3 Ordinary Differential Equations in the NF-kB:E2F-1 Model: Showing ODEs 
representing all model species. Symbol ‘n’ denotes nuclear variables, T  denotes mRNA transcript, 
while ‘p ’ denotes phosphorylated form of IkBa. Symbols denoting cytoplasmic localization were 
omitted. Transport rates for nuclear variables (Equations. (2), (4), (7), (18) and (22)) were adjusted 
by ‘kv‘ (ratio of cytoplasmic and nuclear volume) to reflect smaller nuclear volume; hence increasing 
molecular concentrations within this compartment. Initial Concentrations for these species can be 
found in Appendix 1.
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5.3 Experimental and mathematical reproduction of past NF-kB 
work
In order to experimentally reproduce TNFa-medlated NF-k B dynamics observed via 
time-lapse fluorescence microscopy (Nelson et al. 2004), SK-N-AS cells were 
transfected with a plasmid vector expressing p65-dsRedXP and stimulated with 
10ng/ml TNFa. Resultant oscillatory dynamics display an average MNL time of 30 
minutes, an average NR time of 60 minutes and an oscillatory period of 100 minutes in 
cells with similar p65-dsRedXP expression levels (Figure 5.2, movie M1.13). As 
highlighted in Section 1.3.3, the average dynamic trace masks asynchronous 
oscillations displayed in the population of single cells. Variability in peakl MNL and NR 
times is addressed in Section 6.5. Concurrently to experimental work, implementation 
of the NF-k B:E2F-1 model proceeded, with the E2F-1 module set to zero, to test the 
ability of the new NF-k B:E2F-1 model to recapitulate NFkB dynamics in response to 
TNFa (Ashall et al. 2009). In the model, stimulation with TNFa is assumed to be a 
saturated dose of 10ng/ml and is modelled as a binary switch, i.e. the TNF signal (TR) 
may be on (“1”) or off (“0”). Figure 5.2 shows that the extended mathematical model is 
able to faithfully model the average MNL, NR and oscillatory period times of p65- 
dsRedXP in response to TNFa.
81
T h e  NF-k B:E2F-1 M o d e l : E x t e n s i o n , P r e d ic t io n  a n d  E x p e r im e n t a l  V e r if ic a t io n
Figure 5.2 Experimental and Mathematical reproduction of NF-kB dynamics: A Time series 
showing nucleo-cytoplasmic oscillations in p65-dsRedXP (co-transfected with a plasmid vector 
expressing untagged GFP) in response to TNFa stimulus in SK-N-AS cells B Quantification of p65- 
dsRedXP oscillations in multiple cells, giving an average MNL of 30 minutes, an average NR of 60 
minutes and an oscillatory period of 100 minutes for the first peak of nuclear occupancy. 
Subsequent asynchronous oscillations are masked by the population average (shown in black) C 
Predictive model plot of extended NF-k B model with E2F-1 module set to 0. Model plot concurs 
with experimental data.
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5.4 Implementation of the NF-kB:E2F-1 module
A network diagram of the NF-k B:E2F-1 module is shown in Figure 5.3, which is 
sufficient to reproduce the simple conceptual model outlined in Section 4.5. The ODEs 
forming the basis of the initial version of NF-k B:E2F-1 model can be found in Table 5.2.
a3 0.5 
d3 0.00005
a1 0.5
Figure 5.3 Network “wiring” diagram for major species in NF-kB:E2F-1 model Mk. I: Lines 
connecting related species represent biochemical equations. As such, for any given time the 
concentration of a particular species is the sum of outward and inward reactions. Reactions and 
parameters shown represent the initial NF-k B:E2F-1 model (in s-1).
Competition between Ik Bci and E2F-1 is modelled in the simplest fashion by fitting the 
association rate between NFkB and E2F in both cellular compartments (parameters a3 
and a7, respectively) equivalent to IkBa and NFkB. The resting steady state localisation 
of EGFP-E2F-1 (Section 3.2) was fitted by inhibiting degradation (setting degradation
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rates of E2F and nE2F to zero) whilst fitting import and export rates (parameters ke2= 
k il l5) to give a 9:1 ratio between nuclear and cytoplasmic localisation.
Simulation protocols (described in detail in Section 2.3) were designed to mimic 
transient transfection experiments. Expression of exogenous levels of E2F-1, NF-k B or 
Ik Bci (or combinations thereof) are modelled as Heaviside Functions involving a “step” 
in level from a steady-state in the case of NFkB and 0 in the case of E2F. As such the 
model operates on the assumption that the level of E2F-1 prior to transfection is 
minimal (approximate to its basal level for -80%  of the cell cycle), or at least sufficiently 
low that the level of exogenous E2F-1 introduced during transfection is significant. The 
model assumes transfected species are initiated to the cytoplasm (E2F, NFkB, IkBa) 
corresponding to translation. The high nuclear import rate of E2F (similar to free NFkB 
species) and comparable association rates between E2F and NFkB to IkBa and NFkB 
allow the level of E2F to dramatically effect the localisation of NFKB.
In non-stimulated conditions, the NFk B:E2F-1 model successfully reproduces the 
nuclear co-localisation of p65-dsRedXP and EGFP-E2F-1 (Figure 5.4) shown 
experimentally in transfected SK-N-AS cells (section 4.1). By running the model with 
different initial levels of EGFP-E2F-1, the model is also able to faithfully reproduce the 
proportional relationship between p65-dsRedXP NR time and level of EGFP-E2F-1 
(Figure 5.4). The export of NFkB is intuitively associated with the binding of de-novo 
IkBa to NFkB as it unbinds from E2F in the conceptual model (Section 4.5). In the 
mathematical model, the level of de-novo IkBa present at this point is the result of 
transcription from “free, active” nuclear NF-k B {‘‘nNFKB’) and the NFkBE2F complex. 
Transcription associated with the nNFKBE2F complex is fitted to roughly 0.6 of that of 
the NFKB complex, as suggested by transcriptional studies (Figure 4.7).
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Figure 5.4 Modelling proportional sequestration of E2F-1 on NF-kB: A The NF-k B:E2F-1 
model is able to reproduce a proportionally higher NFkB NR time with increase in initial levels of 
E2F B Experimental data from SK-N-AS cells expressing similar levels of p65-dsRedXP but 
different levels of EGFP-E2F-1. Data shows the proportional effect of EGFP-E2F-1 level of p65- 
dsRedXP NR time. Cells shown are representative of data set of 25+ cells. Green lines represent 
EGFP-E2F-1 fluorescence and are marked to correspond with red lines representing p65-dsRedXP 
fluorescence in the same cell. In each panel, lines with similar shapes are grouped. C The model is 
able to reproduce high correlation (R2=0.94) between initial level of E2Fand corresponding Nuclear 
Retention time of NFkB. See Section 6.3 for the second generation (Mk II) model.
5.5 Model predictions (1): The effect of TNFa on localisation, 
stability and short-term dynamics
With the NFkB:E2F-1 model able to reproduce observed dynamics in un-stimulated 
conditions, TNFa stimulation of the NF-k B system was used to test the model. This 
was a logical choice, as the scientific “questions” were straightforward to both ask of 
the model and to answer experimentally.
The effect of TNFa on the system was simulated over a 200 minute timescale to 
capture the relative dynamics of the first peak of NF-k B nuclear occupancy (Figure
5.5). The model was simulated for three different conditions; transfection with a plasmid 
vector expressing p65-dsRedXP alone with TNFa stimulation (NFkB initialised at 0.1, 
777=1), co-expression of p65-dsRedXP and EGFP-E2F-1 with TNFa stimulation (NFkB
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and E2F initialised at 0.1, 7T?=1) and, for comparison, co-expression of p65-dsRedXP 
and EGFP-E2F-1 in unstimulated conditions [NFkB and E2F initialised at 0.1, TR= 0).
Figure 5.5 NF-kB:E2F-1 Model Prediction(l): Short time-course TNFa: The NF-k B:E2F-1 
model predicts a 30 minute MNL time for NFkB and E2F co-expression (initialised at 0.1 from a 
steady state for the NF-k B system) with TNFa stimulation (blue line) similar to unstimulated 
conditions (black dotted line), and a stimulated expression of NFkB alone (red dotted line) although 
through distinct mechanisms (see text).
The model predicts that TNFa would have little effect on p65-dsRedXP MNL timing 
when co-expressed with EGFP-E2F-1. Intuitively this is due to TNFa not being required 
to cause nuclear translocation when free, cytoplasmic E2F coincides with free, 
cytoplasmic NFkB. However, peak amplitudes vary between stimulated and non- 
stimulated co-transfection conditions due to the TNFa-mediated disruption of the 
steady state (“endogenous”) IkBaNFkB complex and the translocation of a second pool 
of free, cytoplasmic NFkB to the nucleus. The MNL time of p65-dsRedXP co-expressed 
with EGFP-E2F-1 is 30 minutes, similar to that of p65-dsRedXP expressed alone. 
However, the model predicts a clear difference in NR time between a single 
transfection of a plasmid vector expressing p65-dsRedXP and co-transfection with a 
vector expressing EGFP-E2F-1.
Experimental data validated these predictions (Figure 5.6, movie M5.6). The NR times 
of p65-dsRedXP co-expressed with EGFP-E2F-1 were similar, irrespective of TNFa 
stimulation and both stimulated and unstimulated cells had longer NR times than
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stimulated cells expressing p65-dsRedXP alone. Due to co-expression of EGFP-E2F-1 
causing a predominant nuclear localisation on p65-dsRedXP, it was difficult to measure 
the translocation rate of the NF-k B:E2F-1 complex as the localisation of the protein is 
altered from the time of cytoplasmic translation. The question of how to observe the 
MNL time of this association is further raised in the introduction to Chapter 7.
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Figure 5.6 Short time-course dynamics following TNFa stimulation: A SK-N-AS cells 
transfected with a plasmid vector expressing p65-dsRedXP alone i) at time of stimulation showing 
predominant cytoplasmic localisation ii) showing predominant nuclear localisation with a MNL time 
of 30 minutes iii) showing predominant cytoplasmic localisation with a NR time of 50 minutes. B 
Unstimulated cells co-expressing EGFP-E2F-1 and p65-dsRedXP. Showing a 1/2NR time of the 
fluorescent p65-dsRedXP of 80 minutes and an NR of 150 minutes C Stimulated cells co­
expressing EGFP-E2F-1 and p65-dsRedXP showing similar dynamics to unstimulated cells over a 
200 minute time course.
For the purpose of explaining differences in TNFa-associated dynamics between the 
NF-k B model with and without active NF-k B:E2F-1 module (as well as corresponding 
transfection experiments), cell trajectories could be split in terms of their Maximum 
Nuclear Localisation (MNL) timing and Nuclear Retention (NR) timing (recalling 
definitions introduced in Section 1.3.3). For short time-course TNFa experiments 
(Figure 5.7) one may consider; the initial Maximum Nuclear Localisation time, (MNLnfi<b 
for the NF-kB model and MNLnfi<b:E2f for the NF-k B:E2F-1 model), the post-peak 1 
Nuclear Retention Time and V2 Nuclear Retention Times (NRnfkb, NRNFkB:E2F,1/2 NRNFkB, 
1/2 NRnfi<b:E2f) and, in the case of the NF-kB model, the timing from post-peak 1 
cytoplasmic localisation to the second oscillatory peak (MNL2nfi<b).
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Figure 5.7 Modelling short time-course dynamics following TNFa stimulation: Showing model 
trajectories for total Nuclear NFkB with three different initial levels of E2F; 0, (representing single 
transfection of plasmid expressing p65-dsRedXP, red line), 0.1 (matched to NFkB, blue line) and 
0.2 (giving an initial E2F\NFkB ratio of 2:1, orange line), The NF-k B:E2F-1 model is able to predict 
a longer p65-dsRedXP NR time with increase in initial levels of E2F-1. A higher ratio of E2F:NFkB 
is predicted to lead to nuclear retention which is more dependant on the degradation of the 
A/FM3E2F complex than a 1:1 ratio, giving different dynamics.
As has been highlighted above, M N L nfkb and M N L nfkb£ 2f with TNFa are similar, but 
have differing underlying mechanisms; TNFa-mediated degradation of licBa in the 
former case and binding between exogenous levels of E2F-1 and p65 in the later case. 
However, N R N FkB an d  N R nfi<b :E2f are significantly different, with N R Nfkb=  50 minutes (as 
introduced experimentally in Section 1.3.3) and N R nfkb:E2f seen experimentally to vary 
from 40 minutes to 300 minutes dependant on level of E2F-1 (see Section 4.3).
Varying the initial level of the E2F species in the NF-k B:E2F-1 model leads to an 
interesting prediction. An initial E2F level greater than NFkB (NFkB initialised at 0.1, 
E2F initialised at 0.2, Figure 5.7 orange line) generates a different dynamic profile to 
that derived from matched levels (Figure 5.7 blue line) giving a longer NR time. These
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dynamics may be explained by considering how the proportional sequestration effect of 
E2F-1 varies with E2F-1 level, and the stimulation state of the cell. In stimulated 
conditions with matched transfected levels of p65 and E2F-1, there is only sufficient 
E2F-1 to bind to the exogenous pool of p65, leaving endogenous p65 able to 
translocate to the nucleus, transcribe Ik Bo and be “pulled” out of the nucleus by de- 
novo Ik Bo . However, with a level of E2F-1 equal to the total level (exogenous+ 
endogenous) of p65, E2F-1 is able to bind to both pools of NF-k B in the nucleus and 
hence NR time is slowed to the degradation rate of the NF-k B:E2F-1 complex. This 
can be summarised as a prediction: Co-expression of p65-dsRedXP and EGFP-E2F-1 
and subsequent stimulation with TNFa should generate a split in a population of single 
cells based on their NR times. Cells with equal expression levels of p65-dsRedXP and 
EGFP-E2F-1 should have short NR times due to semi independence from 
sequestration by E2F-1 whereas cells with a larger ratio of E2F-1 :p65 should show 
longer NR times due to greater dependence on the stability of the NFkB:E2F-1 
complex.
Experimental evidence supported this prediction with stimulated cells expressing 
EGFP-E2F-1 and p65-dsRedXP at a ratio <1 showing shorter NR times than those for 
which the ratio of expression was > 1. The NR dynamics of these two subsets are 
similar to the blue and orange lines (respectively) in the model plot in Figure 5.7. Figure
5.8 shows two typical cells displaying these different dynamics. Although the two cells 
show similar levels of EGFP-E2F-1, their p65-dsRedXP dynamics are different due to 
the difference in ratio between peak level of EGFP-E2F-1 and p65-dsRedXP.
91
T h e  NF-k B:E2F-1 M o d e l : E x t e n s i o n , P r e d ic t io n  a n d  E x p e r im e n t a l  V e r if ic a t io n
Figure 5.8 Experimental verification of effect of E2F-1:p65 ratio: A Showing SK-N-AS cells 
transfected with plasmids expressing p65-dsRedXP and EGFP-E2F-1. Despite similar levels of 
EGFP-E2F-1 the cells have different EGFP-E2F-1:p65-dsRedXP ratios. Lines marked A  (ratio 
close to 1:1) show partial p65-dsRedXP independence of EGFP-E2F-1 in nuclear retention. Lines 
marked □ (ratio 2:1) show stronger dependence of p65-dsRedXP on EGFP-E2F-1 degradation. B 
Showing increase in relative cytoplasmic p65-dsRedXP fluoresecne levels as nuclear levels 
decrease due to translocation. Fluorescence intensity is measured as average intensity per pixel.
The data set of stimulated co-transfected cells show a proportional relationship 
between EGFP-E2F-1 1/2  degradation time and NRnfkb:E2f (Figure 5.9) similar to 
unstimulated cells considered in Section 4.3. However in the case of cells in which the
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initial ratio of EGFP-E2F-1 to p65-dsRedXP is >1 (green dots Figure 5.9 R2= 0.92) 
there is a slower cytoplasmic translocation than in cells in which this ratio is <1 (pink 
dots Figure 5.9 R2= 0.86).
nuclear EGFP-E2F-1 half degradation time (mins)
Figure 5.9 Proportional analysis of E2F-1 :p65 ratio on p65 dynamics: Showing high degree of 
correlation between EGFP-E2F-1 degradation and p65-dsRedXP translocation into the cytoplasm. 
In the case of cells in which the initial ratio of EGFP-E2F-1 to p65-dsRedXP is >1 (green dots R2= 
0.92) there is a slower cytoplasmic translocation than in cells in which this ratio is <1 (pink dots, 
R2= 0.86). Figure representative of ~20 cells.
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5.6 Predictions (2) - Long time course dynamics after TNFa 
stimulation
Under constant TNFa stimulation, the original NF-k B model (without NF-k B:E2F-1 
module) predicts experimentally observed persistent oscillations in p65-dsRedXP 
nuclear occupancy with MNLnfkb = 20 minutes, NRnfkb = 50 minutes (due to synthesis 
of de-novo Ik Bo), MNL2nfkb = 80 minutes (due to continuous activation IKK in the 
presence of continuous TNFa) and a subsequent peak-to-peak oscillatory period (from 
peak 2 onwards) of -100  minutes as the system reaches a steady state of oscillations 
(Sections 1.3.3 and 5.3). The model and experimental data concur that these 
oscillations persist for several hours. (Section 5.3 shows NF-kB oscillations used to 
“test” model)
The NF-k B:E2F-1 model, however, predicts the silencing of these oscillations whilst 
E2F degrades. Simulating the dynamics over a long time-course (up to 12 hours), 
yields an interesting prediction; the resumption of steady-state NF-k B oscillatory 
behaviour at such a time when E2F has degraded (Figure 5.10)
Figure 5.10 Model prediction: Long time-course dynamics following TNFa stimulation:
Showing NFkB dynamics with E2F initialised at 0 (dashed pink line) and 0.1 (red line). Model 
predicts suspension of nucleo-cytoplasmic oscillations, to resume to a steady state upon 
degradation of nuclear E2F (green line).
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Experimentally, it was observed that this was indeed the case (Figure 5.11, M5.11). In 
the presence of TNFa, oscillations were seen to be suspended coincident with EGFP- 
E2F-1 degradation, and then began several hours after the point of post-peak1 
predominant cytoplasmic localisation. The suspension time (synonymous with 
M N L 2 nfkb:E2f) is defined as the time to reach the first peak of nuclear occupancy once a 
steady-state has been achieved. This data set is considered further in Section 6.4.
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Time (mins)
Figure 5.11 Experimental verification: Long time-course dynamics following TNFa 
stimulation: A Time course showing SK-N-AS cells co-expressing p65-dsRedXP and EGFP-E2F- 
1 stimulated with TNFa at TO. B Showing nuclear p65-dsRedXP dynamics (red line) and 
degradation of nuclear EGFP-E2F-1 (green line). Nucleo-cytoplasmic oscillations are suspended 
and resume coincident with the degradation of nuclear EGFP-E2F-1. Pink dashed line shows 
“normal” nucleo-cytoplasmic oscillations in p65-dsRedXP in a cell from the same experiment with 
negligible detectable levels of EGFP-E2F-1.
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5.7 Discussion -  How can we explain these dynamics?
In the work described in this chapter we have seen that a simple module representing 
interaction between E2F-1 and NF-k B is enough to reproduce experimentally observed 
un-stimulated dynamics of p65-dsRedXP and EGFP-E2F-1 in single SK-N-AS cells 
(Figure 5.4). This achieved, we have a suitable context for testing the effects of E2F-1 
on the stimulated NF-k B system allowing predictions to be made (Figure 5.7). These 
predictions have then been experimentally verified using the same experimental model 
from which the original conceptual model was drawn (Figure 5.11).
We shall now consider a biological explanation for these dynamics over a long time 
course, to try to suggest a mechanism for the suspension of nucleo-cytoplasmic 
oscillations. To this end we shall analyse the NF-k B system in response to TNFa using 
multiple read-outs from the NF-k B:E2F-1 mathematical model to assess any insight 
from their relative dynamics.
0 100 200 300 400 500 600 700
Time (mins)
Figure 5.12 Examining long time course dynamics following TNFa stimulation: Showing 
identical plot to Figure 5.10 with additional species, cytoplasmic IkBa with E2F set to 0 (dashed 
blue line), and cytoplasmic IkBa with E2Fset to 1 (blue line). Model suggests suspension in nucleo- 
cytoplasmic oscillations is due to increased transcription of IkBa.
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Over a long stimulated time-course, the model predicts nucleo-cytoplasmic oscillations 
are suspended as both a direct and indirect result of the NFkB:E2F-1 interaction 
(Figure 5.12). Direct binding of E2F to NFkB gives nuclear sequestration irrespective of 
the presence of active TNFa (TR= 0/1) and a higher period of nuclear retention (longer 
NR time with initial E2F set to 0.1 than 0). The interaction between E2F and NFkB 
leads to indirect suspension of nucleo-cytoplasmic oscillations due to the increased 
“pool” of cytoplasmic IkBo resulting from the prolonged nuclear occupancy of the active 
NF-kB complex. Intuitively, this pool of licBa is able to sequester NF-k B in the 
cytoplasm for a longer period following E2F-1 degradation, as there is more to degrade 
leading to a suspension of steady-state oscillations ( M N L 2 NFkB:E2F > M N L 2 nfi<b ). 
Although the mathematical prediction has been verified experimentally, the predicted 
underlying mechanism, involving the level of Ik Bci, has yet to be examined. In the next 
chapter we will examine this prediction, and begin to consider coupling the context of 
the model of the NF-k B system to the role of E2F-1 in the cell cycle.
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Chapter 6 -
NF-k B:E2F-1 Model Evolution
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6.1 Introduction and rationale
At this stage, there is a mathematical model for E2F-1 interaction with the NF-k B 
system, which adequately represents experimentally observed p65-dsRedXP dynamics 
and is able to make verifiable predictions for suspension of nucleo-cytoplasmic 
oscillations in p65-dsRedXP upon co-expression of EGFP-E2F-1. The model also 
makes accurate predictions regarding variation in 1/2NR time derived from different 
populations of transfected cells; those with a low ratio of E2F-1 to p65 having a shorter 
1/2NR time than those in which levels are matched or higher, i.e. a proportional 
relationship between E2F degradation and p65 nuclear retention.
However, this initial model is not without fault. At this point it is unable to recapitulate 
the total cytoplasmic localisation of p65-dsRedXP in cells co-expressing EGFP-E2F-1 
following the point of maximum nuclear occupancy. In such cells, p65-dsRedXP resides 
in a predominantly cytoplasmic state for several hours following translocation from the 
nucleus (Section 5.6). As the mechanism controlling re-localisation of p65-dsRedXP to 
the cytoplasm concerns Ik Bo , it was decided to investigate in greater detail how Ik Bo 
levels vary with co-expression of p65-dsRedXP and EGFP-E2F-1.
6.2 Re-assessment of transcriptional assumptions
The level of Ik Bci protein was measured in a population of SK-N-AS cells co­
expressing EGFP-E2F-1 and p65-dsRedXP by immuno-blotting, and compared to cells 
transfected with a plasmid expressing p65-dsRedXP alone (Figure 6.1). Surprisingly, 
blots showed a lower level of Ik Bo protein present in cells co-expressing with E2F-1- 
EGFP and p65-dsRedXP compared to p65-dsRedXP single transfection or non 
transfected cells. This trend was common to both SK-N-AS and HeLa cell lines.
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HeLa SKNAS
p65-DsRedXP
IkBq
p65
+
+ + p65-dsRedXP + +
EGFP-E2F-1 +
Figure 6.1 Assessment of Ik Bo protein levels in transfected cells: Showing populations of SK- 
N-AS and HeLa cells assessed for Ik Bo  protein levels via Immunoblot. Cell samples are either 
untransfected, or involve co-expression of p65-dsRedXP or p65-dsRedXP and EGFP-E2F-1. Cells 
expressing p65-dsRedXP show higher levels of Ik Bo  than untransfected cells. Co-expression of 
EGFP-E2F-1 leads to knock-down in Ik Bcj levels in both SK-N-AS and HeLa cells. Samples were 
run together then the blot was cut for separate probing. A composite image was later taken of the 
entire blot.
Quantitative PCR was performed to assess if this result was due to E2F-1 inhibition of 
Ik Bo mRNA production rather than on the stability of the Ik Bo protein (Figure 6.2). It is 
clear that both Ik Bci and Ik Be mRNA levels were knocked down in samples transfected 
with plasmids expressing p65-dsRedXP and E2F-1-EGFP. These results are 
interesting since they appear to contradict luciferase reporter assay data (Figure 4.7), 
which suggested that the effect of exogenous E2F-1 expression is to partially inhibit 
NF-KB-related transcription. Considered together, these data imply that although NF- 
k B may be transcriptionally active whilst associated with E2F-1 in the nucleus (Lim et 
al. 2007), it may not be active at either Ik Bq or Ik Be promoters.
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Figure 6 .2  Assessment of Ik B transcription levels in transfected cells: Showing populations of 
HeLa cells assessed for Ik Bo  and Ik Bs transcription via Quantitative PCR. Samples are either 
transfected with plasmids expressing p65-dsRedXP, EGFP-E2F-1 or p65-dsRedXP and EGFP- 
E2F-1 and assessed 24 hours post-transfection. Data shown as fold induction relative to 
untransfected cells. Cells expressing p65-dsRedXP show induction of Ik Bo  and Ik Bs transcript 
levels (7.9 and 4.1 fold respectively, over untransfected cells). Cells expressing EGFP-E2F-1 show 
no increase in Ik Bo  or Ik Be transcription levels. Cells co-expressing p65-dsRedXP and EGFP- 
E2F-1 show no increase Ik Bo  or Ik Bs transcription levels. Single replicate.
It could be commented that E2F-1-mediated disruption of Ik Bo and z transcription is 
inconsistent with the view of the system thus far, as Ik B protein is required in the model 
to account for the suspension of nucleo-cytoplasmic oscillations (Figure 5.10). Having 
shown that ectopic E2F-1 co-expression does not lead to a larger pool of Ik Bo protein, 
the next logical hypothesis to explain sustained Ik Bo activity (implied by the initial 
model) is that Ik Bo stability is somehow affected by the relationship between E2F-1 
and the NF-k B system.
To investigate this hypothesis, cellular lysates were made from cells transfected with 
plasmid vectors expressing p65-dsRedXP and E2F-1-EGFP, p65-dsRedXP alone (as 
positive control) and non transfected cells over a TNFa stimulation time course (Figure 
6.3). Concurrent with results in Figure 6.2 the “TO” samples (non-stimulated) show 
lower levels of Ik Bo protein in p65-dsRedXP + E2F1-EGFP co-expressing cells, than in 
either of the controls. After 15 minutes exposure to TNFa, Ik Bq levels are seen to be
1 0 2
NF-k B:E2F-1 M o d e l  E v o l u t io n
depleted in both cells expressing p65-dsRedXP (-10%  of “0” time point) and the 
untransfected cells (-5%  of “0” time point). However, the p65-dsRedXP + E2F1-EGFP 
samples show much higher levels of Ik Bo protein (-70%  of “0” time point). A further 
experiment, examining a similar situation in HeLa cells, showed that after 15 minutes 
exposure to TNFa, k B a  levels were depleted in both cells expressing p65-dsRedXP 
(-40%  of “0” time point) and the untransfected cells (-30%  of “0” time point) with the 
p65-dsRedXP + E2F1-EGFP samples showing higher levels of k B a  protein (-90%  of 
“0” time point), consistent with SK-N-AS data Having already assessed that this 
increased level cannot be due to increased transcription associated with ectopic EGFP- 
E2F-1 co-expression (Figure 6.1), this effect was assumed to occur through 
stabilisation of Ik Bq .
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Figure 6.3 Assessment of IkBoi stability in transfected cells stimulated with TNFa: Showing 
populations of HeLa cells either untransfected, transfected with plasmid vectors expressing p65- 
dsRedXP or p65-dsRedXP and EGFP-E2F-1. Samples stimulated with TNFa as indicated. A 
Western blot showing kB a levels in transfected and untransfected samples B Quantification of 
western blot is shown in A, showing a higher level of kB a protein after 15 minutes TNFa 
stimulation in cells expressing EGFP-E2F-1 and p65-dsRedXP than in untransfected cells or cells 
expressing p65-dsRedXP alone. Quanitfication normalised to cyclophilin A levels for each sample. 
Samples were run together then the blot was cut for separate probing. A composite image was 
later taken of the entire blot.
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The apparent effect of E2F-1 on the stability of IkBo raises the question of a possible 
explanatory mechanism. The literature suggests a role for E2F-1 in regulating the 
activity of the IkB kinase, IKK (Phillips et al. 1999). Such regulation could explain the 
lack of IKK-mediated degradation of IkBo and an increase in IkBo stability despite the 
presence of TNFa. Supporting this theory, further work was carried out to investigate 
the effect of exogenous E2F-1 expression on TNFa-mediated NF-k B related 
transcription. Figure 6.4 shows the clear effect of TNFa stimulation on NF-kB related 
transcription in cells transfected with empty vectors, due to the concomitant rise in IKK 
activity, IkBo degradation and release of active NF-k B to translocate into the nucleus 
and begin transcription. As such, the dramatic effect TNFa has on the equilibrium of the 
NF-k B system may be observed. However, expression of EGFP-E2F-1 is seen to 
inhibit this process, consistent with inhibition of IKK activity.
18
Empty-Green EGFP-E2F-1 Empty-Green EGFP-E2F-1
Empty-Red Empty-Red p65-dsRedXP p65-dsRedXP
Figure 6.4 The effect of exogenous E2F-1 on TNFa stimulated NF-kB transcription: Showing 
luciferase reporter assay using NF-luciferase reporter. Expression of EGFP-E2F-1 causes 
significant fold decrease in NF-k B related transcription (*) under populations of cells stimulated for 
6 hours with TNFa (red bars). This effect is consistent to similar populations of cells co-expressing 
with p65-dsRedXP (**). Unstimulated samples represented by blue bars. Representative of 3 
biological replicates +/- SEM in each case.
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To investigate the effect of E2F-1 on IKK-mediated degradation of exogenous IkBo 
and the dynamics of p65-dsRedXP (the model system output characterised in Chapter 
3) time-lapse microscopy experiments were carried out in the presence of exogenous 
IkBci (Figures 6.5 and 6.6). SK-N-AS cells transfected with plasmid vectors expressing 
p65-dsRedXP and Ixfia-AmCyan, show a steady-state predominant cytoplasmic 
localisation for p65-dsRedXP. TNFa stimulation gives a p65-dsRedXP MNL which 
varies dependent on the level of exogenous IkBo in the cell (Figure 6.5, movie M6.5 as 
shown in (Nelson etal. 2002)).
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Figure 6.5 Dynamics of p65-dsRedXP with iKBa-AmCyan after TNFa stimulation: A Time- 
course for p65-dsRedXP in SK-N-As cells, showing MNL time of 60 minutes and NR time of 90 
minutes when ectopically expressing IkBo . B Analysis of IKBa-AmCyan degradation (blue line) and 
p65-dsRedXP dynamics (red line) from cell shown in A. C Strong correlation (R2=0.9126) between 
fitted half-life of licBa-AmCyan and MNL time of p65-dsRedXP in population of single SK-N-AS 
cells. Chart representative of 10 cells.
To assess the effect of exogenous expression of EGFP-E2F-1 on these dynamics, 
triple transfection experiments were planned. However, the overlapping emission 
spectra of the Enhanced Green and AmCyan fluorescent proteins made simultaneous 
detection of exogenous p65-dsRedXP, EGFP-E2F-1 and kBa-AmCyan difficult. To 
circumvent this problem a plasmid vector expressing an kBa-AmCyan fusion protein 
was transfected into cells but not observed, which is an acceptable alteration to 
experimental conditions as the output from the system, p65-dsFtedXP translocation, 
remains visible and is itself dependant on the degradation of Ik Bci.
SK-N-AS cells transfected with plasmid vectors expressing p65-dsRedXP, a non- 
fluorescent licBa fusion protein and EGFP-E2F-1, also showed a steady-state 
predominant cytoplasmic localisation for p65-dsRedXP. However, TNFa stimulation 
yielded a greatly increased p65-dsRedXP MNL time, which was seen to vary
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dependent on the degradation time of cytoplasmic EGFP-E2F-1 in the cell (Figure 6.6, 
movie M6.6).
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Figure 6.6 Dynamics of p65-dsRedXP with EGFP-E2F-1 and exogenous licBa after TNFa 
stimulation: A Time-course for p65-dsRedXP in SK-N-AS cells, showing MNL time of -500 
minutes following stimulation when co-transfected with plasmid vectors expressing EGFP-E2F-1 
and exogenous licBa-AmCyan. Nuclear translocation coincides with the loss of cytoplasmic EGFP- 
E2F-1 fluorescence B Analysis of cytoplasmic EGFP-E2F-1 degradation and p65-dsRedXP 
dynamics from cell shown in A. C Strong correlation (R2=0.9413) between fitted half-life of 
cytoplasmic EGFP-E2F-1 and MNL time of p65-dsRedXP in population of single SK-N-AS cells. 
Chart representative of 10 cells.
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6.3 Model evolution
The first adjustment to the NF-k B:E2F-1 mathematical model involved Ik Bo 
transcription. Although initial transcriptional studies and previously published work (Lim 
et al. 2007) show a positive effect of E2F-1 on the regulation of certain NF-k B target 
genes, it has been subsequently suggested that exogenous expression of E2F-1 
causes a knock-down in transcription of both Ik Bci and Ik Be (Figures 6.2 and 6.3). 
Within the model, it was subsequently assumed that the nuclear NF-k B:E2F-1 species 
(nNFkBE2F) does not contribute to the production of the Ik Bo transcript ( tlkBa). As 
such, levels of tlkBa rise only as the level of free nuclear NF-k B (nNFkB) rises, 
proportional to the disruption of the nNFkBE2F complex. For the model, this effect is 
assumed to be common to A20, based on previous studies showing similar regulatory 
mechanisms between Ik Bo and A20 promoters (Ainbinder etal. 2002).
Secondly, the model was extended to consider inhibition of IKK activity by the 
cytoplasmic fraction of E2F-1. Interestingly, the model made a prediction at this stage. 
As the cytoplasmic fraction of EGFP-E2F-1 accounts for only 10% of total E2F-1 
(Figure 3.2), cytoplasmic E2F-1 (model species E2F) was seen to degrade quickly in 
the initial model, so that inhibition of IKK had little effect on the timing of nucleo- 
cytoplasmic oscillations. In short, the model predicts that in order to fit the suspension 
of oscillations with a mechanism involving cytoplasmic E2F-1 inhibition of IKK, 
cytoplasmic E2F-1 must have a longer half-life than nuclear E2F-1.
Experimentally it was observed that is indeed the case (Figure 6.7) Pooling data from 
all time-lapse imaging experiments involving EGFP-E2F-1, protein degradation curves 
were fitted to exponential functions from which degradation rates were taken. These 
values were then used to calculate the half-life of the EGFP-E2F-1 in nuclear and 
cytoplasmic compartments for each cell in a data set of 40+ cells, using the expression 
Ln(2)/A. The resultant data set shows an average half-life for nuclear EGFP-E2F-1 of 
240 minutes compared to 440 minutes for cytoplasmic EGFP-E2F-1. Performing a 
paired t-test a clear statistical significance may be seen (p-value=1.8x10 8).
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Figure 6.7 Estimated half-life of EGFP-E2F-1 in nucleus and cytoplasm: A The half-life of 
nuclear and cytoplasmic EGFP-E2F-1 was calculated by fitting an exponential function to 
degradation curves generated by time lapse imaging experiments. The A value for these lines were 
then used to calculate to estimated half-life of EGFP-E2F-1 in a cell specific manner, using Ln(2)/A. 
The resultant data set shows an average half-life of nuclear EGFP-E2F-1 of 240 minutes compared 
to 440 minutes for cytoplasmic EGFP-E2F-1. A paired T-test revealed this difference to be 
significant (* P=1.8x10-®). Data taken from 40+ SK-N-AS cells.
The degradation coefficient of E2F(g3) was adjusted with respect to nE2F{g4) fitting to 
experimental data (Table 6.1). Inhibition of IKK was modelled as a reinforcement of the 
IKK inactivation (Table 6.1) and was best fitted as a 2nd order term proportional to the 
total amount of cytoplasmic E2F-1 (E2F+ NFkBE2F).
To improve the fitting of the new model, competition between E2F-1 and Ik Bo for 
binding to NF-k B was re-addressed. Dissociation of NFkBE2F and nNFkBE2F is not 
enough to drive total cytoplasmic localisation in the new model as the level of de-novo 
Ik Bo is not high enough to compete with free nuclear E2F, leading to rebinding 
between nE2F and free nuclear NFkB. To overcome this issue, it was assumed that 
Ik Bo is capable of disrupting nuclear and cytoplasmic complexes of NF-k B and E2F-1 
(Table 6.1).
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original model 
term
latest model designed to 
affect
experimental rationale
A kg3 = 0.0005/3, 
kg4 = 0.0005/3, 
kg3 = 0.0005/5, 
kg4 = 0.0005/3
kg3 = 0.0005/5, 
kg4 = 0.0005/3, 
kg13 =  0.0005/5, 
kg14 =  0.0005/3
E2F,nE2F
NFkBE2F,
nNFkBE2F
half-life of cyto E2F-1 
longer than nuclear E2F- 
1 (Figure 6.7)
B 0.6*kiscptl* 
(nNFkBE2FAh/(n 
NFkBE2FAh +  
kAh))
0*kiscptl* 
(nNFkBE2FAh/(n 
NFkBE2FAh +  
kAh))
tlkba, tA20 null transcription from NF- 
k B whilst bound to E2F-1 
(Figure 6.2)
C kinactVIKK kinactl * ( (kact2+  
E2FA2+NFkBE2 
FA2)/kact2) *1KK
IKKi, IKK IKK inactivation by E2F-1 
(assumed from Figure 
6.3)
D - kd7b *NFkBE2F* 
IkBa
NFkBE2F, 
nNFkBE2F, 
E2F, nE2F, 
IkBaNFkB, 
nlkBaNFkB, 
IkBa, nlkBa
extra intermediate term to 
account for IkBci 
disruption of NF-k B:E2F1 
binding, inferred by 
competition, required to 
drive cytoplasmic 
localisation
Table 6.1 NF-k B:E2F-1 mathematical model Mk.ll evolutionary steps: A D ifference in averag e  
EGFP-E2F-111/2 betw een nuclear and cytoplasm ic com partm ents B EGFP-E2F-1 ablation of Ik Bo 
a n d  Ik Be transcription C C ytoplasm ic E2F-1 related inhibition of IK K  activity D Disruption of the  
NFkB:E2F-1 com plexes by Ik Bo .
The model equations that were altered as a result of these evolutionary steps are 
shown in Table 6.2.
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i  E2F(t) = -k il X E2F(t) +  ke 2 x  nE2F(t) -  kg3 x  E2F(t)
+ kd3 x  0VF KB :E2F\t)~ka3XE2F{t)x NFKB{t) + kdlbx (NFKB \E2F\t)x lKBa(t) 
nE2F{t)  =  + ki2*kvX E 2F (t)-  ke2xkvX nE 2F (t) ~ kg4XnE2F(t)
+ k d lx  (nNFKB : n E 2 F \t)  - k a i x  n E 2F (t)x  nNFKB(t)
+ k d l b x  (nNFKB : n E 2 F \ t ) x  nIK B a(t)
i t i a m = t e c p i > < o x j ^ X $ , -  +kiscP i x i S $ k  -kg5XtlKBa(t) 
jfIKBa(t) = kdl x  (IKS a  : NFkb\ î) -  kal x  im a ( t)  x  NFKB(t) +  far/1 x  tlKßa(t)
-  kg6 x  IKBa(t) -  ki3 x  lKßa(t) +  £e3 x  nIKßa{t) -  kcl x  /F F ( i)  x  IKBa{t)
-  kdlb  x  (jV F xB : E 2F \t)  x  /Äßör(i)
^  nIKßct(t) = kd6x (nlKßcc : nNFKß\t) -  fez6 x  nIKBOC(f) x nNFKB{t)
-  Ag7 x  nIKBoc(t) + ki3xkvx lKBa{t) + ke3xkvx nlKßa(t)
-  kdlb x (fiNFKB : nE2F\t) x nIKßa(t)
i I K K ( t )  = TRXkact\xiK K n(t) -k in a c tix  X IK K ^
i lK K i( t ) = kinactix ^ eifBohnf^ eifÿ-u) X iK K (t)
-  kpd X kiA20+TRxA20(t) x  IK K i( t)
i t A i m ^ s c p a x o x - ^ ^ ^ + k i s c p a x ^ ^ - k g u x M m
i (NFKB : F 2 F ) ( 0  = ka3XE2F(t)x NF*B(t) - kd3x(NFKB : E 2 F \t)
- ki4x (NFKB : E 2 F \t)  +  & e 4 x (nNFKB : n E 2 F \t)~ k g l3 x (NFKB : £ 2 F ) ( 0
-  kd lb  x (nNFKB : n E 2F \t) x  nm a ( t )
£  (nNFKB : nE 2F \t) = k a lx  nE2F(t) x  nNFKB(t) - k d l x  (nNFKB : nE 2F \t) 
+ ki4xkvx(NFKB  : £ 2 F ) ( 0  - ke4x kvx (nNFKB : n E 2F \t)
- k g l4 x  (nNFKB : n E 2F \t)  -  kdlb  x (nNFKB : E 2 F \t)x  nlKBa(t)
i  (jKBcc : NFKB\t) = kal x  lKBa(t) x NFKB(t) -  kd lx  (jkB a :  NFkb\ î)
-  kgl x (jKBa : NFkb\ î) +  ke6 x (nlKBa : nNFKBXt)
-  kc2 x  IKK(t) x (jkB gc : N F x s \t )
+  kd lb  x (NFKB : E 2 F \t) x lKBa(t)
Y, (plKBa : nNFKß\t)  =  ka6XnlKB0C(t)xnNFKB(t) ~kd6x (nlKBa0 nNFKB\t)
-  keßxkvX (nlKBa 0 nNFKB\t) -  kg2 x (nlKBa : nNFKB\t)
+kdlbx(nNFKB  : n E 2 F \t)x nm a { t )
(3)
(4)
(5)
(6)
(7)
(9)
(10) 
( 11)
(17)
(18)
(21)
(22)
Table 6.2 Reactions affected by the evolution of the NF-kB:E2F-1 model Mkll: Showing ODEs 
from the Mkl model that have been altered as a result of evolutionary steps (alterations shown in 
red).
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6.4 Suspended oscillations revisited
Previously, the initial NF-k B:E2F-1 mathematical model was tested through prediction 
of suspended nucleo-cytoplasmic oscillations in p65-dsRedXP when co-transfected 
with a plasmid expressing EGFP-E2F-1 and stimulated with TNFa (Figure 5.12). It is 
now possible to revisit this work, firstly to show that the Mk.ll mathematical model is 
capable of similar predictions, albeit through differing mechanisms (Figure 6.8). Here it 
is shown that the suspension time (equivalent to the second peak of maximum steady- 
state localisation, MNL2) is proportional to the degradation time of cytoplasmic EGFP- 
E2F-1, giving strong correlation (R2=0.972) which the model is able to reproduce. 
Interestingly, the Mkll model also reproduces the lengthening of NF-k B MNL time with 
increase in initial E2F-1 level.
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Figure 6.8 Proportional relationship between E2F-1 degradation and suspension of nucleo- 
cytoplasmic oscillations in p65-dsRedXP: A Model plots showing stimulated time courses with 
different initial levels of E2F; 0 (pink dashed line), 0.05 (orange line), 0.1 (red line), 0.2 (blue line). 
Model predicts suspension time is proportional to E2F degradation time. B Experimental data 
showing SK-N-AS cells showing different nucleo-cytoplasmic suspension times for different 
estimated degradation times (t1/2) of EGFP-E2F-1; orange-136 minutes, red- 217 minutes, blue- 
277 minutes. Pink line shows p65-dsRedXP dynamics from cell with negligible detectable level of 
EGFP-E2F-1. C Showing strong correlation between EGFP-E2F-1t1/2 time and p65-dsRedXP MNL2 
time (R2=0.972). Chart representative of 10 cells. D The model is able to reproduce high correlation 
(R2=0.83) between initial level of E2F and corresponding suspension time of oscillations, calculated 
at sum of the Nuclear Retention time and the post-peak 1 Maximum Nuclear Localisation time.
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6.5 Discussion -  Variability in NF-kB dynamics
To summarise at this point, the Mk.ll mathematical model accurately predicts the 
suspension of nucleo-cytoplasmic oscillations, albeit through a different mechanism to 
the initial model (described in Section 5.4) Figure 6.9 shows the relationship between 
degradation of cytoplasmic E2F and the rise in IKK activity affecting the overall 
dynamics of nuclear NFkB. Progressive activation of IKK leads to nucleo-cytoplasmic 
oscillations in NFkB, which approach a steady-state.
0s
J3 NR MNL2
Figure 6.9 The NF-kB:E2F-1 mathematical model Mk.ll: Showing degradation of cytoplasmic 
E2F (green line) and resultant rise in IKK activity (purple line), leading to nucleo-cytoplasmic 
oscillations in NFkB (red line) in response to TNFa stimulation. Pink dashed line shows “normal” 
NF-k B oscillations, generated with E2Fset to zero.
The Mk.ll model suggests a dual role for E2F-1 in control of the NF-k B system. Firstly, 
interaction with IKK may delay the first peak of nuclear localisation (MNL) expected 
with TNFa stimulation in the absence of exogenous E2F-1 to occur within 30 minutes 
(Section 1.3.3). Secondly, direct interaction between E2F-1 and the NF-k B dimer 
(p65:p50) may delay translocation back to cytoplasmic state (NR), expected in the 
absence of exogenous E2F-1 to occur within 50 minutes (Section 1.3.3).
This suggests an interesting competitive effect between nuclear sequestration by E2F- 
1 which is periodically expressed throughout the cell cycle and cytoplasmic
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sequestration by Ik Bo which is constitutively produced, allowing a second conceptual 
model to be drawn (Figure 7.3) Intuitively one would expect a population of cells 
stimulated with TNFa to show consequential variability in the dynamics of the first peak 
of p65-dsRedXP nuclear occupancy dependant on the level of endogenous E2F-1 
coincident with stimulation time. Figure 6.10 shows first peak dynamics for a population 
of SK-N-AS cells transfected with a plasmid vector expressing p65-dsRedXP alone. 
From the point of stimulation, it can be seen that MNL time varies between 15-45 
minutes and that NR time can vary between 40-120 minutes.
Figure 6.10 Variability in p65-dsRedXP dynamics in SK-N-AS cells: Showing variability in both 
MNL time and NR time of p65-dsRedXP from point of stimulation (black arrow), in cells with similar 
expression levels of p65-dsRedXP.
In order to properly characterise this variability as an effect of E2F-1 it was decided to 
examine the relationship between endogenous E2F-1 and p65:p50. To do this the 
physiological profile of E2F-1 must be considered, placing interaction between E2F-1 
and the NF-k B system within an endogenous context, that of inflammatory response at 
the G1/S checkpoint of the mammalian cell cycle.
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7.1 Introduction and rationale
At this stage we have conceptual and mathematical models of the NF-k B:E2F-1 
system based on exogenous studies. Work on the exogenous system has suggested 
E2F-1 provides a source of variability to NF-k B signalling (Figure 5.9 and 6.8). In this 
chapter we will begin to expand the context of the NF-k B:E2F-1 system to the cell 
cycle. Work on the endogenous system was hoped to both support exogenous studies 
and provide a more physiologically significant model for the NF-k B:E2F-1 system at 
G1/S.
Despite this shift of focus, attempts were made to link exogenous expression of p65- 
dsRedXP and EGFP-E2F-1 to cell cycle events, yielding interesting results. Figure 7.1 
shows the fluorescence dynamics of representative SK-N-AS cell stimulated at to with 
TNFa before and after Mitosis. Nucleo-cytoplasmic oscillations in the parent cell can 
clearly be seen, which lead to predominant nuclear localisation immediately prior to the 
start of Mitosis. Fluorescence traces from the two daughter cells are first observable 10 
hours after this point, and the two daughter cells show different NR dynamics 
dependant on the comparative levels of p65-dsRedXP to EGFP-E2F-1 at the time of 
the first peak (consistent with Section 5.5).
Figure 7.1 Imaging parent and daughter cells: Showing a representative SK-N-AS cell 
expressing EGFP-E2F-1 and p65-dsRedXP in the presence of TNFa. Cell shows oscillations in 
p65-dsRedXP and takes a nuclear localisation prior to the start of Mitosis. Daughter cells imaged 
from point of first observable fluorescence.
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7.2 Conceptual and experimental models for cell cycle studies
In order to investigate the relationship between endogenous E2F-1 and NF-k B 
signalling dynamics it is necessary to develop an experimental model for cell cycle 
synchronisation so as to obtain populations of cells with different levels of E2F-1. 
Double Thymidine block is a common method to obtain late G1 synchronisation of 
HeLa cells ((Whitfield et al. 2000; Whitfield et al. 2002), described in detail in Section 
2.2.2.3) This was chosen as a suitable synchronisation model to extend the SK-N-AS 
exogenous work as HeLa cells display similar NF-k B dynamics to SK-N-AS cells in 
response to TNFa (Nelson et al. 2004). The Double Thymidine Block protocol was 
found to give highly effective synchronisation in HeLa cells (Figure 7.2) and was easily 
adapted for different experimental procedures, as outlined below.
DNA Content (P.l. fluorescence) DNA Content (P.l. fluorescence)
Figure 7.2 Flow Cytometric DNA Analysis of Thymidine synchronisation model: Showing 
populations of HeLa cells assessed for DNA content at various stages after release from Double 
Thymidine Block synchronisation. The data indicate a gradual increase in DNA content at 
increasing times from release, concurrent with cell cycle progression and hence effective 
synchronisation.
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Application of the experimental synchronisation model to characterisation of the 
relationship between endogenous E2F-1 and the NF-k B system requires a new 
conceptual model to be drawn (Figure 7.3).
Figure 7.3 Conceptual “catch” model: NF-kB response at different cell cycle stages: A
Showing a NF-k B response with E2F-1 at low level, similar to 90% cell cycle, giving MNL time of 
30 minutes and NR time of 50 minutes. B Resting equilibrium at G1/S phase, giving NF-k B a 
predominantly cytoplasmic state whilst E2F-1 remains predominantly nuclear. C An NF-KB 
response at G1/S, giving MNL and NR times longer than A due to inhibition of IKK by cytoplasmic 
E2F-1 and sequestration of p65:p50 by nuclear E2F-1.
The conceptual “catch” model for NF-k B response at G1/S suggests that association 
between E2F-1 and the p65:p50 NF-k B dimer may not occur in unstimulated “resting” 
conditions. This is due to constitutive production of Ik Bq compared to periodic
122
NF-k B:E2F-1 - T h e  C e l l  C y c l e  C o n t e x t
production of E2F-1 throughout the cell cycle and a steady-state cytoplasmic 
localisation of the Ik BccNF-k B complex in resting conditions, in contrast to E2F-1 
which is periodically expressed and takes a predominantly nuclear localisation. As such 
there is predicted to be a clear difference between endogenous and exogenous resting 
phenotypes, due to exogenous expression of p65-dsRedXP and EGFP-E2F-1 both 
increasing the amount of free NF-k B in the cell and creating an excess of E2F-1 
relative to Ik Bo .
The situation changes with the addition of TNFa. With NF-k B held in the cytoplasm by 
Ik Bo , stimulation leads to the translocation of NF-k B into the nucleus. If this coincides 
with a cell cycle phase at which the level of E2F-1 is low (such as G2 phase), the 
Maximum Nuclear Localisation (MNL) time and Nuclear Retention (NR) time of NF-k B 
is predicted to be short compared to a response coinciding with high E2F-1 levels at 
G1/S. Figuratively, E2F-1 is able to “catch” the NF-k B dimer and sequester it in the 
nucleus.
Concurrent to the development if this new conceptual model, Thymidine 
synchronisation was tested for the ability to generate a cell cycle profile for E2F-1 and 
E2F-4 equivalent to the current view held in the literature (shown in Figure 7.4, 
reviewed in (Tsantoulis et al. 2005)). Figure 7.4 shows a delay in the peak of 
endogenous E2F-4 protein compared to E2F-1. E2F-1 is shown to rise to a peak at 2 
hours after release from Thymidine block, giving a G1/S timing consistent with FACS 
data shown in Figure 7.3.
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A
E2F-1 E2F-4
0 2 4 8  24 0 2 4 8  24
Time after Thymidine release (hrs) Time after Thymidine release (hrs)
B
Figure 7.4 E2F profiles achieved through Thymidine synchronisation: A Showing 
synchronised populations of Hela cells sampled at intervals after release and probed for E2F-1 or 
E2F-4 via Immuno-blot. B Showing quantification of the blots in A, normalised to Cyclophilin A 
levels. The profiles show a peak of E2F-1 at 2 hours after release from Thymidine block.
A physiological profile for E2F-1 allowed us to derive an experimental model from the 
conceptual model with which to test conceptual hypotheses in Figure 7.3 (Figure 7.5). 
Following the 72-hour Double Thymidine Block synchronisation protocol (Section 
2.2.2.3), HeLa cells are released from arrest (at a time designated TO) re-entering the 
cell cycle synchronised in late G1 phase. Taking into account the -3 0  minute delay 
between TNFa stimulation and total nuclear localisation in non-synchronised cells 
(Section 1.3.3), cells were stimulated with TNFa 30 minutes prior to points of interest in 
the cell cycle, thus providing a suitable experimental model for comparing NF-k B 
dynamics coincident with different endogenous levels of E2F-1.
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Figure 7.5 Experimental model: NF-kB response at different cell cycle stages: Upon release 
from Thymidine block (see text for details) cellular populations are lysed at points in the cell cycle 
with different levels of E2F-1 (green line), 2 hours (peak), 4 and 8 hours. NF-k B stimulation to 
coincide with these time points (red line) optionally occurs 30 minutes prior to lysis.
7.3 Endogenous localisation and binding of E2F-1 and NF-kB
Figure 7.6 shows Immuno-CytoChemistry data for populations of HeLa cells fixed at 
2hours, 4hours and 8 hours after release from Thymidine. All dishes were stimulated 
with TNFa 30 minutes prior to fixation and were stained for both E2F-1 and p65 
Immuno-fluorescence. It is clear in both stimulated and non-stimulated samples that a 
higher proportion of cells have high levels of E2F-1 nuclear fluorescence at 2 hours 
than at 4 or 8 hours. This result concurs with the peak of E2F-1 protein at G1/S 
(Section 1.2.3, Figure 7.4). Interestingly, staining for p65 revealed a higher proportion 
of cells with high N:C fluorescence in stimulated samples coinciding with the peak of 
E2F-1 at 2 hours, compared to 4 hours and 8 hours. This result supports the theory that 
E2F-1 acts to sequester NF-k B in the nucleus in a proportional manner (Section 4.7). 
Both synchronised and non-synchronised non-stimulated samples showed a 
predominant cytoplasmic localisation for p65 as assumed by the conceptual model.
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Figure 7.6 Immuno-cytochemistry to assess p65 and E2F-1 co-localisation in HeLa cells: A
Showing populations of HeLa cells treated as indicated, showing red immuno-fluorescence (E2F-1) 
and green immuno-fluorescence (p65). B Quantification of cellular populations indicated in A. Black 
bars indicate staining for E2F-1, red bars indicate staining for p65, stimulation to coincide with cell 
cycle time points as indicated. Controls used include non-synchronised, stimulated (NSY ST); non- 
synchronised, non-stimulated (NSY NST); and synchronised, non-stimulated (SY NST); Solid 
colour indicates N:C Ratio >2, broken colour >1, no colour <1. Data sets involve 50+ cells per 
condition.
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Interestingly, these data suggest a cell cycle dependant change in localisation for E2F- 
1. This is coincident with a change in the NF-k B response, with a TNFa response 
timed 8 hours after G1/S resulting in a smaller degree of nuclear p65-dsRedXP 
compared to a response timed at G1/S, but comparable to non-synchronised samples. 
These data support the G1/S “catch” model (Figure 7.3), suggesting that a response 
timed at G1/S, when E2F is predominantly nuclear, results in fast nuclear translocation 
(due to uninhibited IKK) and nuclear sequestration of NF-k B (NMR short, NR long). 
However, as E2F moves to take a cytoplasmic localisation, a response is less likely to 
illicit translocation due to inhibition of IKK by E2F-1, resulting in a long NMR time and a 
short NR time due to E2F no longer being localised to affect sequestration. Variability in 
MNL and NR times is investigated further is Section 7.6.
Analysis of endogenous binding between E2F-1 and NF-k B proved difficult as the peak 
of E2F-1 lasts for approximately 10% of the HeLa cell cycle coincident with the G1/S 
phase transition. As has been highlighted above, competition for binding of NF-k B 
between Ik Bo and E2F-1 depends on the comparative level of E2F-1 and Ik Bci. 
Endogenously, with E2F-1 at low levels for -90%  of the cell cycle, p65 is sequestered 
in the cytoplasm by k B a , whilst E2F-1 is predominantly nuclear (Similar to Figure 3.2). 
Intuitively stimulation with TNFa prior to G1/S phase was expected to give the best 
opportunity for measurement of endogenous binding.
To assess binding of E2F-1 to the NF-k B in a cell cycle context, Co- 
immunoprecipitation was performed on synchronised HeLa cells (Figure 7.7) using a 
similar model as for ICC. Unfortunately, evidence for binding between endogenous p50 
and E2F-1 was difficult to obtain due to the presence of a non-specific IgG band at 
50kDa. (Consequently, it is difficult to interpret 50kDa bands present in protein pull- 
downs of E2F-1 taken at TO, 2hours and 2hours+TNFa after release from Thymidine as 
representative of p50, although endogenous Co-immunoprecipitation was shown 
between E2F-1 and p50 in SK-N-AS cells (Section 4.4) as well as in previous work 
(Kundu et al. 1997). Similar samples were probed for p65 and yielded surprising 
results. A clear band of ~50kDa was observed, (in addition to the expected 65kDa 
band) in synchronised control samples probed for p65. Interestingly, this band appears
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in E2F-1 pull-down samples probed for p65 although the 65kDa band is absent.
B E2F-1 pull, p50 W.B.
r  A >>
IgG 2 2s Ctrl 0 IgG 2 2s Ctrl 0 
Rabbit Rabbit
Figure 7.7 Co-lmmunoPrecipitation in synchronised HeLa cells: A Showing possible cleavage 
of p65 B Showing a band at 50kDa in all pull-downs consistent with both p50 control and non 
specific IgG
The next aim was to investigate the apparent processing of p65 in HeLa cells over a 
broader time scale. Synchronised cell populations were stimulated and then lysed at 0, 
2, 4 and 8 hours after release from Thymidine. An immunoblot probed for p65 yielded 
further evidence of p65 processing (Figure 7.8).
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Figure 7.8 Assessment of p65 cleavage in synchronised, stimulated cells: A Showing 
populations of HeLa cells stimulated prior to G1/S (2s) showing 4 bands for p65 (65,55,50 and 40 
kDa) compared to different combinations of these bands in 4s 8s and non-synchronised, 
stimulated samples. Intensity of bands in all lanes summed up to similar totals. B Analysis of bands 
in A normalised to cyclophilin A
7.4 Transcriptional studies revisited
Exogenous studies predict that whilst sequestered by E2F-1 in the nucleus, NF-k B 
transcriptional activity is directed away from the Ik Bo and Ik Be promoters (Section 
6.2), contributing to delay in subsequent nucleo-cytoplasmic oscillations. These data 
suggest the hypothesis that an NF-k B response occurring after the peak of E2F-1 in 
the cell cycle would lead to differential transcription of Ik B proteins. To investigate this 
hypothesis, Quantitative PCR was performed on samples prepared using similar 
methods to those used for the ICC work above (Figure 7.9). These data clearly show
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an increased production of both Ik Bo and Ik Be following the peak of E2F-1 at 4 hours 
and a further increase to 8 hours.
TO T2s T4s T8s TO T2s T4s T8s
Figure 7.9 IkB Levels associated with NF-k B response at different cell cycle stages: Showing 
Fold induction of Ik Bci and Ik Be from populations of HeLa cells stimulated prior to G1/S (2s) giving 
lower Ik B transcript levels than later time points. Single replicate.
To investigate the reciprocal effect of NF-k B on E2F-1 related transcription, preliminary 
work used the exogenous experimental model. Populations of HeLa cells were 
transfected with plasmid vectors expressing p65-dsRedXP and EGFP-E2F-1, EGFP- 
E2F-1 or empty vectors. Quantitative PCR was performed on these samples to assess 
the relative levels of the E2F-1 transcript (Figure 7.10). The results show a clear 
induction of E2F-1 transcription (~47 fold) in cells expressing EGFP-E2F-1 confirming 
work done using the exogenous experimental model (Chapters 4 and 5) allow for E2F 
auto-transcription to be taken into account. Interestingly, cells co-expressing p65- 
dsRedXP show a partial decrease (-20% ) in E2F-1 transcription (Figure 7.10 A). Other 
preliminary work supports a theory of NF-k B inhibition of E2F-1 mediation transcription. 
Populations of SK-N-AS cells transfected in a similar manner were assessed for their 
ability to transactivate the Cyclin E promoter of a CycE-luc luciferase reporter vector 
(Figure 7.10 B). The results show a clear induction of Cyclin E transcription (-2 5  fold)
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in cells expressing EGFP-E2F-1 and an empty-Red vector which is significantly 
reduced (-50% ) in cells co-expressing EGFP-E2F-1 and p65-dsRedXP. Moreover cells 
co-expressing EGFP-E2F-1 and empty-Red stimulated with TNFa over a 6 hour period 
show a significant reduction in Cyclin-E luciferase activity (-30% ) giving evidence that 
the endogenous NF-k B system is able to inhibit the transcriptional effect of exogenous 
E2F-1 expression.
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+
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Empty-Green EGFP-E2F-1 EGFP-E2F-1
Empty-Red Empty-Red p65-dsRedXP
Figure 7.10 Transcriptional studies on cell cycle genes in exogenous system: A Quantitative 
PCR results Showing significant fold increase in E2F-1 transcript levels resultant from EGFP-E2F-1 
expression (*) which are significant decreased by co-expression of p65-dsRedXP (**) B Showing 
luciferase reporter assay using Cyclin-E-luciferase reporter. Expression of EGFP-E2F-1 causes 
significant fold induction in Cyclin E transcription (*) which is significantly decreased by both TNFa 
stimulation (**) and co-expression of p65-dsRedXP (*).
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7.5 Apoptosis revisited
It was previously shown that exogenous expression of p65-dsRedXP significantly 
decreased cell death associated with exogenous E2F expression (Section 4.6). 
Transcription studies (Figure 7.10) suggest a possible explanation might be that 
physical interaction between E2F-1 and NF-k B is blocking E2F-1 -mediated 
transcription of genes required to move into S-Phase (E2F-1, Cyclin E), thereby 
inhibiting cell death caused by premature S-phase entry through exogenous expression 
of E2F-1 (Johnson et al. 1993; Qin et al. 1994). It was subsequently possible to 
consider the effect of TNFa stimulation in such cases. Figure 7.11 shows populations 
of SK-N-AS cells derived from imaging experiments involving expression of EGFP-E2F- 
1 in combination with either p65-dsRedXP or an empty-Red vector as indicated. The 
presence of TNFa stimulation is also indicated. Consistent with previous work (Section
4.6), the number of transfected cells at the start of imaging was calculated, and 
compared to the number of these cells that remained healthy after a 12-hour period. 
The percentage of cell death was compared across populations of at least 50 cells.
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Figure 7.11 E2F-1 related Apoptosis (II): Populations of SK-N-AS cells assessed for cell death 
over 12 hours period by live cell imaging. Showing 68% cell death due to EGFP-E2F-1 which is 
decreased by both p65-dsRedXP (28%) and TNFa stimulation (29%). Red section of bar 
represents proportion of live cells, blue represents proportion of dead cells.
Commenting on these results, it may be observed that TNFa has a clear effect on the 
level of apoptosis related to exogenous E2F-1 expression, reducing cell death by
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nearly 40%. This result is comparable with the effect of co-expression with p65- 
dsRedXP and suggests the endogenous NF-k B system is just as efficient at blocking 
E2F-1 related apoptosis and the exogenous system. Interestingly, p65-dsRedXP co­
expression in addition to TNFa stimulation has little cumulative effect on the level of cell 
death implying a threshold of efficiency for NF-k B in blocking E2F-1-mediated cell 
death.
7.6 Variability in NF-kB dynamics revisited
Previously we addressed the question of variability in the dynamics on the first peak of 
p65-dsRedXP nuclear occupancy after stimulation with TNFa in SK-N-AS cells (Section 
6.5). It was hypothesised that E2F-1 may have a dual role as a source of this variability. 
Firstly, E2F-1 extended the Maximum Nuclear Localisation (MNL) time after TNFa  
stimulation and the degradation of Ik Bo was slowed (Section 6.2) potentially through 
inhibition of IKK. Secondly, evidence was presented that E2F-1 interacted with the NF- 
k B complex (Section 4.4), sequestering it in the nucleus and silencing transcription of 
Ik Bo and Ik Be (Section 6.2) which are necessary for NF-k B secondment to the 
cytoplasm, thereby effecting the p65-dsRedXP Nuclear Retention (NR) time. 
Concurrently, both MNL and NR times have been shown to be proportional to E2F-1 
half-life in the exogenous system (Sections 5.5 and 6.4). Addressing variability in NF- 
k B dynamics in the endogenous system required further use of the synchronisation 
model (Figures 7.5 and 7.6).
A non-synchronised population of HeLa cells expressing transiently expressed p65- 
dsRedXP was imaged over a long time course (Figure 7.12, movie M7.12). The cells 
were stimulated with TNFa and assessed for their initial peak dynamics. The resultant 
data set showed high variability in MNL and NR times in response to TNFa, similar to 
identical experiments carried out in SK-N-AS cells. Interestingly, cells which divide 
within 9 hours from the point of stimulation show different p65-dsRedXP dynamics than 
cells which do not divide during the 15 hour time course. In this case, although the cells 
are “synchronous” in terms of their stimulation time, they are at different stages in the 
cell cycle when stimulus occurs. The cells 8 hours away from division, intuitively close 
to M-phase when E2F-1 levels are low, give an MNL time of -4 0  minutes and a NR
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time of ~20 minutes. The cells which are at least 15 hours away from division, 
intuitively closer to S-phase where levels of E2F-1 are higher, give an MNL time of ~80 
minutes and a NR time of ~60 minutes. This leads to the conclusion that NF-k B 
responses coincident with different phases of the cell cycle give different NF-k B 
dynamics.
A
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Figure 7.12 Variability in NF-kB dynamics in non-synchronised HeLa cells: A showing MNL 
time of 80 minutes and NR time of 60 minutes in cells at least 15 hours from Mitosis B showing 
MNL time of 40 minutes and NR time of 20 minutes in cells 8 hours from Mitosis C Analysis of 
representative cells in A and B
To further investigate this hypothesis, a population of HeLa cells expressing p65- 
dsRedXP was synchronised and released from synchronisation 2 hours before the 
expected peak of endogenous E2F-1. Live cell imaging proceeded with TNFa
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stimulation occurring 30 minutes prior to the expected peak. Figure 7.13 (movie M7.13) 
shows the first peak dynamics of a typical cell, with MNL time of ~30 minutes, and an 
NR time of ~60minutes.
A
0 30 90 240
Time (mins)
Figure 7.13 NF-kB dynamics in synchronised HeLa cells stimulated prior to G1/S: Showing 
MNL time of 30 minutes and NR time of 60 minutes
Most interestingly, when considering the non-synchronous and synchronous 
populations side-by-side it is possible to observe a high variability in the NF-k B 
dynamics of non-synchronous cells compared to a high degree of consistency in cells 
stimulated to coincide with G1/S and the peak of endogenous E2F-1 (Figure 7.14). By 
synchronising the cells in terms of cell cycle phase in addition to stimulation time the 
variability in the endogenous system has been reduced. This evidence concurs with the 
theory that TNFa-mediated NF-k B dynamics change with respect to the level of 
endogenous E2F-1.
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Time imitisi
Figure 7.14 Variability in NF-kB dynamics in synchronised and non-synchronised HeLa 
cells: A Showing high degree of variability in NF-k B dynamics of stimulated, non-synchronous 
cells. B Showing high degree of consistency in NF-k B dynamics of stimulated, synchronous cells.
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7.7 Discussion
In the work described in this chapter the aim was to place previous exogenous work 
into the context of the endogenous Cell Cycle system. Initially a conceptual model was 
developed for response at G1/S (Figure 7.3) together with an experimental model 
involving synchronisation with which to test it (Figure 7.5). To parallel exogenous work, 
evidence was obtained to support the presence of endogenous co-localisation of p65 
and E2F-1 (Figure 7.6), showing a more prevalent nuclear co-localisation across a 
cellular population stimulated prior to G1/S than at later times in the cell cycle. Although 
binding between endogenous p65 and E2F-1 in Hela cells proved difficult to reproduce 
due to technical reasons (Figure 7.7), endogenous binding in SK-N-AS cells was 
previously shown (Section 4.4). Transcriptional studies focussed on the transcription of 
Ik B proteins due to NF-k B stimulation in the endogenous system, seen to increase as 
level of E2F-1 decreases (Figure 7.9) concurrent with (Section 6.2). Further 
transcription work used an exogenous model to make preliminary investigations into 
the effect of NFk B on E2F-1 -mediated transcription (Figure 7.10). These results 
showed an NF-KB-mediated inhibition of E2F-1 transcription which was hypothesised 
to be the cause of a decrease in apoptosis linked to exogenous E2F-1 expression 
(Figure 7.11). Finally, the issue of variability in NF-k B dynamics was re-addressed in 
the endogenous system (Figures 7 .12 ,7 .13 ,7 .14), leading to the conclusion that E2F-1 
was indeed a source of variability affecting both MNL and NR timings observed for the 
NF-k B response. This presents the intriguing hypothesis that NF-k B dynamics and 
transcription profiles resulting from an inflammatory response might vary dependant on 
cell cycle phase.
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Chapter 8 - 
General Discussion
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8.1 Overall reflection on project
8.1.1 General comments
The broad aim of this project was to take a combined experimental and theoretical 
approach to characterising interaction between two intra-cellular signalling systems. In 
order to achieve these aims, it was necessary to consider precisely the requirements of 
a mathematical Systems Biology approach in this case, and to select biological and 
experimental model systems accordingly. As such, this project has tackled two 
common Systems Biology questions, “Why do I need a mathematical model?” -  to 
make predictions of a system that is too complex to suggest intuitive predictions, and 
“What does a mathematical model need?” -  model systems able to experimentally 
resolve predictions within an appropriate context.
8.1.2 Reflection on Thesis aims
This project aimed to apply a Mathematical Systems Biology approach to investigate 
the interaction between the NF-k B system and the mammalian cell cycle at G1/S (“The 
E2F system”). Initial work, however, was arguably reductionist in nature, characterising 
proteimprotein interactions between E2F-1, p65 and p50 through FRET and Co- 
ImmunoPrecipitation studies (Section 4.4). Indeed it has been claimed that “successful 
integration on a systems level must be built on successful reductlori’, although 
“reduction alone is far from sufficient' (Noble 2006). Concurrently, interaction data was 
necessary to support subsequent live cell imaging work, on which the foundation for a 
conceptual model was based (Section 4.5).
The overall outcome of this investigation has been an increased understanding of the 
relationship between NF-k B and a cell cycle regulator, E2F-1. Evidence is provided 
that suggests the NF-k B:E2F-1 interaction to be a mechanism which allows E2F-1 to 
take temporal control of the immune response. The implications of these data may be 
considered across multiple contexts.
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8.2 The NF-kB context
8.2.1 Results in perspective
This project began with work towards a conceptual model for E2F-1 interaction with the 
NF-k B system. The model took into account physical interactions between E2F-1, p65 
and p50 (Section 4.4). A functional effect of these interactions was observed to be a 
temporary silencing of NF-k B oscillations by direct sequestration of the NF-k B complex 
in the nucleus. Whilst bound, the NF-k B:E2F complex was suggested to be 
transcriptionally inactive at Ik B promoters, thereby lengthening NF-k B nuclear 
retention time (Sections 5.5 and 6.2). Through further investigation, a second 
interaction was characterised between E2F-1 and the NF-k B system which suggested 
inhibition of IKK activity, leading to a delay in NF-k B maximum nuclear localisation time 
in response to TNFa stimulation, proportional to the level of cytoplasmic E2F-1 in the 
cell (Section 6.2). Considered together, these relationships gave evidence for the role 
of E2F-1 as temporal coordinator of the NF-k B response, with high correlation between 
EGFP-E2F-1 half life and p65 dynamic timings (Section 5.5). This hypothesis was 
supported using an endogenous model to observe variability in NF-k B dynamics 
coincident with TNFa stimulation prior to different cell cycle stages (Sections 7.3 and
7.6).
The endogenous model also provided evidence that E2F-1 may change its 
predominant localisation in a cell cycle dependent manner (Figure 7.6). Intuitively, this 
suggests that NF-k B dynamics in response to TNFa may vary depending on cell cycle 
phase, due not only to the periodic expression of E2F-1, but also due to changes in 
localisation of E2F-1 (Figure 8.1). Examining this prediction, we may suggest that a 
TNFa response coinciding with G1/S, when E2F-1 is at it’s peak level and 
predominantly nuclear, may result in a maximum nuclear localisation timing 
comparable with cells in which E2F-1 levels are low (or the observed average from non 
synchronous cells), as there is comparatively little cytoplasmic E2F-1 present to inhibit 
IKK. However, the nuclear retention time associated with stimulation at G1/S is 
predicted to be elongated due to nuclear sequestration of NF-k B by nuclear E2F-1. 
Complimentarily, stimulation during S-phase, when E2F-1 is both depleted in level and 
predominantly cytoplasmic (the cytoplasmic fraction having been shown to have a
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longer half-life (Figure 6.3)) is predicted to result in an elongated MNL time due to the 
inhibition of IKK activity by E2F-1 leading to the prolonged stability of the Ik BccNF-k B 
complex. Assuming that NF-k B is only freed to translocate to the nucleus upon 
degradation of cytoplasmic E2F-1 and IKK-mediated phosphorylation of Ik Bo , the NR 
time of NF-k B in S-phase is predicted to be short due to the low level of nuclear E2F-1. 
These predictions, illustrated in Figure 8.1, are supported by the variability observed in 
NF-k B dynamics compared to stimulation timed to coincide with G1/S (Section 6.5), 
and further complimentary work is planned (Section 8.2.2).
A Stimulation early G1 Stimulation at G1&S Stimulation in S-phase
Figure 8.1 Conceptual “Catch” model Mk.ll for NF-kB:E2F-1 interaction: A Showing 
mechanisms controlling NF-k B dynamics. Stimulation in early G1 phase, when levels of E2F-1 are 
low, leads to “normal” NF-k B response (outlined in Section 1.3.1). Stimulation at G1/S, when levels 
of E2F-1 are both high and predominantly nuclear, results in nuclear sequestration of the NF-k B 
complex. Stimulation in S-phase, when E2F-1 is predominantly cytoplasmic, results in a delayed 
response due to inhibition of IKK activity. B Showing the effects of these mechanisms on the 
dynamics of NF-k B (see text for details).
1 4 2
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The NF-k B:E2F mathematical models played important roles in the development of 
these theories. Predictions were made for the proportional lengthening of both NR and 
MNL times, which were verified experimentally (Sections 5.5 and 6.4). Crucially, the 
models demonstrated that an initial assumption regarding Ik Bo transcription, whilst 
incorrect at least in part, fitted observed data (Section 5.6), thereby leading 
experimentation towards the effect of E2F-1 on the stability of Ik Bcl In fitting the 
IKK:E2F-1 relationship a model made a prediction for a difference in degradation rates 
between nuclear and cytoplasmic E2F-1 species, which has since been shown to be 
the case (Section 6.3). From a Systems Biology perspective, this study makes a 
contribution towards the eventual goal of linking the NF-k B system to the G1/S system, 
as illustrated in Figure 8 .2 ..
Figure 8.2 Review of steps taken towards coupling the NF-kB and G1/S linked systems: A1
and A2 Showing models defined for NF-k B and, hypothetically, for G1/S progression, system A1 
has a unique input, TNFa stimulation, and output, p65-dsRedXP dynamics. A# Model A2 is 
expanded to include interaction between protein ‘p65’ (system A2, NF-k B) and protein ‘E2F-1’ 
(system A1, G1/S). Interaction between p65 and E2F-1 may now be considered within the context 
of system A2 (NF-k B). B Expansion of A# to encompass system A1 (G1/S progression).
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8.2.2 Future work
Previously, we began with a well defined model for The NF-k B system (“A-type”, Figure 
8.2). This has now been extended to include multiple interactions with E2F-1 (as a “A#- 
type” model). With a view to continuing the coupling procedure, and expanding the 
context of this model, we have a choice of how to proceed. Firstly, we may consider 
linking this A#-type model to an A-type cell cycle model providing a suitable 
physiological profile for endogenous E2F-1. However, experimentation in a cell cycle 
context will require the development of new experimental model systems (considered in 
Section 8.5). Secondly, within the NF-k B context, future development of the A#-type 
model may proceed by considering interactions between NF-k B and other cell cycle 
proteins from the G1/S system.
A p65-dsRedXP + EGFP-E2F-3 (high) B p65-dsRedXP + EGFP-E2F-2 (high)
p65-dsRedXP + EGFP-E2F-3 (low) p65-dsRedXP + EGFP-E2F-2 (low)
Figure 8.3 Localisation of transiently expressed p65 with E2F-2 and E2F-3 fluorescent 
reporter proteins: Showing SK-N-AS cells transfected with plasmid vectors expressing 
combinations of fluorescent fusion proteins. A The effects of high and low levels of EGFP-E2F-3 on 
p65-dsRedXP localisation, suggesting a dynamic relationship and nuclear sequestration similar to 
the effect of EGFP-E2F-1 on p65-dsRedXP. B The effects of high and low levels of EGFP-E2F-2 
on p65-dsRedXP localisation (no change).
Figure 8.3 shows preliminary work investigating the effect of expression of EGFP-E2F- 
2 and EGFP-E2F-3 on p65-dsRedXP localisation. Interestingly, nuclear co-localisation 
between EGFP-E2F-1 and p65-dsRedXP appears to be common to EGFP-E2F-3 but 
not to EGFP-E2F-2. Although there is a high degree of structural and functional 
similarity between E2F-1, 2 and 3, E2F-2 has also been shown to have distinct roles
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(Opavsky et al. 2007; Infante et al. 2008) Characterisation of these observations 
provides an obvious and interesting area for future investigation.
To further investigate the predictions made for different NF-k B dynamic profiles 
resulting from stimulation coincident with different stages of the cell cycle (Figure 8.1), 
further live cell imaging experiments are required to complement the data set shown in 
Figure 6.5, involving stimulation at time points later than the G1/S checkpoint. It may 
also be possible to repeat these experiments using stably transfected cell lines, 
although this is dependent on their susceptibility to synchronisation.
Throughout the course of this study, several live cell imaging experiments were carried 
out in an attempt to observe the dynamics of kBa-AmCyan in the presence of EGFP- 
E2F-1 and p65-dsRedXP. However, due to spectral overlap between EGFP and 
AmCyam fluorescence, a certain degree of “spill-over" was detected between 
fluorescence channels. This made it difficult to make definite interpretations regarding 
the dynamics of EGFP-E2F-1 or licBa-AmCyan when expressed together, although it 
looks likely from initial data that exogenous E2F-1 expression does abate apoptosis 
habitually associated with exogenous Ik Bci expression. These difficulties were 
reconciled by imaging EGFP-E2F-1 and p65-dsRedXP from a triple transfection with a 
plasmid vector expressing kBa-AmCyan which was not observed. We therefore 
assumed that exogenous Ik Bo was present in such experiments through the 
observation of a predominantly cytoplasmic localisation for p65-dsRedXP prior to TNFa 
stimulation (considered as 1.3.3). Further development of the experimental model to 
allow observation of all three of these proteins is desirable.
To provide insight into the effects of E2F-1 on NF-k B transcription, a generic reporter 
construct (NF-luc) was used in luciferase reporter assays (Section 4.5). The artificial 
nature of this construct, which contains a 5x NF-k B consensus sequence, makes the 
development of more accurate reporters on NF-k B transcription desirable, such as the 
creation of Bacterial Artificial Chromosome (BAC) constructs containing large promoter 
regions for NF-k B target genes. Concurrent with this approach, future studies may 
include further Q-PCR work involving an expanded set of NF-k B target genes.
The majority of this project involved work in an exogenous system, requiring a 
significant amount of subsequent work in the endogenous system to ensure the 
observed effects were physiologically “real” and not simply artefacts of transient
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transfection or ectopic expression. The move into an endogenous system required a 
change of cell line from SK-N-AS to HeLa which were able to be synchronised by 
Double Thymidine Block (Section 7.2). The development of a (synchronisable) cell line 
with stably integrated p65-dsRedXP and EGFP-E2F-1 provides perhaps the most 
beneficial direction for future development of the experimental model system.
8.3 The cell cycle context
8.3.1 Results in perspective
Although the primary focus of this work was the NF-k B system, the data gathered 
provided novel observations regarding NF-k B interaction with E2F-1 in a cell cycle 
context. Most strikingly, it was shown that exogenous E2F-1 expression caused 
apoptosis in transfected cells but that co-expression of p65-dsRedXP is enough to 
rescue a proportion of these cells from cell death (Sections 4.6 and 7.5). Similarly, 
death caused by expression of EGFP-E2F-1 alone, was partially abated by TNFa  
stimulation, suggesting that endogenous NF-k B activation blocked EGFP-E2F-1 
related apoptosis. Initial transcriptional studies suggest a possible mechanism for this 
effect, with EGFP-E2F-1-mediated expression of both E2F-1 and Cyclin E impaired by 
co-expression of p65-dsRedXP, possibly abating premature S-phase entry habitually 
associated with E2F-1 related apoptosis (Section 7.4). As such, a more comprehensive 
study of transcriptional activity associated with the NF-k B:E2F-1 complex is desirable, 
possibly utilising Chromatin-lmmunoPrecipitation (ChIP) at E2F-1 and NF-k B 
responsive promoters. Complimentarily, in the near future it is intended to begin a 
collaboration working towards predicting a structure for the NF-k B:E2F-1 complex.
In addition, evidence was provided for differential degradation of E2F-1 in different 
cellular compartments (Section 6.3). Initial work characterising the localisation of E2F-1 
have shown both exogenous and endogenous protein to take a predominantly nuclear 
localisation (Sections 4.2 and 7.3), however the localisation of endogenous E2F-1 has 
been observed to change, to predominantly cytoplasmic, as the cell proceeds into S- 
phase away from the G1/S checkpoint (Figure 7.3). Although exogenous, GFP-tagged, 
E2F-1 has not been seen to consistently change localisation when ectopically 
expressed alone, initial work involving SK-N-AS cells co-expressing E2F-1 and Cyclin
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E fluorescent fusion proteins does show variation in the localisation of exogenous E2F- 
1 (Figure 8.4). This preliminary work supports the idea of interaction with Cyclin E as a 
mechanism influencing the localisation of E2F-1, which has been previously 
hypothesised in theoretical studies (Baguley et al. 2005).
CyclinE-EGFP + dsRedXP-E2F-1 (high)
CyclinE-EGFP + dsRedXP-E2F-1 (low)
Figure 8.4 Localisation of transiently expressed E2F-1 and Cyclin E fluorescent reporter 
proteins: Showing SK-N-AS cells transfected with plasmid vectors expressing combinations of 
fluorescent fusion proteins. The effects of CyclinE-GFP on high and low levels of EGFP-E2F-1 
localisation, consistent wih a dynamic relationship.
8.3.2 Future work
Within a cell cycle context, there is considerable opportunity for live cell imaging 
experiments applied to the characterisation of cell cycle events, such as the use of 
fluorescent cell cycle markers of restriction point transition (Sakaue-Sawano et at. 
2008) in cancer cell lines, or a live cell imaging approach to investigating the nucleo- 
cytoplasmic shuttling of Cyclin complexes (Jackman et at. 2002). Indeed, arguably the 
biggest priority for future work is characterisation of the potential oscillatory relationship 
between Cyclin E and E2F-1, which may be investigated using a similar systems-level 
approach to that applied in this study.
Within the context of NF-k B interaction with the cell cycle, preliminary results suggest 
further evidence for oscillatory behaviour of EGFP-E2F-1, in this case upon ectopic co­
expression of p50 precursor protein p105 in unstimulated conditions (Figure 8.5, movie
147
References
M8.5). This observation may suggest a role for the NF-k B system in regulating the 
nuclear occupancy of E2F-1 in certain situations.
time (mins)
Figure 8.5 Localisation of transiently expressed E2F-1 and p105 fluorescent reporter 
proteins: Showing SK-N-AS cells transfected with plasmid vectors expressing EGFP-E2F-1 and 
p105-dsRedXP. A time course showing oscillatory behaviour in EGFP-E2F-1 in unstimulated 
conditions.
The development of experimental models for cell cycle studies has already begun, 
such as the procurement of knock-out MEF cell lines for E2F proteins (Wu etal. 2001), 
and the design of cloning strategies for expression vectors involving cell cycle proteins 
under endogenous promoters. These approaches may be combined in the future with 
emergent time-lapse FRET techniques involving expression vectors with photo­
convertible fluorophores, allowing FRET to be assessed in real time at various cell 
cycle stages.
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8.3.3 The Systems Biology of the cell cycle
Consideration of the characterisation of the NF-k B:E2F-1 interaction alongside initial 
work in a cell cycle context provides an impetus for the coupling of the NF-k B:E2F 
model with an A or A#-type model for cell cycle progression to form a “B-type” model 
(recalling definitions from Figure 8.2) for NF-k B interaction with E2F-1 within the 
context of G1/S progression.
There have been many Systems Biology approaches to modelling cell cycle 
progression. Current modelling approaches vary in level of abstraction from the entire 
mammalian cell cycle (Basse et al. 2003) to G1/S progression (Qu et al. 2003; Novak 
etal. 2004; Haberichter etal. 2007) to a consideration of feedback loops involving E2F- 
1 at G1/S (Baguley et al. 2005; Yao et al. 2008). These approaches are often carefully 
abstracted from complex conceptual models (Kohn 1999; Calzone et al. 2008), the 
circuitry of which may hide “a central cell-cycle engine (Novak et al. 2004). The 
importance of a carefully drawn conceptual model is clear in the literature, but so too is 
the need for a justifiable rationale for taking the interdisciplinary approach, with 
modelling approaches used to suggest “gaps” in the current view of a system 
(Haberichter et al. 2007). It has even been argued that the complexities of cancer can 
only be fully understood through Systems Biology approaches (Hornberg etal. 2006). 
The creation of a cell cycle model for coupling to the NF-k B model has the immediate 
advantage that a more realistic profile for E2F-1 can be generated. This would provide 
a suitable physiological context with which to investigate the predictions made for the 
role of E2F-1 in coordinating the dynamics of an NF-k B response (Figure 8.1).
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8.5 G1/S Response context -  Physiological perspective
The balance model for response at G1/S previously hypothesised for both the p53 and 
NF-k B systems (Sections 1.2.5.2 and 1.3.4) is generalised in Figure 8.6. We may now 
consider the similarities between p53 and NF-k B related mechanisms controlling 
temporary arrest of the cell cycle.
Figure 8.6 G1/S “Balance” model: Showing the processes Involved in temporary arrest at G1/S, 
involving arrest of the cell cycle, a period of balance whereby cell fate decisions are coordinated. 
The outcome may be apoptosis, senescence, differentiation or the resumption of proliferation.
Both p53 and NF-k B may transactivate p21 to initiate cell cycle arrest (el-Deiry et al. 
1993; Hinata et al. 2003), and Cyclin D1 to encourage proliferation (Spitkovsky et al. 
1995; Guttridge etal. 1999), placing both systems in a G1/S context. Resumption of the 
cell cycle is dependent on a period of balance during which cell fate decisions are 
made. Both p53 and NF-k B have strong links to apoptosis (Kucharczak et al. 2003; 
Braithwaite etal. 2006), differentiation (Feng etal. 1999; Stiewe 2007) and senescence 
(Shay et al. 1991; Helenius et al. 1996), reviewed futher in (Mathon et al. 2001). 
However, for these processes to be coordinated within a G1/S context, one would 
expect temporal regulation by G1/S proteins in order to appropriately govern cell fate 
decisions prior to S-phase.
Accordingly, p53 has been previously shown to interact directly with E2F-1. E2F-1 
binds to p53 at a region which overlaps the p53 NES thereby retaining active p53 in the 
nucleus (O'Connor et al. 1995; Hsieh et al. 2002). This binding is overturned by p53-
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mediated transcription of inhibitor MDM2, which leads to the export of p53 to the 
cytoplasm whilst stabilising E2F-1 (Zhang et al. 2005) and by increasing levels of 
Cyclin A, which competes with p53 for binding to E2F-1 ending E2F-related 
transcription (Peeper et al. 1995; Hsieh et al. 2002). This story is startlingly similar to 
the story presented in this work, NF-k B binds directly to E2F-1 and is retained in the 
nucleus (Sections 4.3 and 5.5), subsequent translocation to the cytoplasm is 
dependant on the transcription of inhibitor Ik Bo (Section 7.4) and proportional to E2F-1 
degradation (Section 6.4). Both balance models therefore intuitively lead not only to 
resumption of the cell cycle but also a re-set steady state for both p53 and NF-k B 
systems.
The interactions between G1/S proteins and p53 or G1/S proteins and NF-k B, that 
contribute to cell cycle suspension, balance and resumption of the cell cycle have been 
previously described (Sections 1.2.5.1 and 1.3.4) and are summarised in detail in 
Figures 8 .7 ,8 .8  and 8.9 respectively.
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Figure 8.7 G1/S Balance model -  cell cycle suspension mechanisms for p53 and NF-k B: 
SUSPENSION (p53) Showing p53-mediated induction of p21, CDKI for CDK4, inhibition of E2F-1 
by p53 activator p14 and direct binding between E2F-1 and p53 at a region which prevents re­
associated between pRB and E2F-1 and S-phase entry. See text for details. SUSPENSION (NF- 
k B) Showing NF-KB-mediated induction of p21, IKK inhibition of CDK4, and binding between NF-
k B and E2F-1 which inhibits E2F-1-mediated transcription of E2F-1 and Cyclin E, as shown in this 
study. See text for details. Solid black lines represent direct processes, dotted lines represent
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indirect and delayed processes. An arrowhead represents positive regulation, a flat-head line 
represents repression. Large arrows mark the transition between cell cycle stages. Red lines 
represent mechanisms contributing to cell cycle arrest.
153
References
Figure 8.8 G1/S Balance model -  G1/S-mediated co-ordination of p53 and NF-kB signalling: 
BALANCE (p53) Showing E2F-1-mediated induction of p14, activator of p53 and the direct binding 
of E2F-1 to p53 at a region which overlaps the p53 NES, which is overturned by Cyclin A 
phosphorylation, a target gene of E2F-1. See text for details. BALANCE (NF-kB) Showing E2F-1- 
mediated inhibition of IKK and NF-KB-mediated transcription of Ik B proteins, as shown in this 
study. See text for details.
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Figure 8.9 G1/S Balance Model -  cell cycle resumption mechanisms for p53 and NF-kB: 
RESUMPTION (p53) Showing p53-mediated transcription of Cyclin D, and MDM2 which releases 
p53 from binding to E2F-1, whilst stabilising E2F-1. E2F-1 can then be targeted for phosphorylation 
by Cyclins A and E. The p53 system is “reset” to a dormant state. See text for details. 
RESUMPTION (NF-kB) Showing transcription of Cyclin D, and, as shown in this study, 
transcription of Ik Bci at a point at which NF-k B is unbound from E2F-1. The NF-k B system is 
“reset” to a dormant state. See text for details.
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The development of live cell imaging techniques for cell cycle studies may also provide 
the opportunity to investigate the relationship between localisation of Cyclin A, p53 and 
E2F-1 outlined above. Indeed, the balance model provides arguably the most intriguing 
area for future investigation, given the mechanistic similarities between p53 and NF-k B 
responses within a G1/S context, and published interaction between the p53 and NF- 
k B systems (Webster etal. 1999; Chang 2002; Furuya etal. 2007) considered further 
in (Tergaonkar et al. 2007). Complementarity to the development of these models, the 
concept of temporary delay at G1/S is implicit in the current views of both p53 and NF- 
k B systems (Braithwaite et al. 2006; Perkins et al. 2006; Maddika et al. 2007) with 
recent studies characterising an NF-KB-mediated “short-term cell cycle block” (Penzo 
et al. 2009) and a similar model for p53 (Toettcher et al. 2009). The work presented is 
therefore believed to concur fully with the current view of NF-k B immune response 
G1/S and allows logical comparisons to be drawn with p53-mediated DNA damage 
response at G1/S.
Considering the NF-k B:E2F-1 interactions within the context of G1/S balance, we 
propose that the cell may act to give an inflammatory response “priority” prior to 
beginning DNA synthesis. However, during S-phase, when DNA synthesis must take 
the priority, the inflammatory response may be either delayed or abated. Interactions of 
this type provide an interesting paradigm in Systems Biology, i.e. cross-talk between 
two systems which results in a differential “switch” between systems - as one system is 
“switched on” the other is “switched off”. In contrast to what we expect when linking 
such signalling systems, interactions such as these may actually lead to a reduction in 
complexity.
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8.6 Final Comment -  The importance of metaphor
It can be argued that metaphors are essential to Systems Biology as the process of 
abstraction involves the definition of systems analogous to physiological context. 
However, metaphor serves a further purpose in aiding understanding, particularly when 
comparing similar processes with shared properties (Noble 2006). For example, as 
highlighted in Chapter 1, oscillatory processes have been seen to span periods of time 
from fractions of a second/minutes (Calcium) to minutes/hours (NF-k B, p53, 
segmentation clock) to hours/days (circadian clock and cell cycle). We considered the 
possibility that interactions between these dynamic processes may well link together 
like the cogs in a clockwork mechanism. The clock metaphor is well established for 
circadian rhythms (Pittendrigh 1957; Dunlap 1999) and the cell cycle (Sherr 1996; 
Morgan 1997), in which oscillatory behaviour is generated by multiple levels of 
feedback, controlling phase transition. The strength of the clock metaphor in these 
cases is that key events are ‘limed” by the use of oscillations (considered in detail in 
(Rensing etal. 2001)).
I propose that the clockwork metaphor may be taken a step further to consider the 
Balance model characterised in this work (Figure 8.5) in similar terms, i.e. as an 
integral component of the cell cycle clock. The control of the “pace” of proliferation 
through a restriction point may well be analogous to the way in which an escapement 
mechanism controls the pace of a pendulum. This analogy has been considered 
previously, albeit for different mechanisms, in bacteria (Holtzendorff etal. 2004).
Denis Noble, pioneer of work modelling ion wave patterns across the human heart 
(DiFrancesco etal. 1985; Noble 2006), has recently underlined the importance of such 
metaphors to highlighting the principles of Systems Biology (Noble 2006). Noble 
chooses to compare collaboration and subtlety in protein interaction to musical 
orchestration, as an answer to the question of complexity arising from a relative small 
genome (the “organ of 30,000 pipes”), an analogy we have recently sought to apply to 
single cell model systems (Ankers etal. 2008), and others have compared to oscillatory 
patterns of gene activation (Sun et al. 2008). “Different, even competing metaphors”, 
Noble claims, “can illuminate different aspects of the same situatioii’, but are merely 
“ladders to understanding... Once you have climbed them, you can throw them aw a f.
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A1.1 Complete plots for NF-kB:E2F-1 model Mk.l
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I) Total E2F
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Figure A.1 Model plots for species in the NF-k B:E2F-1 model Mk.l: Showing traces 
representing exogenous expression of p65 with TNFa stimulation (blue line), exogenous 
expression of p65 and E2F-1 without TNFa stimulation (black line) and exogenous expression of 
p65 and E2F-1 with TNFa stimulation (red line).
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A1.2 Complete plots for NF-kB:E2F-1 model Mk.ll
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Figure A.2 Model plots for species in the NF-kB:E2F-1 model Mk.ll: Showing traces 
representing exogenous expression of p65 with TNFa stimulation (blue line), exogenous 
expression of p65 and E2F-1 without TNFa stimulation (black line) and exogenous expression of 
p65 and E2F-1 with TNFa stimulation (red line).
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